Clustering NN O
of IN O
missense JJ O
mutations NNS O
in IN O
the DT O
ataxia NN B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
in IN O
a DT O
sporadic JJ B-Disease
T NNP I-Disease
- : I-Disease
cell NN I-Disease
leukaemia NN I-Disease
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
is VBZ O
a DT O
recessive JJ B-Disease
multi NN I-Disease
- : I-Disease
system NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
at IN O
11q22 CD O
- : O
q23 NN O
( ( O
ref NN O
. . O
3 CD O
) ) O
. . O

The DT O
risk NN O
of IN O
cancer NN B-Disease
, , O
especially RB O
lymphoid JJ B-Disease
neoplasias NN I-Disease
, , O
is VBZ O
substantially RB O
elevated VBN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
and CC O
has VBZ O
long RB O
been VBN O
associated VBN O
with IN O
chromosomal JJ O
instability NN O
. . O

By IN O
analysing VBG O
tumour JJ B-Disease
DNA NN O
from IN O
patients NNS O
with IN O
sporadic JJ B-Disease
T NNP I-Disease
- : I-Disease
cell NN I-Disease
prolymphocytic JJ I-Disease
leukaemia NN I-Disease
( ( O
T NNP B-Disease
- : I-Disease
PLL NN I-Disease
) ) O
, , O
a DT O
rare JJ O
clonal JJ B-Disease
malignancy NN I-Disease
with IN O
similarities NNS O
to TO O
a DT O
mature NN B-Disease
T NNP I-Disease
- : I-Disease
cell NN I-Disease
leukaemia NN I-Disease
seen VBN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
, , O
we PRP O
demonstrate VBP O
a DT O
high JJ O
frequency NN O
of IN O
ATM NNP O
mutations NNS O
in IN O
T NNP B-Disease
- : I-Disease
PLL NN I-Disease
. . O

In IN O
marked VBN O
contrast NN O
to TO O
the DT O
ATM NNP O
mutation NN O
pattern NN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
, , O
the DT O
most RBS O
frequent JJ O
nucleotide NN O
changes NNS O
in IN O
this DT O
leukaemia NN B-Disease
were VBD O
missense JJ O
mutations NNS O
. . O

These DT O
clustered VBN O
in IN O
the DT O
region NN O
corresponding VBG O
to TO O
the DT O
kinase NN O
domain NN O
, , O
which WDT O
is VBZ O
highly RB O
conserved VBN O
in IN O
ATM NNP O
- : O
related JJ O
proteins NNS O
in IN O
mouse NN O
, , O
yeast NN O
and CC O
Drosophila NNP O
. . O

The DT O
resulting VBG O
amino JJ O
- : O
acid NN O
substitutions NNS O
are VBP O
predicted VBN O
to TO O
interfere VB O
with IN O
ATP NNP O
binding VBG O
or CC O
substrate JJ O
recognition NN O
. . O

Two CD O
of IN O
seventeen NN O
mutated VBN O
T NNP B-Disease
- : I-Disease
PLL NN I-Disease
samples NNS O
had VBD O
a DT O
previously RB O
reported VBN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
allele NN O
. . O

In IN O
contrast NN O
, , O
no DT O
mutations NNS O
were VBD O
detected VBN O
in IN O
the DT O
p53 NN O
gene NN O
, , O
suggesting VBG O
that IN O
this DT O
tumour NN B-Disease
suppressor NN O
is VBZ O
not RB O
frequently RB O
altered VBN O
in IN O
this DT O
leukaemia NN B-Disease
. . O

Occasional JJ O
missense NN O
mutations NNS O
in IN O
ATM NNP O
were VBD O
also RB O
found VBN O
in IN O
tumour JJ B-Disease
DNA NN O
from IN O
patients NNS O
with IN O
B NNP B-Disease
- : I-Disease
cell NN I-Disease
non SYM I-Disease
- : I-Disease
Hodgkins VBZ I-Disease
lymphomas FW I-Disease
( ( O
B NNP B-Disease
- : I-Disease
NHL NN I-Disease
) ) O
and CC O
a DT O
B NNP B-Disease
- : I-Disease
NHL NNP I-Disease
cell NN O
line NN O
. . O

The DT O
evidence NN O
of IN O
a DT O
significant JJ O
proportion NN O
of IN O
loss NN O
- : O
of IN O
- : O
function NN O
mutations NNS O
and CC O
a DT O
complete JJ O
absence NN O
of IN O
the DT O
normal JJ O
copy NN O
of IN O
ATM NNP O
in IN O
the DT O
majority NN O
of IN O
mutated JJ O
tumours NNS B-Disease
establishes VBZ O
somatic JJ O
inactivation NN O
of IN O
this DT O
gene NN O
in IN O
the DT O
pathogenesis NN O
of IN O
sporadic JJ B-Disease
T NNP I-Disease
- : I-Disease
PLL NN I-Disease
and CC O
suggests VBZ O
that IN O
ATM NNP O
acts VBZ O
as IN O
a DT O
tumour NN B-Disease
suppressor NN O
. . O

As IN O
constitutional JJ O
DNA NNP O
was VBD O
not RB O
available JJ O
, , O
a DT O
putative JJ O
hereditary JJ O
predisposition NN O
to TO O
T NNP B-Disease
- : I-Disease
PLL NN I-Disease
will MD O
require VB O
further JJ O
investigation NN O
. . O
. . O

Myotonic NNP B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
is VBZ O
involved VBN O
in IN O
the DT O
modulation NN O
of IN O
the DT O
Ca2 NNP O
+ NNP O
homeostasis NN O
in IN O
skeletal JJ O
muscle NN O
cells NNS O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
, , O
the DT O
most RBS O
prevalent JJ O
muscular JJ B-Disease
disorder NN I-Disease
in IN O
adults NNS O
, , O
is VBZ O
caused VBN O
by IN O
( ( O
CTG NNP O
) ) O
n SYM O
- : O
repeat NN O
expansion NN O
in IN O
a DT O
gene NN O
encoding VBG O
a DT O
protein NN O
kinase NN O
( ( O
DM NNP B-Disease
protein RB O
kinase VBD O
; : O
DMPK NNP O
) ) O
and CC O
involves VBZ O
changes NNS O
in IN O
cytoarchitecture NN O
and CC O
ion NN O
homeostasis NN O
. . O

To TO O
obtain VB O
clues NNS O
to TO O
the DT O
normal JJ O
biological JJ O
role NN O
of IN O
DMPK NNP O
in IN O
cellular JJ O
ion NN O
homeostasis NN O
, , O
we PRP O
have VBP O
compared VBN O
the DT O
resting VBG O
[ NNP O
Ca2 NNP O
+ NNP O
] NNP O
i NN O
, , O
the DT O
amplitude NN O
and CC O
shape NN O
of IN O
depolarization NN O
- : O
induced JJ O
Ca2 NNP O
+ NN O
transients NNS O
, , O
and CC O
the DT O
content NN O
of IN O
ATP NNP O
- : O
driven JJ O
ion NN O
pumps NNS O
in IN O
cultured JJ O
skeletal JJ O
muscle NN O
cells NNS O
of IN O
wild JJ O
- : O
type NN O
and CC O
DMPK NNP O
[ NNP O
- : O
/ SYM O
- : O
] NN O
knockout NN O
mice NN O
. . O

In IN O
vitro JJ O
- : O
differentiated VBN O
DMPK NNP O
[ NNP O
- : O
/ SYM O
- : O
] NN O
myotubes NNS O
exhibit VBP O
a DT O
higher JJR O
resting NN O
[ JJ O
Ca2 NNP O
+ NNP O
] NNP O
i NN O
than IN O
do VBP O
wild JJ O
- : O
type NN O
myotubes NNS O
because IN O
of IN O
an DT O
altered JJ O
open JJ O
probability NN O
of IN O
voltage NN O
- : O
dependent NN O
l NN O
- : O
type NN O
Ca2 NNP O
+ NNP O
and CC O
Na NNP O
+ NNP O
channels NNS O
. . O

The DT O
mutant JJ O
myotubes NNS O
exhibit VBP O
smaller JJR O
and CC O
slower JJR O
Ca2 NNP O
+ NNP O
responses VBZ O
upon IN O
triggering VBG O
by IN O
acetylcholine NN O
or CC O
high JJ O
external JJ O
K NNP O
+ NNP O
. . O

In IN O
addition NN O
, , O
we PRP O
observed VBD O
that IN O
these DT O
Ca2 NNP O
+ NN O
transients NNS O
partially RB O
result VBP O
from IN O
an DT O
influx NN O
of IN O
extracellular JJ O
Ca2 NNP O
+ NNP O
through IN O
the DT O
l NN O
- : O
type NN O
Ca2 NNP O
+ NNP O
channel NN O
. . O

Neither CC O
the DT O
content NN O
nor CC O
the DT O
activity NN O
of IN O
Na NNP O
+ NNP O
/ NNP O
K NNP O
+ NNP O
ATPase NNP O
and CC O
sarcoplasmic JJ O
reticulum NN O
Ca2 NNP O
+ NNP O
- : O
ATPase NN O
are VBP O
affected VBN O
by IN O
DMPK NNP O
absence NN O
. . O

In IN O
conclusion NN O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
DMPK NNP O
is VBZ O
involved VBN O
in IN O
modulating VBG O
the DT O
initial JJ O
events NNS O
of IN O
excitation NN O
- : O
contraction NN O
coupling NN O
in IN O
skeletal JJ O
muscle NN O
. . O
. . O

Constitutional NNP O
RB1 NNP O
- : O
gene NN O
mutations NNS O
in IN O
patients NNS O
with IN O
isolated JJ O
unilateral JJ B-Disease
retinoblastoma NN I-Disease
. . O

In IN O
most JJS O
patients NNS O
with IN O
isolated JJ O
unilateral JJ B-Disease
retinoblastoma NN I-Disease
, , O
tumor NN B-Disease
development NN O
is VBZ O
initiated VBN O
by IN O
somatic JJ O
inactivation NN O
of IN O
both DT O
alleles NNS O
of IN O
the DT O
RB1 NNP O
gene NN O
. . O

However RB O
, , O
some DT O
of IN O
these DT O
patients NNS O
can MD O
transmit VB O
retinoblastoma VB B-Disease
predisposition NN O
to TO O
their PRP$ O
offspring NN O
. . O

To TO O
determine VB O
the DT O
frequency NN O
and CC O
nature NN O
of IN O
constitutional JJ O
RB1 NNP O
- : O
gene NN O
mutations NNS O
in IN O
patients NNS O
with IN O
isolated JJ O
unilateral JJ B-Disease
retinoblastoma NN I-Disease
, , O
we PRP O
analyzed VBD O
DNA NN O
from IN O
peripheral JJ O
blood NN O
and CC O
from IN O
tumor NN B-Disease
tissue NN O
. . O

The DT O
analysis NN O
of IN O
tumors NNS B-Disease
from IN O
54 CD O
( ( O
71 CD O
% NN O
) ) O
of IN O
76 CD O
informative JJ O
patients NNS O
showed VBD O
loss NN O
of IN O
constitutional JJ O
heterozygosity NN O
( ( O
LOH NNP O
) ) O
at IN O
intragenic JJ O
loci NN O
. . O

Three CD O
of IN O
13 CD O
uninformative JJ O
patients NNS O
had VBD O
constitutional JJ O
deletions NNS O
. . O

For IN O
39 CD O
randomly RB O
selected VBN O
tumors NNS B-Disease
, , O
SSCP NNP O
, , O
hetero SYM O
- : O
duplex JJ O
analysis NN O
, , O
sequencing NN O
, , O
and CC O
Southern NNP O
blot NN O
analysis NN O
were VBD O
used VBN O
to TO O
identify VB O
mutations NNS O
. . O

Mutations NNS O
were VBD O
detected VBN O
in IN O
21 CD O
( ( O
91 CD O
% NN O
) ) O
of IN O
23 CD O
tumors NNS B-Disease
with IN O
LOH NNP O
. . O

In IN O
6 CD O
( ( O
38 CD O
% NN O
) ) O
of IN O
16 CD O
tumors NNS B-Disease
without IN O
LOH NNP O
, , O
one CD O
mutation NN O
was VBD O
detected VBN O
, , O
and CC O
in IN O
9 CD O
( ( O
56 CD O
% NN O
) ) O
of IN O
the DT O
tumors NNS B-Disease
without IN O
LOH NNP O
, , O
both DT O
mutations NNS O
were VBD O
found VBN O
. . O

Thus RB O
, , O
a DT O
total NN O
of IN O
45 CD O
mutations NNS O
were VBD O
identified VBN O
in IN O
tumors NNS B-Disease
of IN O
36 CD O
patients NNS O
. . O

Thirty NNP O
- : O
nine CD O
of IN O
the DT O
mutations NNS O
- : O
including VBG O
34 CD O
small JJ O
mutations NNS O
, , O
2 CD O
large JJ O
structural JJ O
alterations NNS O
, , O
and CC O
hypermethylation NN O
in IN O
3 CD O
tumors NNS O
- : O
were VBD O
not RB O
detected VBN O
in IN O
the DT O
corresponding JJ O
peripheral JJ O
blood NN O
DNA NN O
. . O

In IN O
6 CD O
( ( O
17 CD O
% NN O
) ) O
of IN O
the DT O
36 CD O
patients NNS O
, , O
a DT O
mutation NN O
was VBD O
detected VBN O
in IN O
constitutional JJ O
DNA NNP O
, , O
and CC O
1 CD O
of IN O
these DT O
mutations NNS O
is VBZ O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
reduced JJ O
expressivity NN O
. . O

The DT O
presence NN O
of IN O
a DT O
constitutional JJ O
mutation NN O
was VBD O
not RB O
associated VBN O
with IN O
an DT O
early JJ O
age NN O
at IN O
treatment NN O
. . O

In IN O
1 CD O
patient NN O
, , O
somatic JJ O
mosaicism NN O
was VBD O
demonstrated VBN O
by IN O
molecular JJ O
analysis NN O
of IN O
DNA NNP O
and CC O
RNA NNP O
from IN O
peripheral JJ O
blood NN O
. . O

In IN O
2 CD O
patients NNS O
without IN O
a DT O
detectable JJ O
mutation NN O
in IN O
peripheral JJ O
blood NN O
, , O
mosaicism NN O
was VBD O
suggested VBN O
because IN O
1 CD O
of IN O
the DT O
patients NNS O
showed VBD O
multifocal JJ O
tumors NNS B-Disease
and CC O
the DT O
other JJ O
later RB O
developed VBN O
bilateral JJ B-Disease
retinoblastoma NN I-Disease
. . O

In IN O
conclusion NN O
, , O
our PRP$ O
results NNS O
emphasize VB O
that IN O
the DT O
manifestation NN O
and CC O
transmissibility NN O
of IN O
retinoblastoma NN B-Disease
depend NN O
on IN O
the DT O
nature NN O
of IN O
the DT O
first JJ O
mutation NN O
, , O
its PRP$ O
time NN O
in IN O
development NN O
, , O
and CC O
the DT O
number NN O
and CC O
types NNS O
of IN O
cells NNS O
that WDT O
are VBP O
affected VBN O
. . O
. . O

Hereditary JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
fifth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
man NN O
. . O

I PRP O
. . O

Clinical NNP O
, , O
immunochemical JJ O
, , O
and CC O
family NN O
studies NNS O
. . O

The DT O
first JJ O
recognized VBN O
human JJ O
kindred VBN O
with IN O
hereditary JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
fifth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C5 NNP O
) ) O
is VBZ O
described VBN O
. . O

The DT O
proband NN O
, , O
a DT O
20 CD O
- : O
year NN O
- : O
old JJ O
black JJ O
female NN O
with IN O
systemic JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
since IN O
age NN O
11 CD O
, , O
lacked VBD O
serum JJ O
hemolytic JJ O
complement NN O
activity NN O
, , O
even RB O
during IN O
remission NN O
. . O

C5 NNP O
was VBD O
undetectable JJ O
in IN O
her PRP$ O
serum NN O
by IN O
both DT O
immunodiffusion NN O
and CC O
hemolytic JJ O
assays NNS O
. . O

Other JJ O
complement JJ O
components NNS O
were VBD O
normal JJ O
during IN O
remission NN O
of IN O
lupus NN O
, , O
but CC O
C1 NNP O
, , O
C4 NNP O
, , O
C2 NNP O
, , O
and CC O
C3 NNP O
levels NNS O
fell VBD O
during IN O
exacerbations NNS O
. . O

A DT O
younger JJR O
half NN O
- : O
sister NN O
, , O
who WP O
had VBD O
no DT O
underlying JJ O
disease NN O
, , O
was VBD O
also RB O
found VBN O
to TO O
lack VB O
immunochemically RB O
detectable JJ O
C5 NNP O
. . O

By IN O
hemolytic JJ O
assay NN O
, , O
she PRP O
exhibited VBD O
1 CD O
- : O
2 CD O
% NN O
of IN O
the DT O
normal JJ O
serum NN O
C5 NNP O
level NN O
and CC O
normal JJ O
concentrations NNS O
of IN O
other JJ O
complement JJ O
components NNS O
. . O

C5 NNP O
levels NNS O
of IN O
other JJ O
family NN O
members NNS O
were VBD O
either RB O
normal JJ O
or CC O
approximately RB O
half JJ O
- : O
normal JJ O
, , O
consistent JJ O
with IN O
autosomal JJ O
codominant JJ O
inheritance NN O
of IN O
the DT O
gene NN O
determining VBG O
C5 NNP B-Disease
deficiency NN I-Disease
. . O

Normal NNP O
hemolytic JJ O
titers NNS O
were VBD O
restored VBN O
to TO O
both DT O
homozygous JJ O
C5 NNP B-Disease
- : I-Disease
deficient NN I-Disease
( ( O
C5D NNP B-Disease
) ) O
sera NN O
by IN O
addition NN O
of IN O
highly RB O
purified VBN O
human JJ O
C5 NNP O
. . O

In IN O
specific JJ O
C5 NNP O
titrations NNS O
, , O
however RB O
, , O
it PRP O
was VBD O
noted VBN O
that IN O
when WRB O
limited JJ O
amounts NNS O
of IN O
C5 NNP O
were VBD O
assayed VBN O
in IN O
the DT O
presence NN O
of IN O
low JJ O
dilutions NNS O
of IN O
either DT O
C5D NNP B-Disease
serum NN O
, , O
curving VBG O
rather RB O
than IN O
linear VB O
dose JJ O
- : O
response NN O
plots NNS O
were VBD O
consistently RB O
obtained VBN O
, , O
suggesting VBG O
some DT O
inhibitory JJ O
effect NN O
. . O

Further JJ O
studies NNS O
suggested VBD O
that IN O
low JJ O
dilutions NNS O
of IN O
C5D NNP B-Disease
serum NN O
contain NN O
a DT O
factor NN O
( ( O
or CC O
factors NNS O
) ) O
interfering VBG O
at IN O
some DT O
step NN O
in IN O
the DT O
hemolytic JJ O
assay NN O
of IN O
C5 NNP O
, , O
rather RB O
than IN O
a DT O
true JJ O
C5 NNP O
inhibitor NN O
or CC O
inactivator NN O
. . O

Of IN O
clinical JJ O
interest NN O
are VBP O
( ( O
a DT O
) ) O
the DT O
documentation NN O
of IN O
membranous JJ O
glomerulonephritis NN B-Disease
, , O
vasculitis NN B-Disease
, , O
and CC O
arthritis NN B-Disease
in IN O
an DT O
individual JJ O
lacking NN O
C5 NNP O
( ( O
and CC O
its PRP$ O
biologic JJ O
functions NNS O
) ) O
, , O
and CC O
( ( O
b NN O
) ) O
a DT O
remarkable JJ O
propensity NN O
to TO O
bacterial JJ B-Disease
infections NNS I-Disease
in IN O
the DT O
proband NN O
, , O
even RB O
during IN O
periods NNS O
of IN O
low JJ O
- : O
dose NN O
or CC O
alternate JJ O
- : O
day NN O
corticosteroid JJ O
therapy NN O
. . O

Other JJ O
observations NNS O
indicate VBP O
that IN O
the DT O
C5D NNP B-Disease
state NN O
is VBZ O
compatible JJ O
with IN O
normal JJ O
coagulation NN O
function NN O
and CC O
the DT O
capacity NN O
to TO O
mount VB O
a DT O
neutrophilic JJ O
leukocytosis NN O
during IN O
pyogenic JJ B-Disease
infection NN I-Disease
. . O
. . O

Susceptibility NN O
to TO O
ankylosing VBG B-Disease
spondylitis NN I-Disease
in IN O
twins NNS O
: : O
the DT O
role NN O
of IN O
genes NNS O
, , O
HLA NNP O
, , O
and CC O
the DT O
environment NN O
. . O

OBJECTIVE NN O
To TO O
determine VB O
the DT O
relative JJ O
effects NNS O
of IN O
genetic JJ O
and CC O
environmental JJ O
factors NNS O
in IN O
susceptibility NN O
to TO O
ankylosing VBG B-Disease
spondylitis NN I-Disease
( ( O
AS IN B-Disease
) ) O
. . O

METHODS NNP O
Twins VBZ O
with IN O
AS NNP B-Disease
were VBD O
identified VBN O
from IN O
the DT O
Royal NNP O
National NNP O
Hospital NNP O
for IN O
Rheumatic NNP B-Disease
Diseases NNP I-Disease
database NN O
. . O

Clinical JJ O
and CC O
radiographic JJ O
examinations NNS O
were VBD O
performed VBN O
to TO O
establish VB O
diagnoses NNS O
, , O
and CC O
disease NN O
severity NN O
was VBD O
assessed VBN O
using VBG O
a DT O
combination NN O
of IN O
validated JJ O
scoring VBG O
systems NNS O
. . O

HLA NNP O
typing VBG O
for IN O
HLA NNP O
- : O
B27 NNP O
, , O
HLA NNP O
- : O
B60 NNP O
, , O
and CC O
HLA NNP O
- : O
DR1 NN O
was VBD O
performed VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
with IN O
sequence NN O
- : O
specific JJ O
primers NNS O
, , O
and CC O
zygosity NN O
was VBD O
assessed VBN O
using VBG O
microsatellite JJ O
markers NNS O
. . O

Genetic JJ O
and CC O
environmental JJ O
variance NN O
components NNS O
were VBD O
assessed VBN O
with IN O
the DT O
program NN O
Mx NNP O
, , O
using VBG O
data NNS O
from IN O
this DT O
and CC O
previous JJ O
studies NNS O
of IN O
twins NNS O
with IN O
AS NNP B-Disease
. . O

RESULTS NNP O
Six NNP O
of IN O
8 CD O
monozygotic JJ O
( ( O
MZ NNP O
) ) O
twin VBP O
pairs NNS O
were VBD O
disease JJ O
concordant NN O
, , O
compared VBN O
with IN O
4 CD O
of IN O
15 CD O
B27 NNP O
- : O
positive JJ O
dizygotic JJ O
( ( O
DZ NNP O
) ) O
twin NN O
pairs NNS O
( ( O
27 CD O
% NN O
) ) O
and CC O
4 CD O
of IN O
32 CD O
DZ NNP O
twin NN O
pairs NNS O
overall JJ O
( ( O
12 CD O
. . O
5 CD O
% NN O
) ) O
. . O

Nonsignificant JJ O
increases NNS O
in IN O
similarity NN O
with IN O
regard NN O
to TO O
age NN O
at IN O
disease NN O
onset NN O
and CC O
all DT O
of IN O
the DT O
disease NN O
severity NN O
scores NNS O
assessed VBN O
were VBD O
noted VBN O
in IN O
disease NN O
- : O
concordant NN O
MZ NNP O
twins NNS O
compared VBN O
with IN O
concordant JJ O
DZ NNP O
twins NNS O
. . O

HLA NNP O
- : O
B27 NNP O
and CC O
B60 NNP O
were VBD O
associated VBN O
with IN O
the DT O
disease NN O
in IN O
probands NNS O
, , O
and CC O
the DT O
rate NN O
of IN O
disease NN O
concordance NN O
was VBD O
significantly RB O
increased VBN O
among IN O
DZ NNP O
twin VBP O
pairs NNS O
in IN O
which WDT O
the DT O
co NN O
- : O
twin NN O
was VBD O
positive JJ O
for IN O
both DT O
B27 NNP O
and CC O
DR1 NNP O
. . O

Additive NNP O
genetic JJ O
effects NNS O
were VBD O
estimated VBN O
to TO O
contribute VB O
97 CD O
% NN O
of IN O
the DT O
population NN O
variance NN O
. . O

CONCLUSION NNP O
Susceptibility NNP O
to TO O
AS NNP B-Disease
is VBZ O
largely RB O
genetically RB O
determined VBN O
, , O
and CC O
the DT O
environmental JJ O
trigger NN O
for IN O
the DT O
disease NN O
is VBZ O
probably RB O
ubiquitous JJ O
. . O

HLA NNP O
- : O
B27 NNP O
accounts NNS O
for IN O
a DT O
minority NN O
of IN O
the DT O
overall JJ O
genetic JJ O
susceptibility NN O
to TO O
AS NNP B-Disease
. . O

Cell NNP O
cycle NN O
- : O
dependent JJ O
colocalization NN O
of IN O
BARD1 NNP O
and CC O
BRCA1 NNP O
proteins NNS O
in IN O
discrete JJ O
nuclear JJ O
domains NNS O
. . O

Germ NNP O
- : O
line NN O
mutations NNS O
of IN O
the DT O
BRCA1 NNP O
gene NN O
predispose JJ O
women NNS O
to TO O
early JJ O
- : O
onset NN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
by IN O
compromising VBG O
the DT O
genes NNS O
presumptive JJ O
function NN O
as IN O
a DT O
tumor NN B-Disease
suppressor NN O
. . O

Although IN O
the DT O
biochemical JJ O
properties NNS O
of IN O
BRCA1 NNP O
polypeptides NNS O
are VBP O
not RB O
understood JJ O
, , O
their PRP$ O
expression NN O
pattern NN O
and CC O
subcellular JJ O
localization NN O
suggest VBP O
a DT O
role NN O
in IN O
cell NN O
- : O
cycle NN O
regulation NN O
. . O

When WRB O
resting VBG O
cells NNS O
are VBP O
induced VBN O
to TO O
proliferate VB O
, , O
the DT O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
BRCA1 NNP O
increase NN O
in IN O
late JJ O
G1 NNP O
and CC O
reach VB O
a DT O
maximum JJ O
during IN O
S NNP O
phase NN O
. . O

Moreover RB O
, , O
in IN O
S NNP O
phase NN O
cells NNS O
, , O
BRCA1 NNP O
polypeptides NNS O
are VBP O
hyperphosphorylated VBN O
and CC O
accumulate VB O
into IN O
discrete JJ O
subnuclear JJ O
foci NN O
termed VBD O
"""" NNP O
BRCA1 NNP O
nuclear JJ O
dots NNS O
. . O

"""" JJ O
BRCA1 NNP O
associates NNS O
in IN O
vivo NN O
with IN O
a DT O
structurally RB O
related JJ O
protein NN O
termed VBD O
BARD1 NNP O
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
BARD1 NNP O
, , O
unlike IN O
those DT O
of IN O
BRCA1 NNP O
, , O
remain VBP O
relatively RB O
constant JJ O
during IN O
cell NN O
cycle NN O
progression NN O
. . O

However RB O
, , O
immunostaining VBG O
revealed VBD O
that IN O
BARD1 NNP O
resides NNS O
within IN O
BRCA1 NNP O
nuclear JJ O
dots NNS O
during IN O
S NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
, , O
but CC O
not RB O
during IN O
the DT O
G1 NNP O
phase NN O
. . O

Nevertheless RB O
, , O
BARD1 NNP O
polypeptides NNS O
are VBP O
found VBN O
exclusively RB O
in IN O
the DT O
nuclear JJ O
fractions NNS O
of IN O
both DT O
G1 NNP O
- : O
and CC O
S NNP O
- : O
phase NN O
cells NNS O
. . O

Therefore RB O
, , O
progression NN O
to TO O
S NNP O
phase NN O
is VBZ O
accompanied VBN O
by IN O
the DT O
aggregation NN O
of IN O
nuclear JJ O
BARD1 NNP O
polypeptides NNS O
into IN O
BRCA1 NNP O
nuclear JJ O
dots NNS O
. . O

This DT O
cell NN O
cycle NN O
- : O
dependent JJ O
colocalization NN O
of IN O
BARD1 NNP O
and CC O
BRCA1 NNP O
indicates VBZ O
a DT O
role NN O
for IN O
BARD1 NNP O
in IN O
BRCA1 NNP O
- : O
mediated VBD O
tumor JJ B-Disease
suppression NN O
. . O

Ethnic JJ O
differences NNS O
in IN O
the DT O
HFE NNP O
codon NN O
282 CD O
( ( O
Cys NNP O
/ NNP O
Tyr NNP O
) ) O
polymorphism NN O
. . O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
( ( O
HH NNP B-Disease
) ) O
is VBZ O
likely JJ O
to TO O
be VB O
caused VBN O
by IN O
homozygosity NN O
for IN O
a DT O
Cys282Tyr NNP O
mutation NN O
in IN O
the DT O
HFE NNP O
gene NN O
located VBD O
4 CD O
. . O

5 CD O
Mb NNP O
telomeric NN O
to TO O
HLA NNP O
- : O
A DT O
. . O

Population NNP O
studies NNS O
of IN O
this DT O
polymorphism NN O
are VBP O
facilitated VBN O
by IN O
the DT O
fact NN O
that IN O
the DT O
Cys282Tyr NNP O
mutation NN O
creates VBZ O
a DT O
Rsal NNP O
restriction NN O
site NN O
. . O

We PRP O
have VBP O
studied VBN O
the DT O
codon NN O
282 CD O
( ( O
Cys NNP O
/ NNP O
Tyr NNP O
) ) O
polymorphism NN O
in IN O
different JJ O
ethnic JJ O
groups NNS O
. . O

In IN O
agreement NN O
with IN O
previous JJ O
observations NNS O
the DT O
Tyr NNP O
allele NN O
appeared VBD O
to TO O
be VB O
rare JJ O
or CC O
absent NN O
in IN O
Asiatic NNP O
( ( O
Indian JJ O
, , O
Chinese JJ O
) ) O
populations NNS O
. . O

The DT O
highest JJS O
allele JJ O
frequency NN O
( ( O
7 CD O
. . O
5 CD O
% NN O
) ) O
was VBD O
found VBN O
in IN O
Swedes NNP O
. . O

Saamis NNP O
( ( O
2 CD O
% NN O
) ) O
and CC O
Mordvinians NNPS O
( ( O
1 CD O
. . O
8 CD O
% NN O
) ) O
had VBD O
significantly RB O
lower JJR O
frequencies NNS O
of IN O
the DT O
Tyr NNP O
allele NN O
. . O

Comparisons NNS O
with IN O
allele JJ O
frequencies NNS O
based VBN O
on IN O
prevalence NN O
estimates NNS O
of IN O
HH NNP B-Disease
showed VBD O
some DT O
disagreements NNS O
with IN O
the DT O
RFLP NNP O
data NNS O
, , O
particularly RB O
in IN O
Finns NNP O
. . O

The DT O
newly RB O
described VBN O
HFE NNP O
marker NN O
provides VBZ O
a DT O
new JJ O
approach NN O
to TO O
the DT O
screening NN O
of IN O
HH NNP B-Disease
as RB O
well RB O
as IN O
studies NNS O
of IN O
the DT O
relationship NN O
between IN O
the DT O
HFE NNP O
Tyr NNP O
allele NN O
and CC O
different JJ O
disorders NNS O
including VBG O
cancer NN B-Disease

Autosomal NNP B-Disease
dominant JJ I-Disease
neurohypophyseal NN I-Disease
diabetes VBZ I-Disease
insipidus RB I-Disease
associated VBN O
with IN O
a DT O
missense JJ O
mutation NN O
encoding VBG O
Gly23 NNP O
- : O
- : O
> NN O
Val NNP O
in IN O
neurophysin JJ O
II NNP O
. . O

Autosomal NNP B-Disease
dominant JJ I-Disease
neurohypophyseal NN I-Disease
diabetes NNS I-Disease
insipidus VBP I-Disease
( ( O
ADNDI NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ B-Disease
disease NN I-Disease
caused VBN O
by IN O
progressive JJ O
degeneration NN O
of IN O
the DT O
magnocellular JJ O
neurons NNS O
of IN O
the DT O
hypothalamus NN O
leading VBG O
to TO O
decreased VBN O
ability NN O
to TO O
produce VB O
the DT O
hormone NN O
arginine NN O
vasopressin NN O
( ( O
AVP NNP O
) ) O
. . O

Affected JJ O
individuals NNS O
are VBP O
not RB O
symptomatic JJ O
at IN O
birth NN O
, , O
but CC O
usually RB O
develop VB O
diabetes NNS B-Disease
insipidus VBP I-Disease
at IN O
1 CD O
- : O
6 CD O
yr NN O
of IN O
age NN O
. . O

The DT O
genetic JJ O
locus NN O
of IN O
the DT O
disease NN O
is VBZ O
the DT O
AVP NNP O
- : O
neurophysin NN O
II NNP O
( ( O
NPII NNP O
) ) O
gene NN O
, , O
and CC O
mutations NNS O
that WDT O
cause VBP O
ADNDI NNP B-Disease
have VBP O
been VBN O
found VBN O
in IN O
both DT O
the DT O
signal JJ O
peptide NN O
of IN O
the DT O
prepro JJ O
- : O
AVP NNP O
- : O
NPII NNP O
precursor NN O
and CC O
within IN O
NPII NNP O
itself PRP O
. . O

An DT O
affected JJ O
girl NN O
who WP O
presented VBD O
at IN O
9 CD O
months NNS O
of IN O
age NN O
and CC O
her PRP$ O
similarly RB O
affected JJ O
younger JJR O
brother NN O
and CC O
father NN O
were VBD O
all DT O
found VBN O
to TO O
have VB O
a DT O
novel JJ O
missense NN O
mutation NN O
( ( O
G1758 NNP O
- : O
- : O
> NN O
T NNP O
) ) O
encoding VBG O
the DT O
amino NN O
acid JJ O
substitution NN O
Gly23 NNP O
- : O
- : O
> NN O
Val NNP O
within IN O
NPII NNP O
. . O

The DT O
mutation NN O
was VBD O
confirmed VBN O
by IN O
restriction NN O
endonuclease NN O
analysis NN O
. . O

A DT O
T1 NNP O
- : O
weighted VBD O
magnetic JJ O
resonance NN O
imaging NN O
of IN O
the DT O
fathers NNS O
pituitary JJ O
gland NN O
demonstrates VBZ O
an DT O
attenuated JJ O
posterior JJ O
pituitary JJ O
bright NN O
spot NN O
. . O

This DT O
mutation NN O
may MD O
be VB O
valuable JJ O
for IN O
developing VBG O
models NNS O
of IN O
dominantly RB B-Disease
inherited VBN I-Disease
neurodegeneration NN I-Disease
, , O
as IN O
the DT O
early JJ O
age NN O
of IN O
onset NN O
of IN O
symptoms NNS O
suggests VBZ O
that IN O
this DT O
mutation NN O
may MD O
be VB O
particularly RB O
deleterious JJ O
to TO O
the DT O
magnocellular JJ O
neuron NN O
. . O
. . O

Frequent JJ O
inactivation NN O
of IN O
PTEN NNP O
/ NNP O
MMAC1 NNP O
in IN O
primary JJ O
prostate NN B-Disease
cancer NN I-Disease
. . O

Sporadic JJ B-Disease
prostate NN I-Disease
carcinoma NN I-Disease
is VBZ O
the DT O
most RBS O
common JJ O
male NN B-Disease
cancer NN I-Disease
in IN O
the DT O
Western JJ O
world NN O
, , O
yet RB O
many JJ O
of IN O
the DT O
major JJ O
genetic JJ O
events NNS O
involved VBN O
in IN O
the DT O
progression NN O
of IN O
this DT O
often RB O
fatal JJ O
cancer NN B-Disease
remain NN O
to TO O
be VB O
elucidated VBN O
. . O

Numerous JJ O
cytogenetic JJ O
and CC O
allelotype JJ O
studies NNS O
have VBP O
reported VBN O
frequent JJ O
loss NN O
of IN O
heterozygosity NN O
on IN O
chromosomal JJ O
arm NN O
10q CD O
in IN O
sporadic JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
. . O

Deletion NN O
mapping VBG O
studies NNS O
have VBP O
unambiguously RB O
identified VBN O
a DT O
region NN O
of IN O
chromosome NN O
10q23 CD O
to TO O
be VB O
the DT O
minimal JJ O
area NN O
of IN O
loss NN O
. . O

A DT O
new JJ O
tumor NN B-Disease
suppressor NN O
gene NN O
, , O
PTEN NNP O
/ NNP O
MMAC1 NNP O
, , O
was VBD O
isolated VBN O
recently RB O
at IN O
this DT O
region NN O
of IN O
chromosome NN O
10q23 CD O
and CC O
found VBD O
to TO O
be VB O
inactivated VBN O
by IN O
mutation NN O
in IN O
three CD O
prostate NN B-Disease
cancer NN I-Disease
cell NN O
lines NNS O
. . O

We PRP O
screened VBD O
80 CD O
prostate NN B-Disease
tumors NNS I-Disease
by IN O
microsatellite JJ O
analysis NN O
and CC O
found VBD O
chromosome RB O
10q23 CD O
to TO O
be VB O
deleted VBN O
in IN O
23 CD O
cases NNS O
. . O

We PRP O
then RB O
proceeded VBD O
with IN O
sequence NN O
analysis NN O
of IN O
the DT O
entire JJ O
PTEN NNP O
/ NNP O
MMAC1 NNP O
coding VBG O
region NN O
and CC O
tested VBN O
for IN O
homozygous JJ O
deletion NN O
with IN O
new JJ O
intragenic JJ O
markers NNS O
in IN O
these DT O
23 CD O
cases NNS O
with IN O
10q23 CD O
loss NN O
of IN O
heterozygosity NN O
. . O

The DT O
identification NN O
of IN O
the DT O
second JJ O
mutational JJ O
event NN O
in IN O
10 CD O
( ( O
43 CD O
% NN O
) ) O
tumors NNS B-Disease
establishes VBP O
PTEN NNP O
/ NNP O
MMAC1 NNP O
as IN O
a DT O
main JJ O
inactivation NN O
target NN O
of IN O
10q CD O
loss NN O
in IN O
sporadic JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
. . O
. . O

Risk NN O
reversals NNS O
in IN O
predictive JJ O
testing NN O
for IN O
Huntington NNP B-Disease
disease NN I-Disease
. . O

The DT O
first JJ O
predictive JJ O
testing NN O
for IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
was VBD O
based VBN O
on IN O
analysis NN O
of IN O
linked VBN O
polymorphic JJ O
DNA NNP O
markers NNS O
to TO O
estimate VB O
the DT O
likelihood NN O
of IN O
inheriting VBG O
the DT O
mutation NN O
for IN O
HD NNP B-Disease
. . O

Limits NNS O
to TO O
accuracy VB O
included JJ O
recombination NN O
between IN O
the DT O
DNA NNP O
markers NNS O
and CC O
the DT O
mutation NN O
, , O
pedigree JJ O
structure NN O
, , O
and CC O
whether IN O
DNA NN O
samples NNS O
were VBD O
available JJ O
from IN O
family NN O
members NNS O
. . O

With IN O
direct JJ O
tests NNS O
for IN O
the DT O
HD NNP B-Disease
mutation NN O
, , O
we PRP O
have VBP O
assessed VBN O
the DT O
accuracy NN O
of IN O
results NNS O
obtained VBN O
by IN O
linkage NN O
approaches NNS O
when WRB O
requested VBN O
to TO O
do VB O
so RB O
by IN O
the DT O
test NN O
individuals NNS O
. . O

For IN O
six CD O
such JJ O
individuals NNS O
, , O
there EX O
was VBD O
significant JJ O
disparity NN O
between IN O
the DT O
tests NNS O
. . O

Three CD O
went VBD O
from IN O
a DT O
decreased VBN O
risk NN O
to TO O
an DT O
increased VBN O
risk NN O
, , O
while IN O
in IN O
another DT O
three CD O
the DT O
risk NN O
was VBD O
decreased VBN O
. . O

Knowledge NNP O
of IN O
the DT O
potential JJ O
reasons NNS O
for IN O
these DT O
changes NNS O
in IN O
results NNS O
and CC O
impact NN O
of IN O
these DT O
risk NN O
reversals NNS O
on IN O
both DT O
patients NNS O
and CC O
the DT O
counseling NN O
team NN O
can MD O
assist VB O
in IN O
the DT O
development NN O
of IN O
strategies NNS O
for IN O
the DT O
prevention NN O
and CC O
, , O
where WRB O
necessary JJ O
, , O
management NN O
of IN O
a DT O
risk NN O
reversal NN O
in IN O
any DT O
predictive JJ O
testing NN O
program NN O
. . O
. . O

A DT O
novel JJ O
common JJ O
missense NN O
mutation NN O
G301C NNP O
in IN O
the DT O
N NNP O
- : O
acetylgalactosamine NN O
- : O
6 CD O
- : O
sulfate NN O
sulfatase NN O
gene NN O
in IN O
mucopolysaccharidosis NN B-Disease
IVA NNP I-Disease
. . O

Mucopolysaccharidosis NN B-Disease
IVA NNP I-Disease
( ( O
MPS NNP B-Disease
IVA NNP I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive NN I-Disease
lysosomal JJ I-Disease
storage NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
genetic JJ B-Disease
defect NN I-Disease
in IN O
N NNP O
- : O
acetylgalactosamine NN O
- : O
6 CD O
- : O
sulfate NN O
sulfatase NN O
( ( O
GALNS NNP O
) ) O
. . O

In IN O
previous JJ O
studies NNS O
, , O
we PRP O
have VBP O
found VBN O
two CD O
common JJ O
mutations NNS O
in IN O
Caucasians NNPS O
and CC O
Japanese JJ O
, , O
respectively RB O
. . O

To TO O
characterize VB O
the DT O
mutational JJ O
spectrum NN O
in IN O
various JJ O
ethnic JJ O
groups NNS O
, , O
mutations NNS O
in IN O
the DT O
GALNS NNP O
gene NN O
in IN O
Colombian JJ O
MPS NNP B-Disease
IVA NNP I-Disease
patients NNS O
were VBD O
investigated VBN O
, , O
and CC O
genetic JJ O
backgrounds NNS O
were VBD O
extensively RB O
analyzed VBN O
to TO O
identify VB O
racial JJ O
origin NN O
, , O
based VBN O
on IN O
mitochondrial JJ O
DNA NNP O
( ( O
mtDNA NN O
) ) O
lineages VBZ O
. . O

Three CD O
novel JJ O
missense NN O
mutations NNS O
never RB O
identified VBN O
previously RB O
in IN O
other JJ O
populations NNS O
and CC O
found VBN O
in IN O
16 CD O
out IN O
of IN O
19 CD O
Colombian JJ O
MPS NNP B-Disease
IVA NNP I-Disease
unrelated JJ O
alleles NNS O
account VBP O
for IN O
84 CD O
. . O

2 CD O
% NN O
of IN O
the DT O
alleles NNS O
in IN O
this DT O
study NN O
. . O

The DT O
G301C NNP O
and CC O
S162F NNP O
mutations NNS O
account VBP O
for IN O
68 CD O
. . O

4 CD O
% NN O
and CC O
10 CD O
. . O

5 CD O
% NN O
of IN O
mutations NNS O
, , O
respectively RB O
, , O
whereas IN O
the DT O
remaining VBG O
F69V NNP O
is VBZ O
limited VBN O
to TO O
a DT O
single JJ O
allele NN O
. . O

The DT O
skewed JJ O
prevalence NN O
of IN O
G301C NNP O
in IN O
only RB O
Colombian JJ O
patients NNS O
and CC O
haplotype JJ O
analysis NN O
by IN O
restriction NN O
fragment NN O
length NN O
polymorphisms NN O
in IN O
the DT O
GALNS NNP O
gene NN O
suggest VBP O
that IN O
G301C NNP O
originated VBD O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

Investigation NN O
of IN O
the DT O
genetic JJ O
background NN O
by IN O
means NNS O
of IN O
mtDNA NN O
lineages NNS O
indicate VBP O
that IN O
all DT O
our PRP$ O
patients NNS O
are VBP O
probably RB O
of IN O
native JJ O
American JJ O
descent NN O

Low JJ O
frequency NN O
of IN O
BRCA1 NNP O
germline NN O
mutations NNS O
in IN O
45 CD O
German JJ O
breast NN B-Disease
/ NNP I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

In IN O
this DT O
study NN O
we PRP O
investigated VBD O
45 CD O
German JJ O
breast NN B-Disease
/ NNP I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
for IN O
germline JJ O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
. . O

We PRP O
identified VBD O
four CD O
germline NN O
mutations NNS O
in IN O
three CD O
breast NN B-Disease
cancer NN I-Disease
families NNS O
and CC O
in IN O
one CD O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
family NN O
. . O
among IN O
these DT O
were VBD O
one CD O
frameshift NN O
mutation NN O
, , O
one CD O
nonsense NN O
mutation NN O
, , O
one CD O
novel NN O
splice NN O
site NN O
mutation NN O
, , O
and CC O
one CD O
missense NN O
mutation NN O
. . O

The DT O
missense NN O
mutation NN O
was VBD O
also RB O
found VBN O
in IN O
2 CD O
. . O

8 CD O
% NN O
of IN O
the DT O
general JJ O
population NN O
, , O
suggesting VBG O
that IN O
it PRP O
is VBZ O
not RB O
disease JJ O
associated VBN O
. . O

The DT O
average JJ O
age NN O
of IN O
disease NN O
onset VBN O
in IN O
those DT O
families NNS O
harbouring VBG O
causative JJ O
mutations NNS O
was VBD O
between IN O
32 CD O
. . O

3 CD O
and CC O
37 CD O
. . O

4 CD O
years NNS O
, , O
whereas IN O
the DT O
family NN O
harbouring VBG O
the DT O
missense NN O
mutation NN O
had VBD O
an DT O
average JJ O
age NN O
of IN O
onset NN O
of IN O
51 CD O
. . O

2 CD O
years NNS O
. . O

These DT O
findings NNS O
show VBP O
that IN O
BRCA1 NNP O
is VBZ O
implicated VBN O
in IN O
a DT O
small JJ O
fraction NN O
of IN O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
suggesting VBG O
the DT O
involvement NN O
of IN O
another DT O
susceptibility NN O
gene NN O
( ( O
s PRP O
) ) O

Paternal JJ O
transmission NN O
of IN O
congenital JJ B-Disease
myotonic JJ I-Disease
dystrophy NN I-Disease
. . O

We PRP O
report VBP O
a DT O
rare JJ O
case NN O
of IN O
paternally RB O
transmitted VBN O
congenital JJ B-Disease
myotonic JJ I-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
. . O

The DT O
proband NN O
is VBZ O
a DT O
23 CD O
year NN O
old JJ O
, , O
mentally RB B-Disease
retarded JJ I-Disease
male NN O
who WP O
suffers VBZ O
severe JJ O
muscular JJ B-Disease
weakness NN I-Disease
. . O

He PRP O
presented VBD O
with IN O
respiratory NN O
and CC O
feeding NN O
difficulties NNS O
at IN O
birth NN O
. . O

His PRP$ O
two CD O
sibs NNS O
suffer VBP O
from IN O
childhood NN O
onset VBN O
DM NNP B-Disease
. . O

Their PRP$ O
late JJ O
father NN O
had VBD O
the DT O
adult NN O
type NN O
of IN O
DM NNP B-Disease
, , O
with IN O
onset VBN O
around IN O
30 CD O
years NNS O
. . O

Only RB O
six CD O
other JJ O
cases NNS O
of IN O
paternal JJ O
transmission NN O
of IN O
congenital JJ B-Disease
DM NNP I-Disease
have VBP O
been VBN O
reported VBN O
recently RB O
. . O

We PRP O
review VBP O
the DT O
sex NN O
related JJ O
effects NNS O
on IN O
transmission NN O
of IN O
congenital JJ B-Disease
DM NNP I-Disease
. . O

Decreased VBN O
fertility NN O
of IN O
males NNS O
with IN O
adult NN O
onset VBN O
DM NNP B-Disease
and CC O
contraction NN O
of IN O
the DT O
repeat NN O
upon IN O
male JJ O
transmission NN O
contribute NN O
to TO O
the DT O
almost RB O
absent JJ O
occurrence NN O
of IN O
paternal JJ O
transmission NN O
of IN O
congenital JJ B-Disease
DM NNP I-Disease
. . O

Also RB O
the DT O
fathers NNS O
of IN O
the DT O
reported VBN O
congenitally RB O
affected JJ O
children NNS O
showed VBD O
, , O
on IN O
average NN O
, , O
shorter JJR O
CTG NNP O
repeat NN O
lengths NNS O
and CC O
hence RB O
less JJR O
severe JJ O
clinical NN O
symptoms NNS O
than IN O
the DT O
mothers NNS O
of IN O
children NNS O
with IN O
congenital JJ B-Disease
DM NNP I-Disease
. . O

We PRP O
conclude VBP O
that IN O
paternal JJ O
transmission NN O
of IN O
congenital JJ B-Disease
DM NNP I-Disease
is VBZ O
rare JJ O
and CC O
preferentially RB O
occurs VBZ O
with IN O
onset NN O
of IN O
DM NNP B-Disease
past IN O
30 CD O
years NNS O
in IN O
the DT O
father NN O
. . O
. . O

The DT O
RB1 NNP O
gene NN O
mutation NN O
in IN O
a DT O
child NN O
with IN O
ectopic JJ B-Disease
intracranial JJ I-Disease
retinoblastoma NN I-Disease
. . O

The DT O
RB1 NNP O
gene NN O
mutation NN O
was VBD O
investigated VBN O
in IN O
a DT O
child NN O
with IN O
ectopic JJ B-Disease
intracranial JJ I-Disease
retinoblastoma NN I-Disease
using VBG O
DNA NNP O
obtained VBN O
from IN O
both CC O
the DT O
pineal NN B-Disease
and CC I-Disease
retinal JJ I-Disease
tumours NN I-Disease
of IN O
the DT O
patient NN O
. . O

A DT O
nonsense JJ O
mutation NN O
in IN O
exon JJ O
17 CD O
( ( O
codon VB O
556 CD O
) ) O
of IN O
the DT O
RB1 NNP O
gene NN O
was VBD O
found VBN O
to TO O
be VB O
present JJ O
homozygously RB O
in IN O
both CC O
the DT O
retinal NN B-Disease
and CC I-Disease
the DT I-Disease
pineal NN I-Disease
tumours NN I-Disease
. . O

The DT O
same JJ O
mutation NN O
was VBD O
present JJ O
heterozygously RB O
in IN O
the DT O
DNA NN O
from IN O
the DT O
constitutional JJ O
cells NNS O
of IN O
the DT O
patient NN O
, , O
proving VBG O
it PRP O
to TO O
be VB O
of IN O
germline JJ O
origin NN O
. . O

The DT O
initial JJ O
mutation NN O
was VBD O
shown VBN O
to TO O
have VB O
occurred VBN O
in IN O
the DT O
paternally RB O
derived VBN O
RB1 NNP O
allele NN O
. . O

The DT O
mutation NN O
is VBZ O
in IN O
an DT O
area NN O
of IN O
the DT O
gene NN O
that WDT O
encodes VBZ O
the DT O
protein NN O
- : O
binding JJ O
region NN O
known VBN O
as IN O
the DT O
pocket NN O
region NN O
and CC O
has VBZ O
been VBN O
detected VBN O
in IN O
other JJ O
cases NNS O
of IN O
retinoblastoma NN B-Disease
. . O
. . O

Low JJ O
levels NNS O
of IN O
beta NN O
hexosaminidase NN O
A NNP O
in IN O
healthy JJ O
individuals NNS O
with IN O
apparent JJ O
deficiency NN O
of IN O
this DT O
enzyme NN O
. . O

Appreciable JJ O
beta NN O
hexosaminidase NN O
A NNP O
( ( O
hex VB O
A DT O
) ) O
activity NN O
has VBZ O
been VBN O
detected VBN O
in IN O
cultured JJ O
skin NN O
fibroblasts NNS O
and CC O
melanoma NNS B-Disease
tissue NN O
from IN O
healthy JJ O
individuals NNS O
previously RB O
reported VBD O
as IN O
having VBG O
deficiency NN B-Disease
of IN I-Disease
hex NN I-Disease
A NNP I-Disease
activity NN O
indistinguishable NN O
from IN O
that DT O
of IN O
patients NNS O
with IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
. . O

Identification NN O
and CC O
quantitation NN O
of IN O
hex NN O
A NNP O
, , O
amounting VBG O
to TO O
3 CD O
. . O

5 CD O
% NN O
- : O
6 CD O
. . O

9 CD O
% NN O
of IN O
total JJ O
beta JJ O
hexosaminidase NN O
activity NN O
, , O
has VBZ O
been VBN O
obtained VBN O
by IN O
cellulose JJ O
acetate NN O
gel NN O
electrophoresis NN O
, , O
DEAE NNP O
- : O
cellulose NN O
ion NN O
- : O
exchange NN O
chromatography NN O
, , O
radial JJ O
immunodiffusion NN O
, , O
and CC O
radioimmunoassay NN O
. . O

Previous JJ O
family NN O
studies NNS O
suggested VBD O
that IN O
these DT O
individuals NNS O
may MD O
be VB O
compound VBN O
heterozygotes NNS O
for IN O
the DT O
common JJ O
mutant NN O
TSD NNP B-Disease
gene NN O
and CC O
a DT O
rare JJ O
( ( O
allelic JJ O
) ) O
mutant JJ O
gene NN O
. . O

Thus RB O
, , O
the DT O
postulated JJ O
rate NN O
mutant JJ O
gene NN O
appears VBZ O
to TO O
code VB O
for IN O
the DT O
expression NN O
of IN O
low JJ O
amounts NNS O
of IN O
hex NN O
A NNP O
. . O

Heterozygotes NNS O
for IN O
the DT O
rare JJ O
mutant NN O
may MD O
be VB O
indistinguishable JJ O
from IN O
heterozygotes NNS O
for IN O
the DT O
common JJ O
TSD NNP B-Disease
mutant NN O
. . O

However RB O
, , O
direct JJ O
visualization NN O
and CC O
quantitation NN O
of IN O
hex NN O
A NNP O
by IN O
the DT O
methods NNS O
described VBD O
may MD O
prevent VB O
false JJ O
- : O
positive JJ O
prenatal JJ O
diagnosis NN O
of IN O
TSD NNP B-Disease
in IN O
fetuses NNS O
having VBG O
the DT O
incomplete JJ O
hex NN B-Disease
A NNP I-Disease
deficiency NN I-Disease
of IN O
the DT O
type NN O
described VBN O
in IN O
the DT O
four CD O
healthy JJ O
individuals NNS O

The DT O
tumor NN B-Disease
suppressor NN O
gene NN O
Smad4 NNP O
/ NNP O
Dpc4 NNP O
is VBZ O
required VBN O
for IN O
gastrulation NN O
and CC O
later RB O
for IN O
anterior JJ O
development NN O
of IN O
the DT O
mouse NN O
embryo NN O
. . O

Mutations NNS O
in IN O
the DT O
SMAD4 NNP O
/ NNP O
DPC4 NNP O
tumor NN B-Disease
suppressor NN O
gene NN O
, , O
a DT O
key JJ O
signal JJ O
transducer NN O
in IN O
most JJS O
TGFbeta NNP O
- : O
related JJ O
pathways NNS O
, , O
are VBP O
involved VBN O
in IN O
50 CD O
% NN O
of IN O
pancreatic JJ B-Disease
cancers NNS I-Disease
. . O

Homozygous JJ O
Smad4 NNP O
mutant NN O
mice NN O
die NN O
before IN O
day NN O
7 CD O
. . O

5 CD O
of IN O
embryogenesis NN O
. . O

Mutant NNP O
embryos NN O
have VBP O
reduced VBN O
size NN O
, , O
fail VBP O
to TO O
gastrulate VB O
or CC O
express VB O
a DT O
mesodermal JJ O
marker NN O
, , O
and CC O
show VB O
abnormal JJ O
visceral JJ O
endoderm NN O
development NN O
. . O

Growth NNP B-Disease
retardation NN I-Disease
of IN O
the DT O
Smad4 NNP O
- : O
deficient NN O
embryos JJ O
results NNS O
from IN O
reduced VBN O
cell NN O
proliferation NN O
rather RB O
than IN O
increased VBN O
apoptosis NN O
. . O

Aggregation NN O
of IN O
mutant JJ O
Smad4 NNP O
ES NNP O
cells NNS O
with IN O
wild JJ O
- : O
type NN O
tetraploid NN O
morulae NN O
rescues VBZ O
the DT O
gastrulation NN B-Disease
defect NN I-Disease
. . O

These DT O
results NNS O
indicate VBP O
that IN O
Smad4 NNP O
is VBZ O
initially RB O
required VBN O
for IN O
the DT O
differentiation NN O
of IN O
the DT O
visceral JJ O
endoderm NN O
and CC O
that IN O
the DT O
gastrulation NN B-Disease
defect NN I-Disease
in IN O
the DT O
epiblast NN O
is VBZ O
secondary JJ O
and CC O
non JJ O
- : O
cell NN O
autonomous JJ O
. . O

Rescued VBN O
embryos JJ O
show NN O
severe JJ O
anterior JJ O
truncations NNS O
, , O
indicating VBG O
a DT O
second JJ O
important JJ O
role NN O
for IN O
Smad4 NNP O
in IN O
anterior JJ O
patterning NN O
during IN O
embryogenesis NN O
. . O

Prevalence NN O
of IN O
p16 NN O
and CC O
CDK4 NNP O
germline VBP O
mutations NNS O
in IN O
48 CD O
melanoma NN B-Disease
- : O
prone NN O
families NNS O
in IN O
France NNP O
. . O

The DT O
French JJ O
Familial NNP B-Disease
Melanoma NNP I-Disease
Study NNP O
Group NNP O
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
p16 NN O
and CC O
CDK4 NNP O
genes NNS O
have VBP O
been VBN O
reported VBN O
in IN O
a DT O
subset NN O
of IN O
melanoma NN B-Disease
pedigrees NNS O
, , O
but CC O
their PRP$ O
prevalence NN O
is VBZ O
not RB O
well RB O
known VBN O
. . O

We PRP O
searched VBD O
for IN O
such JJ O
germline JJ O
mutations NNS O
in IN O
48 CD O
French JJ O
melanoma NN B-Disease
- : O
prone NN O
families NNS O
selected VBN O
according VBG O
to TO O
two CD O
major JJ O
criteria NNS O
families NNS O
with IN O
at IN O
least JJS O
three CD O
affected JJ O
members NNS O
( ( O
n JJ O
= NNP O
20 CD O
) ) O
or CC O
families NNS O
with IN O
two CD O
affected JJ O
members NNS O
, , O
one CD O
of IN O
them PRP O
affected VBD O
before IN O
the DT O
age NN O
of IN O
50 CD O
( ( O
n JJ O
= NNP O
28 CD O
) ) O
, , O
and CC O
one CD O
additional JJ O
minor JJ O
criterion NN O
. . O

Sixteen JJ O
different JJ O
p16 NN O
germline NN O
mutations NNS O
were VBD O
found VBN O
in IN O
21 CD O
families NNS O
, , O
while IN O
one CD O
germline NN O
mutation NN O
, , O
Arg24His NNP O
, , O
was VBD O
detected VBN O
in IN O
the DT O
CDK4 NNP O
gene NN O
. . O

The DT O
frequency NN O
of IN O
p16 JJ O
gene NN O
mutation NN O
in IN O
our PRP$ O
sample NN O
( ( O
44 CD O
% NN O
) ) O
is VBZ O
among IN O
the DT O
highest JJS O
rates NNS O
yet RB O
reported VBN O
and CC O
the DT O
CDK4 NNP O
mutation NN O
is VBZ O
the DT O
second JJ O
mutation NN O
detected VBN O
in IN O
this DT O
gene NN O
worldwide NN O
. . O

In IN O
summary JJ O
, , O
our PRP$ O
results NNS O
show VBP O
frequent JJ O
involvement NN O
of IN O
the DT O
p16 JJ O
gene NN O
in IN O
familial JJ B-Disease
melanoma NN I-Disease
and CC O
confirm VBP O
the DT O
role NN O
of IN O
the DT O
CDK4 NNP O
gene NN O
as IN O
a DT O
melanoma NN B-Disease
- : O
predisposing NN O
gene NN O
. . O
. . O

Progression NN O
of IN O
somatic JJ O
CTG NNP O
repeat NN O
length NN O
heterogeneity NN O
in IN O
the DT O
blood NN O
cells NNS O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
patients NNS O
. . O

The DT O
genetic JJ O
basis NN O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
the DT O
expansion NN O
of IN O
an DT O
unstable JJ O
CTG NNP O
repeat NN O
in IN O
the DT O
34 CD O
UTR NNP O
of IN O
the DT O
DM NNP B-Disease
protein NN O
kinase VBD O
gene NN O
on IN O
chromosome NN O
19 CD O
. . O

One CD O
of IN O
the DT O
principal JJ O
features NNS O
of IN O
the DT O
DM NNP B-Disease
mutation NN O
is VBZ O
an DT O
extraordinarily RB O
high JJ O
level NN O
of IN O
somatic JJ O
mosaicism NN O
, , O
due JJ O
to TO O
an DT O
extremely RB O
high JJ O
degree NN O
of IN O
somatic JJ O
instability NN O
both DT O
within IN O
and CC O
between IN O
different JJ O
tissues NNS O
. . O

This DT O
instability NN O
appears VBZ O
to TO O
be VB O
biased VBN O
towards IN O
further JJ O
expansion NN O
and CC O
continuous JJ O
throughout IN O
the DT O
life NN O
of IN O
an DT O
individual NN O
, , O
features VBZ O
that DT O
could MD O
be VB O
associated VBN O
with IN O
the DT O
progressive JJ O
nature NN O
of IN O
the DT O
disease NN O
. . O

Although IN O
increasing VBG O
measured VBN O
allele JJ O
size NN O
between IN O
patients NNS O
clearly RB O
correlates VBZ O
with IN O
an DT O
increased JJ O
severity NN O
of IN O
symptoms NNS O
and CC O
an DT O
earlier JJR O
age NN O
of IN O
onset NN O
, , O
this DT O
correlation NN O
is VBZ O
not RB O
precise JJ O
and CC O
measured VBD O
allele NNS O
length NN O
cannot NN O
be VB O
used VBN O
as IN O
an DT O
accurate JJ O
predictor NN O
of IN O
age NN O
of IN O
onset NN O
. . O

In IN O
order NN O
to TO O
further RBR O
characterize VB O
the DT O
dynamics NNS O
of IN O
DM NNP B-Disease
CTG NNP O
repeat NN O
somatic JJ O
instability NN O
, , O
we PRP O
have VBP O
studied VBN O
repeat NN O
length NN O
changes NNS O
over IN O
time NN O
in IN O
111 CD O
myotonic JJ B-Disease
dystrophy NN I-Disease
patients NNS O
with IN O
varying VBG O
clinical JJ O
severity NN O
and CC O
CTG NNP O
repeat NN O
size NN O
over IN O
time NN O
intervals NNS O
of IN O
1 CD O
- : O
7 CD O
years NNS O
. . O

We PRP O
have VBP O
found VBN O
a DT O
direct JJ O
progression NN O
of IN O
the DT O
size NN O
heterogeneity NN O
over IN O
time NN O
related VBN O
to TO O
initial JJ O
CTG NNP O
repeat NN O
size NN O
and CC O
the DT O
time NN O
interval NN O
and CC O
always RB O
biased VBN O
towards NNS O
further JJ O
expansion NN O
. . O

Attempts NNS O
to TO O
mathematically RB O
model VB O
the DT O
dynamics NNS O
have VBP O
proved VBN O
only RB O
partially RB O
successful JJ O
suggesting VBG O
that IN O
individual JJ O
specific JJ O
genetic JJ O
and CC O
/ NN O
or CC O
environmental JJ O
factors NNS O
also RB O
play VBP O
a DT O
role NN O
in IN O
somatic JJ O
mosaicism NN O
. . O
. . O

Aspartylglucosaminuria NNP B-Disease
among IN O
Palestinian JJ O
Arabs NNPS O
. . O

Aspartylglucosaminuria NNP B-Disease
( ( O
AGU NNP B-Disease
) ) O
is VBZ O
a DT O
rare JJ O
disorder NN B-Disease
of IN I-Disease
glycoprotein JJ I-Disease
metabolism NN I-Disease
caused VBN O
by IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
lysosomal JJ I-Disease
enzyme NN I-Disease
aspartylglucosaminidase NN I-Disease
( ( O
AGA NNP O
) ) O
. . O

AGU NNP B-Disease
is VBZ O
inherited VBN O
as IN O
an DT O
autosomal JJ O
recessive JJ O
trait NN O
and CC O
occurs VBZ O
with IN O
a DT O
high JJ O
frequency NN O
in IN O
Finland NNP O
because IN O
of IN O
a DT O
founder NN O
effect NN O
. . O

While IN O
very RB O
few JJ O
patients NNS O
with IN O
AGU NNP B-Disease
have VBP O
been VBN O
reported VBN O
from IN O
non JJ O
- : O
Finnish JJ O
origin NN O
, , O
we PRP O
diagnosed VBD O
the DT O
disorder NN O
in IN O
8 CD O
patients NNS O
originating VBG O
from IN O
3 CD O
unrelated JJ O
families NNS O
, , O
all DT O
Palestinian JJ O
Arabs NNP O
from IN O
the DT O
region NN O
of IN O
Jerusalem NNP O
. . O

The DT O
clinical JJ O
diagnosis NN O
of IN O
AGU NNP B-Disease
is VBZ O
often RB O
difficult JJ O
, , O
in IN O
particular JJ O
early JJ O
in IN O
the DT O
course NN O
of IN O
the DT O
disease NN O
, , O
and CC O
most JJS O
of IN O
the DT O
patients NNS O
are VBP O
diagnosed VBN O
after IN O
the DT O
age NN O
of IN O
5 CD O
years NNS O
. . O

However RB O
, , O
since IN O
these DT O
patients NNS O
excrete VBP O
early RB O
large JJ O
amounts NNS O
of IN O
aspartylglucosamine NN O
in IN O
urine NN O
, , O
biochemical JJ O
screening NN O
is VBZ O
easy JJ O
by IN O
urine JJ O
chromatography NN O
. . O
. . O

Detection NN O
of IN O
heterozygous JJ O
carriers NNS O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
ATM NNP O
) ) O
gene NN O
by IN O
G2 NNP O
phase NN O
chromosomal JJ O
radiosensitivity NN O
of IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

In IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
patients NNS O
, , O
mutations NNS O
in IN O
a DT O
single JJ O
gene NN O
, , O
ATM NNP O
, , O
result NN O
in IN O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
syndrome NN I-Disease
that WDT O
embraces VBZ O
a DT O
variety NN O
of IN O
clinical JJ O
features NNS O
and CC O
manifests NNS O
extreme VBP O
radiosensitivity NN O
and CC O
a DT O
strong JJ O
pre NN O
- : O
disposition NN O
to TO O
malignancy NN B-Disease
. . O

Heterozygotes NNS O
for IN O
the DT O
ATM NNP O
gene NN O
have VBP O
no DT O
clinical JJ O
expression NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
but CC O
may MD O
be VB O
cancer NN B-Disease
prone NN O
with IN O
a DT O
moderate JJ O
increase NN O
in IN O
in IN O
vitro JJ O
radiosensitivity NN O
. . O

We PRP O
performed VBD O
a DT O
blind NN O
chromosomal JJ O
analysis NN O
on IN O
G2 NNP O
- : O
phase NN O
lymphocytes VBZ O
from IN O
7 CD O
unrelated VBD O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
, , O
13 CD O
obligate NN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
heterozygotes NNS O
( ( O
parents NNS O
of IN O
the DT O
patients NNS O
) ) O
, , O
and CC O
14 CD O
normal JJ O
controls NNS O
following VBG O
X NNP O
- : O
irradiation NN O
with IN O
1 CD O
Gy NNP O
in IN O
order NN O
to TO O
evaluate VB O
this DT O
cytogenetic JJ O
method NN O
as IN O
a DT O
tool NN O
for IN O
detection NN O
of IN O
ATM NNP O
carriers NNS O
. . O

Both DT O
A NNP B-Disease
- : I-Disease
T NN I-Disease
homozygotes NNS O
and CC O
heterozygotes NNS O
showed VBD O
significantly RB O
increased VBN O
levels NNS O
of IN O
radiation NN O
- : O
induced JJ O
chromatid JJ O
damage NN O
relative NN O
to TO O
that DT O
of IN O
normal JJ O
controls NNS O
. . O

These DT O
results NNS O
show VBP O
that IN O
the DT O
G2 NNP O
- : O
phase NN O
chromosomal JJ O
radiosensitivity NN O
assay VBP O
can MD O
be VB O
used VBN O
for IN O
the DT O
detection NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
heterozygotes NNS O
. . O

In IN O
combination NN O
with IN O
molecular JJ O
genetic JJ O
analyses NNS O
, , O
this DT O
test NN O
may MD O
be VB O
of IN O
value NN O
in IN O
studies NNS O
of IN O
familial JJ B-Disease
and CC I-Disease
sporadic JJ I-Disease
cancers NNS I-Disease
aimed VBN O
at IN O
determination NN O
of IN O
the DT O
potential JJ O
involvement NN O
of IN O
ATM NNP O
mutations NNS O
in IN O
tumor NN B-Disease
risk NN O
or CC O
development NN O
. . O
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
: : O
identification NN O
and CC O
detection NN O
of IN O
founder NN O
- : O
effect NN O
mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
in IN O
ethnic JJ O
populations NNS O
. . O

To TO O
facilitate VB O
the DT O
evaluation NN O
of IN O
ATM NNP O
heterozygotes NNS O
for IN O
susceptibility NN O
to TO O
other JJ O
diseases NNS O
, , O
such JJ O
as IN O
breast NN B-Disease
cancer NN I-Disease
, , O
we PRP O
have VBP O
attempted VBN O
to TO O
define VB O
the DT O
most RBS O
common JJ O
mutations NNS O
and CC O
their PRP$ O
frequencies NNS O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
homozygotes VBZ O
from IN O
10 CD O
ethnic JJ O
populations NNS O
. . O

Both DT O
genomic JJ O
mutations NNS O
and CC O
their PRP$ O
effects NNS O
on IN O
cDNA NN O
were VBD O
characterized VBN O
. . O

Protein NNP O
- : O
truncation NN O
testing NN O
of IN O
the DT O
entire JJ O
ATM NNP O
cDNA NN O
detected VBD O
92 CD O
( ( O
66 CD O
% NN O
) ) O
truncating VBG O
mutations NNS O
in IN O
140 CD O
mutant JJ O
alleles NNS O
screened VBN O
. . O

The DT O
haplotyping NN O
of IN O
patients NNS O
with IN O
identical JJ O
mutations NNS O
indicates VBZ O
that IN O
almost RB O
all DT O
of IN O
these DT O
represent JJ O
common JJ O
ancestry NN O
and CC O
that DT O
very RB O
few JJ O
spontaneously RB O
recurring VBG O
ATM NNP O
mutations NNS O
exist VBP O
. . O

Assays NNS O
requiring VBG O
minimal JJ O
amounts NNS O
of IN O
genomic JJ O
DNA NNP O
were VBD O
designed VBN O
to TO O
allow VB O
rapid JJ O
screening NN O
for IN O
common JJ O
ethnic JJ O
mutations NNS O
. . O

These DT O
rapid JJ O
assays NNS O
detected VBN O
mutations NNS O
in IN O
76 CD O
% NN O
of IN O
Costa JJ O
Rican JJ O
patients NNS O
( ( O
3 CD O
) ) O
, , O
50 CD O
% NN O
of IN O
Norwegian JJ O
patients NNS O
( ( O
1 CD O
) ) O
, , O
25 CD O
% NN O
of IN O
Polish JJ O
patients NNS O
( ( O
4 CD O
) ) O
, , O
and CC O
14 CD O
% NN O
of IN O
Italian JJ O
patients NNS O
( ( O
1 CD O
) ) O
, , O
as RB O
well RB O
as IN O
in IN O
patients NNS O
of IN O
Amish NNP O
/ NNP O
Mennonite NNP O
and CC O
Irish NNP O
English NNP O
backgrounds NNS O
. . O

Additional JJ O
mutations NNS O
were VBD O
observed VBN O
in IN O
Japanese JJ O
, , O
Utah NNP O
Mormon NNP O
, , O
and CC O
African JJ O
American JJ O
patients NNS O
. . O

These DT O
assays NNS O
should MD O
facilitate VB O
screening VBG O
for IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
heterozygotes NNS O
in IN O
the DT O
populations NNS O
studied VBN O
. . O
. . O

The DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
tumor NN I-Disease
suppressor NN O
gene NN O
is VBZ O
required VBN O
for IN O
cell NN O
cycle NN O
exit NN O
upon IN O
serum NN O
withdrawal NN O
. . O

The DT O
inactivation NN O
of IN O
the DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( I-Disease
VHL NNP I-Disease
) ) I-Disease
tumor NN I-Disease
suppressor NN O
gene NN O
predisposes NNS O
affected VBD O
individuals NNS O
to TO O
the DT O
human JJ O
VHL NNP B-Disease
cancer NN I-Disease
syndrome NN I-Disease
and CC O
is VBZ O
associated VBN O
with IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinomas NN I-Disease
( ( O
RCC NNP B-Disease
) ) O
and CC O
brain NN B-Disease
hemangioblastomas NN I-Disease
. . O

VHL NNP O
- : O
negative JJ O
786 CD O
- : O
0 CD O
RCC NNP B-Disease
cells NNS O
are VBP O
tumorigenic JJ O
in IN O
nude JJ O
mice NN O
which WDT O
is VBZ O
suppressed VBN O
by IN O
the DT O
reintroduction NN O
of IN O
VHL NNP B-Disease
. . O

Remarkably RB O
, , O
this DT O
occurs VBZ O
without IN O
affecting VBG O
the DT O
growth NN O
rate NN O
and CC O
cell NN O
cycle NN O
profile NN O
of IN O
these DT O
cells NNS O
in IN O
culture NN O
. . O

The DT O
786 CD O
- : O
0 CD O
cell NN O
line NN O
, , O
like IN O
many JJ O
cancer NN B-Disease
cells NNS O
, , O
fails VBZ O
to TO O
exit VB O
the DT O
cell NN O
cycle NN O
upon IN O
serum NN O
withdrawal NN O
. . O

Here RB O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
reintroduction NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
VHL NNP B-Disease
gene NN O
restores VBZ O
the DT O
ability NN O
of IN O
VHL NNP O
- : O
negative JJ O
RCC NNP B-Disease
cancer NN I-Disease
cells NNS O
to TO O
exit VB O
the DT O
cell NN O
cycle NN O
and CC O
enter NN O
G0 NNP O
/ NNP O
quiescence NN O
in IN O
low JJ O
serum NN O
. . O

Both DT O
VHL NNP O
- : O
positive JJ O
and CC O
VHL NNP O
- : O
negative JJ O
RCC NNP B-Disease
cells NNS O
exit VBP O
the DT O
cell NN O
cycle NN O
by IN O
contact JJ O
inhibition NN O
. . O

The DT O
cyclin NN O
- : O
dependent JJ O
kinase NN O
inhibitor NN O
, , O
p27 NN O
, , O
accumulates VBZ O
upon IN O
serum NN O
withdrawal NN O
, , O
only RB O
in IN O
the DT O
presence NN O
of IN O
VHL NNP B-Disease
, , O
as IN O
a DT O
result NN O
of IN O
the DT O
stabilization NN O
of IN O
the DT O
protein NN O
. . O

We PRP O
propose VBP O
that IN O
the DT O
loss NN O
of IN O
wild JJ O
- : O
type NN O
VHL NNP B-Disease
gene NN O
results NNS O
in IN O
a DT O
specific JJ O
cellular JJ O
defect NN O
in IN O
serum JJ O
- : O
dependent JJ O
growth NN O
control NN O
, , O
which WDT O
may MD O
initiate VB O
tumor NN B-Disease
formation NN O
. . O

This DT O
is VBZ O
corrected VBN O
by IN O
the DT O
reintroduction NN O
of IN O
wild JJ O
- : O
type NN O
VHL NNP B-Disease
, , O
implicating VBG O
VHL NNP B-Disease
as IN O
the DT O
first JJ O
tumor NN B-Disease
suppressor NN O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
cycle NN O
exit NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
its PRP$ O
gatekeeper NN O
function NN O
in IN O
the DT O
kidney NN O
. . O
. . O

Piebaldism NN B-Disease
with IN O
deafness NN B-Disease
: : O
molecular JJ O
evidence NN O
for IN O
an DT O
expanded JJ O
syndrome NN O
. . O

In IN O
a DT O
South JJ O
African JJ O
girl NN O
of IN O
Xhosa NNP O
stock NN O
with IN O
severe JJ O
piebaldism NN B-Disease
and CC O
profound JJ O
congenital JJ O
sensorineural JJ B-Disease
deafness NN I-Disease
we PRP O
identified VBD O
a DT O
novel JJ O
missense NN O
substitution NN O
at IN O
a DT O
highly RB O
conserved VBN O
residue NN O
in IN O
the DT O
intracellular JJ O
kinase NN O
domain NN O
of IN O
the DT O
KIT NNP O
proto NN O
- : O
oncogene NN O
, , O
R796G NNP O
. . O

Though IN O
auditory JJ B-Disease
anomalies NNS I-Disease
have VBP O
been VBN O
observed VBN O
in IN O
mice NN O
with IN O
dominant JJ O
white JJ O
spotting NN O
( ( O
W NNP O
) ) O
due JJ O
to TO O
KIT NNP O
mutations NNS O
, , O
deafness NN B-Disease
is VBZ O
not RB O
typical JJ O
in IN O
human JJ O
piebaldism NN B-Disease
. . O

Thus RB O
, , O
the DT O
occurrence NN O
of IN O
sensorineural JJ B-Disease
deafness NN I-Disease
in IN O
this DT O
patient JJ O
extends VBZ O
considerably RB O
the DT O
phenotypic NN O
range NN O
of IN O
piebaldism NN B-Disease
due JJ O
to TO O
KIT NNP O
gene NN O
mutation NN O
in IN O
humans NNS O
and CC O
tightens VBZ O
the DT O
clinical JJ O
similarity NN O
between IN O
piebaldism NN B-Disease
and CC O
the DT O
various JJ O
forms NNS O
of IN O
Waardenburg NNP B-Disease
syndrome NN I-Disease
. . O
. . O

Cycloheximide NNP O
facilitates VBZ O
the DT O
identification NN O
of IN O
aberrant JJ O
transcripts NNS O
resulting VBG O
from IN O
a DT O
novel JJ O
splice NN O
- : O
site NN O
mutation NN O
in IN O
COL17A1 NNP O
in IN O
a DT O
patient NN O
with IN O
generalized JJ O
atrophic JJ B-Disease
benign NN I-Disease
epidermolysis NN I-Disease
bullosa NN I-Disease
. . O

Patients NNS O
with IN O
generalized JJ O
atrophic JJ B-Disease
benign NN I-Disease
epidermolysis NN I-Disease
bullosa NN I-Disease
often RB O
show VBP O
decreased JJ O
expression NN O
of IN O
type NN O
XVII NNP O
collagen NN O
, , O
a DT O
transmembrane NN O
hemidesmosomal JJ O
protein NN O
encoded VBN O
by IN O
COL17A1 NNP O
. . O

This DT O
report NN O
documents NNS O
a DT O
novel JJ O
splice NN O
- : O
site NN O
mutation NN O
in IN O
COL17A1 NNP O
in IN O
a DT O
patient NN O
with IN O
generalized JJ O
atrophic JJ B-Disease
benign NN I-Disease
epidermolysis NN I-Disease
bullosa NN I-Disease
, , O
and CC O
applies VBZ O
a DT O
new JJ O
methodology NN O
to TO O
define VB O
and CC O
characterize VB O
the DT O
resulting VBG O
mRNA JJ O
splice NN O
variants NNS O
. . O

Mutational JJ O
analysis NN O
of IN O
COL17A1 NNP O
identified VBD O
a DT O
maternally RB O
inherited VBN O
G NNP O
- : O
to TO O
- : O
T VB O
transversion NN O
at IN O
the DT O
- : O
1 CD O
position NN O
of IN O
exon JJ O
32 CD O
. . O

This DT O
acceptor NN O
splice NN O
- : O
site NN O
mutation NN O
led VBD O
to TO O
the DT O
formation NN O
of IN O
aberrant JJ O
transcripts NNS O
present JJ O
at IN O
extremely RB O
low JJ O
levels NNS O
. . O

Based VBN O
on IN O
our PRP$ O
recent JJ O
finding NN O
that IN O
cycloheximide NN O
stabilized VBD O
mutant JJ O
COL17A1 NNP O
transcripts NNS O
in IN O
keratinocytes NNS O
homozygous JJ O
for IN O
a DT O
frameshift NN O
mutation NN O
, , O
the DT O
effects NNS O
of IN O
the DT O
splice NN O
- : O
site NN O
mutation NN O
on IN O
splicing NN O
of IN O
COL17A1 NNP O
transcripts NNS O
were VBD O
determined VBN O
using VBG O
reverse JJ O
transcriptase NN O
polymerase NN O
chain NN O
reaction NN O
of IN O
total JJ O
RNA NNP O
from IN O
keratinocytes NNS O
incubated VBN O
for IN O
2 CD O
. . O

5 CD O
h NN O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
10 CD O
microg NNS O
cycloheximide JJ O
per IN O
ml NN O
. . O

Using VBG O
this DT O
approach NN O
, , O
an DT O
abnormally RB O
spliced JJ O
transcript NN O
was VBD O
identified VBN O
that IN O
contains VBZ O
an DT O
extra JJ O
264 CD O
bases NNS O
upstream RB O
from IN O
exon JJ O
32 CD O
, , O
resulting VBG O
in IN O
a DT O
premature NN O
termination NN O
codon VBZ O
27 CD O
bp NN O
downstream NN O
from IN O
the DT O
cryptic JJ O
splice NN O
site NN O
. . O

Three CD O
other JJ O
splice NN O
variants NNS O
, , O
including VBG O
one CD O
derived VBN O
from IN O
the DT O
skipping NN O
of IN O
exon $ O
32 CD O
, , O
were VBD O
also RB O
identified VBN O
. . O

These DT O
results NNS O
indicate VBP O
the DT O
usefulness NN O
of IN O
cycloheximide JJ O
treatment NN O
in IN O
evaluating VBG O
the DT O
abnormal JJ O
processing NN O
of IN O
mRNA NN O
due JJ O
to TO O
splice VB O
- : O
site NN O
mutations NNS O
, , O
because IN O
( ( O
i NN O
) ) O
aberrant NN O
splicing VBG O
often RB O
generates VBZ O
a DT O
premature JJ O
termination NN O
codon NN O
, , O
( ( O
ii NN O
) ) O
transcripts NNS O
with IN O
premature JJ O
termination NN O
codons NNS O
can MD O
occur VB O
at IN O
low JJ O
or CC O
undetectable JJ O
levels NNS O
due JJ O
to TO O
nonsense VB O
- : O
mediated VBN O
mRNA NN O
decay NN O
, , O
and CC O
( ( O
iii NN O
) ) O
the DT O
levels NNS O
of IN O
these DT O
transcripts NNS O
can MD O
be VB O
increased VBN O
by IN O
cycloheximide NN O
. . O

A DT O
deletion NN O
mutation NN O
in IN O
COL17A1 NNP O
in IN O
five CD O
Austrian JJ O
families NNS O
with IN O
generalized JJ O
atrophic JJ B-Disease
benign NN I-Disease
epidermolysis NN I-Disease
bullosa NN I-Disease
represents VBZ O
propagation NN O
of IN O
an DT O
ancestral JJ O
allele NN O
. . O

Patients NNS O
with IN O
generalized JJ O
atrophic JJ B-Disease
benign NN I-Disease
epidermolysis NN I-Disease
bullosa NN I-Disease
, , O
a DT O
usually RB O
nonlethal JJ O
form NN O
of IN O
junctional JJ B-Disease
epidermolysis NN I-Disease
bullosa NN I-Disease
, , O
have VBP O
generalized VBN O
blistering NN B-Disease
, , O
nail JJ B-Disease
dystrophy NN I-Disease
, , O
patchy NN B-Disease
alopecia NN I-Disease
, , O
and CC O
dental JJ B-Disease
abnormalities NNS I-Disease
. . O

Skin NNP B-Disease
fragility NN I-Disease
in IN O
most JJS O
cases NNS O
is VBZ O
due JJ O
to TO O
mutations NNS O
in IN O
the DT O
gene NN O
encoding VBG O
type JJ O
XVII NN O
collagen NN O
( ( O
COL17A1 NNP O
) ) O
. . O

Recently RB O
, , O
we PRP O
reported VBD O
five CD O
Austrian JJ O
families NNS O
with IN O
generalized JJ O
atrophic JJ B-Disease
benign NN I-Disease
epidermolysis NN I-Disease
bullosa NN I-Disease
who WP O
share NN O
the DT O
same JJ O
COL17A1 NNP O
mutation NN O
. . O

Affected JJ O
individuals NNS O
in IN O
three CD O
families NNS O
are VBP O
homozygous JJ O
for IN O
4003delTC CD O
, , O
whereas NNS O
those DT O
in IN O
two CD O
others NNS O
are VBP O
compound JJ O
heterozygotes NNS O
. . O

To TO O
determine VB O
if IN O
the DT O
occurrence NN O
of IN O
4003delTC CD O
in IN O
these DT O
unrelated JJ O
families NNS O
signifies VBZ O
propagation NN O
of IN O
an DT O
ancestral JJ O
allele NN O
or CC O
a DT O
mutational JJ O
hot JJ O
spot NN O
, , O
haplotypes NNS O
were VBD O
determined VBN O
for IN O
polymorphisms NNS O
both DT O
within IN O
and CC O
flanking VBG O
COL17A1 NNP O
. . O

Five CD O
intragenic JJ O
polymorphisms NNS O
were VBD O
chosen VBN O
based VBN O
on IN O
their PRP$ O
informativeness NN O
. . O

One CD O
of IN O
these DT O
, , O
not RB O
previously RB O
reported VBN O
, , O
was VBD O
2988 CD O
A NNP O
or CC O
C NNP O
that WDT O
introduces VBZ O
a DT O
new JJ O
restriction NN O
site NN O
for IN O
Eco0109 NNP O
I PRP O
. . O

All PDT O
the DT O
4003delTC CD O
alleles NNS O
showed VBD O
the DT O
same JJ O
haplotype NN O
for IN O
these DT O
five CD O
polymorphic JJ O
markers NNS O
. . O

Fourteen NNP O
microsatellite JJ O
polymorphisms NNS O
were VBD O
selected VBN O
based VBN O
on IN O
their PRP$ O
high JJ O
heterozygosity NN O
and CC O
their PRP$ O
location NN O
within IN O
10q23 CD O
- : O
q25 NN O
near IN O
COL17A1 NNP O
. . O

Three CD O
families NNS O
shared VBD O
microsatellite JJ O
polymorphisms NNS O
covering VBG O
at IN O
most JJS O
19 CD O
cM NN O
, , O
whereas IN O
the DT O
others NNS O
shared VBD O
smaller JJR O
regions NNS O
consistent VBP O
with IN O
cross NN O
- : O
over IN O
events NNS O
during IN O
passage NN O
of IN O
this DT O
mutation NN O
through IN O
several JJ O
generations NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
4003delTC CD O
occurs NNS O
on IN O
a DT O
single JJ O
ancestral JJ O
allele NN O
. . O
. . O

The DT O
haptoglobin NN O
- : O
gene NN O
deletion NN O
responsible JJ O
for IN O
anhaptoglobinemia NN B-Disease
. . O

We PRP O
have VBP O
found VBN O
an DT O
allelic JJ O
deletion NN O
of IN O
the DT O
haptoglobin NN O
( ( O
Hp NNP O
) ) O
gene NN O
from IN O
an DT O
individual NN O
with IN O
anhaptoglobinemia NN B-Disease
. . O

The DT O
Hp NNP O
gene NN O
cluster NN O
consists VBZ O
of IN O
coding VBG O
regions NNS O
of IN O
the DT O
alpha NN O
chain NN O
and CC O
beta NN O
chain NN O
of IN O
the DT O
haptoglobin NN O
gene NN O
( ( O
Hp NNP O
) ) O
and CC O
of IN O
the DT O
alpha NN O
chain NN O
and CC O
beta NN O
chain NN O
of IN O
the DT O
haptoglobin NN O
- : O
related VBN O
gene NN O
( ( O
Hpr NNP O
) ) O
, , O
in IN O
tandem NN O
from IN O
the DT O
5 CD O
side NN O
. . O

Southern NNP O
blot NN O
and CC O
PCR NNP O
analyses NNS O
have VBP O
indicated VBN O
that IN O
the DT O
individual NN O
with IN O
anhaptoglobinemia NN B-Disease
was VBD O
homozygous JJ O
for IN O
the DT O
gene NN O
deletion NN O
and CC O
that IN O
the DT O
gene NN O
deletion NN O
was VBD O
included VBN O
at IN O
least JJS O
from IN O
the DT O
promoter NN O
region NN O
of IN O
Hp NNP O
to TO O
Hpr NNP O
alpha NN O
but CC O
not RB O
to TO O
Hpr NNP O
beta NN O
( ( O
Hpdel NNP O
) ) O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
seven CD O
individuals NNS O
with IN O
hypohaptoglobinemia NN B-Disease
in IN O
three CD O
families NNS O
, , O
and CC O
the DT O
genotypes NNS O
of IN O
six CD O
of IN O
the DT O
seven CD O
individuals NNS O
were VBD O
found VBN O
to TO O
be VB O
Hp2 NNP O
/ NNP O
Hpdel NNP O
. . O

The DT O
phenotypes NNS O
and CC O
genotypes NNS O
in IN O
one CD O
of IN O
these DT O
three CD O
families NNS O
showed VBD O
the DT O
father NN O
to TO O
be VB O
hypohaptoglobinemic JJ B-Disease
( ( O
Hp2 NNP O
) ) O
and CC O
Hp2 NNP O
/ NNP O
Hpdel NNP O
, , O
the DT O
mother NN O
to TO O
be VB O
Hp2 NNP O
- : O
1 CD O
and CC O
Hp1 NNP O
/ NNP O
Hp2 NNP O
, , O
one CD O
of IN O
the DT O
two CD O
children NNS O
to TO O
be VB O
hypohaptoglobinemic JJ B-Disease
( ( O
Hp2 NNP O
) ) O
and CC O
Hp2 NNP O
/ NNP O
Hpdel NNP O
, , O
and CC O
the DT O
other JJ O
child NN O
to TO O
be VB O
Hp1 NNP O
and CC O
Hp1 NNP O
/ NNP O
Hpdel NNP O
, , O
showing VBG O
an DT O
anomalous JJ O
inheritance NN O
of IN O
Hp NNP O
phenotypes NNS O
in IN O
the DT O
child NN O
with IN O
Hp1 NNP O
. . O

The DT O
Hp2 NNP O
/ NNP O
Hpdel NNP O
individuals NNS O
had VBD O
an DT O
extremely RB O
low JJ O
level NN O
of IN O
Hp NNP O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NNP O
= VBZ O
0 CD O
. . O
49 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
43 CD O
mg JJ O
/ NNP O
ml NN O
; : O
n CC O
= VB O
6 CD O
) ) O
, , O
compared VBN O
with IN O
the DT O
level NN O
( ( O
1 CD O
. . O
64 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
7 CD O
mg JJ O
/ NNP O
ml NN O
) ) O
obtained VBD O
from IN O
52 CD O
healthy JJ O
volunteers NNS O
having VBG O
phenotype NN O
Hp2 NNP O
, , O
whereas IN O
the DT O
serum NN O
Hp NNP O
level NN O
of IN O
an DT O
individual NN O
with IN O
Hp1 NNP O
/ NNP O
Hpdel NNP O
was VBD O
0 CD O
. . O

50 CD O
mg NN O
/ NNP O
ml NN O
, , O
which WDT O
was VBD O
approximately RB O
half PDT O
the DT O
level NN O
of IN O
Hp NNP O
in IN O
control NN O
sera NN O
from IN O
the DT O
Hp1 NNP O
phenotype NN O
( ( O
1 CD O
. . O
26 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
33 CD O
mg JJ O
/ NNP O
ml NN O
; : O
n CC O
= VB O
9 CD O
) ) O
, , O
showing VBG O
a DT O
gene NN O
- : O
dosage NN O
effect NN O
. . O

The DT O
other JJ O
allele NN O
( ( O
Hp2 NNP O
) ) O
of IN O
individuals NNS O
with IN O
Hp2 NNP O
/ NNP O
Hpdel NNP O
was VBD O
found VBN O
to TO O
have VB O
, , O
in IN O
all DT O
exons NNS O
, , O
no DT O
mutation NN O
, , O
by IN O
DNA NNP O
sequencing NN O
. . O

On IN O
the DT O
basis NN O
of IN O
the DT O
present JJ O
study NN O
, , O
the DT O
mechanism NN O
of IN O
anhaptoglobinemia NN B-Disease
and CC O
the DT O
mechanism NN O
of IN O
anomalous JJ O
inheritance NN O
of IN O
Hp NNP O
phenotypes NNS O
were VBD O
well RB O
explained VBN O
. . O

However RB O
, , O
the DT O
mechanism NN O
of IN O
hypohaptoglobinemia NN B-Disease
remains VBZ O
unknown JJ O

ATM NNP O
mutations NNS O
and CC O
phenotypes NNS O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
families NNS O
in IN O
the DT O
British JJ O
Isles NNS O
: : O
expression NN O
of IN O
mutant JJ O
ATM NNP O
and CC O
the DT O
risk NN O
of IN O
leukemia NN B-Disease
, , O
lymphoma NN B-Disease
, , O
and CC O
breast NN B-Disease
cancer NN I-Disease
. . O

We PRP O
report VBP O
the DT O
spectrum NN O
of IN O
59 CD O
ATM NNP O
mutations NNS O
observed VBD O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
patients NNS O
in IN O
the DT O
British JJ O
Isles NNP O
. . O

Of IN O
51 CD O
ATM NNP O
mutations NNS O
identified VBN O
in IN O
families NNS O
native VBP O
to TO O
the DT O
British JJ O
Isles NNP O
, , O
11 CD O
were VBD O
founder NN O
mutations NNS O
, , O
and CC O
2 CD O
of IN O
these DT O
11 CD O
conferred VBD O
a DT O
milder NN O
clinical JJ O
phenotype NN O
with IN O
respect NN O
to TO O
both DT O
cerebellar JJ B-Disease
degeneration NN I-Disease
and CC O
cellular JJ O
features NNS O
. . O

We PRP O
report VBP O
, , O
in IN O
two CD O
A NNP B-Disease
- : I-Disease
T NN I-Disease
families NNS O
, , O
an DT O
ATM NNP O
mutation NN O
( ( O
7271T CD O
- : O
- : O
> NN O
G NNP O
) ) O
that WDT O
may MD O
be VB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
in IN O
both DT O
homozygotes NNS O
and CC O
heterozygotes NNS O
( ( O
relative JJ O
risk NN O
12 CD O
. . O
7 CD O
; : O
P NNP O
= NNP O
. . O
25 CD O
) ) O
, , O
although IN O
there EX O
is VBZ O
a DT O
less RBR O
severe JJ O
A NNP B-Disease
- : I-Disease
T NN I-Disease
phenotype NN O
in IN O
terms NNS O
of IN O
the DT O
degree NN O
of IN O
cerebellar JJ B-Disease
degeneration NN I-Disease
. . O

This DT O
mutation NN O
( ( O
7271T CD O
- : O
- : O
> NN O
G NNP O
) ) O
also RB O
allows VBZ O
expression NN O
of IN O
full JJ O
- : O
length NN O
ATM NNP O
protein NN O
at IN O
a DT O
level NN O
comparable JJ O
with IN O
that DT O
in IN O
unaffected JJ O
individuals NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
have VBP O
studied VBN O
18 CD O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
, , O
in IN O
15 CD O
families NNS O
, , O
who WP O
developed VBD O
leukemia NN B-Disease
, , O
lymphoma NN B-Disease
, , O
preleukemic JJ O
T NNP O
- : O
cell NN O
proliferation NN O
, , O
or CC O
Hodgkin NNP B-Disease
lymphoma NN I-Disease
, , O
mostly RB O
in IN O
childhood NN O
. . O

A DT O
wide JJ O
variety NN O
of IN O
ATM NNP O
mutation NN O
types NNS O
, , O
including VBG O
missense JJ O
mutations NNS O
and CC O
in IN O
- : O
frame NN O
deletions NNS O
, , O
were VBD O
seen VBN O
in IN O
these DT O
patients NNS O
. . O

We PRP O
also RB O
show VBP O
that IN O
25 CD O
% NN O
of IN O
all PDT O
A DT B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
carried VBD O
in IN O
- : O
frame NN O
deletions NNS O
or CC O
missense NN O
mutations NNS O
, , O
many JJ O
of IN O
which WDT O
were VBD O
also RB O
associated VBN O
with IN O
expression NN O
of IN O
mutant JJ O
ATM NNP O
protein NN O
. . O

The DT O
DMPK NNP O
gene NN O
of IN O
severely RB O
affected JJ O
myotonic JJ B-Disease
dystrophy NN I-Disease
patients NNS O
is VBZ O
hypermethylated VBN O
proximal JJ O
to TO O
the DT O
largely RB O
expanded JJ O
CTG NNP O
repeat NN O
. . O

Using VBG O
methylation NN O
- : O
sensitive JJ O
restriction NN O
enzymes NNS O
, , O
we PRP O
characterized VBD O
the DT O
methylation NN O
pattern NN O
on IN O
the DT O
5 CD O
side NN O
of IN O
the DT O
CTG NNP O
repeat NN O
in IN O
the DT O
DMPK NNP O
gene NN O
of IN O
normal JJ O
individuals NNS O
and CC O
of IN O
patients NNS O
affected VBN O
with IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
showing VBG O
expansions NNS O
of IN O
the DT O
repetitive JJ O
sequence NN O
. . O

The DT O
gene NN O
segment NN O
analyzed VBD O
corresponds NNS O
to TO O
the DT O
genomic JJ O
SacI NNP O
- : O
HindIII NNP O
fragment NN O
carrying VBG O
exons NNS O
11 CD O
- : O
15 CD O
. . O

There EX O
is VBZ O
constitutive JJ O
methylation NN O
in IN O
intron NN O
12 CD O
at IN O
restriction NN O
sites NNS O
of IN O
SacII NNP O
and CC O
HhaI NNP O
, , O
localized VBD O
1 CD O
, , O
159 CD O
- : O
1 CD O
, , O
232 CD O
bp NN O
upstream NN O
of IN O
the DT O
CTG NNP O
repeat NN O
, , O
whereas IN O
most JJS O
, , O
if IN O
not RB O
all DT O
, , O
of IN O
the DT O
other JJ O
sites NNS O
of IN O
SacII NNP O
, , O
HhaI NNP O
, , O
and CC O
HpaII NNP O
in IN O
this DT O
region NN O
are VBP O
unmethylated VBN O
, , O
in IN O
normal JJ O
individuals NNS O
and CC O
most JJS O
of IN O
the DT O
patients NNS O
. . O

In IN O
a DT O
number NN O
of IN O
young JJ O
and CC O
severely RB O
affected JJ O
patients NNS O
, , O
however RB O
, , O
complete JJ O
methylation NN O
of IN O
these DT O
restriction NN O
sites NNS O
was VBD O
found VBN O
in IN O
the DT O
mutated JJ O
allele NN O
. . O

In IN O
most JJS O
of IN O
these DT O
patients NNS O
, , O
the DT O
onset NN O
of IN O
the DT O
disease NN O
was VBD O
congenital JJ O
. . O

Preliminary JJ O
in IN O
vivo JJ O
footprinting VBG O
data NNS O
gave VBD O
evidence NN O
for IN O
protein NN O
- : O
DNA NN O
contact NN O
in IN O
normal JJ O
genes NNS O
at IN O
an DT O
Sp1 NNP O
consensus NN O
binding VBG O
site NN O
upstream NN O
of IN O
the DT O
CTG NNP O
repeat NN O
and CC O
for IN O
a DT O
significant JJ O
reduction NN O
of IN O
this DT O
interaction NN O
in IN O
cells NNS O
with IN O
a DT O
hypermethylated VBN O
DMPK NNP O
gene NN O
. . O
. . O

The DT O
hemochromatosis NN B-Disease
gene NN O
product NN O
complexes NNS O
with IN O
the DT O
transferrin NN O
receptor NN O
and CC O
lowers VBZ O
its PRP$ O
affinity NN O
for IN O
ligand NN O
binding NN O
. . O

We PRP O
recently RB O
reported VBD O
the DT O
positional JJ O
cloning NN O
of IN O
a DT O
candidate NN O
gene NN O
for IN O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
called VBN O
HFE NNP O
. . O

The DT O
gene NN O
product NN O
, , O
a DT O
member NN O
of IN O
the DT O
major JJ O
histocompatibility NN O
complex JJ O
class NN O
I PRP O
- : O
like IN O
family NN O
, , O
was VBD O
found VBN O
to TO O
have VB O
a DT O
mutation NN O
, , O
Cys NNP O
- : O
282 CD O
- : O
- : O
> NN O
Tyr NNP O
( ( O
C282Y NNP O
) ) O
, , O
in IN O
85 CD O
% NN O
of IN O
patient JJ O
chromosomes NNS O
. . O

This DT O
mutation NN O
eliminates VBZ O
the DT O
ability NN O
of IN O
HFE NNP O
to TO O
associate VB O
with IN O
beta2 JJ O
- : O
microglobulin NN O
( ( O
beta2m NN O
) ) O
and CC O
prevents NNS O
cell VBP O
- : O
surface NN O
expression NN O
. . O

A DT O
second JJ O
mutation NN O
that WDT O
has VBZ O
no DT O
effect NN O
on IN O
beta2m NN O
association NN O
, , O
H63D NNP O
, , O
was VBD O
found VBN O
in IN O
eight CD O
out IN O
of IN O
nine CD O
patients NNS O
heterozygous JJ O
for IN O
the DT O
C282Y NNP O
mutant NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
demonstrate VBP O
in IN O
cultured JJ O
293 CD O
cells NNS O
overexpressing VBG O
wild JJ O
- : O
type NN O
or CC O
mutant JJ O
HFE NNP O
proteins VBZ O
that IN O
both DT O
the DT O
wild JJ O
- : O
type NN O
and CC O
H63D NNP O
HFE NNP O
proteins VBZ O
form VB O
stable JJ O
complexes NNS O
with IN O
the DT O
transferrin NN O
receptor NN O
( ( O
TfR NNP O
) ) O
. . O

The DT O
C282Y NNP O
mutation NN O
nearly RB O
completely RB O
prevents VBZ O
the DT O
association NN O
of IN O
the DT O
mutant JJ O
HFE NNP O
protein NN O
with IN O
the DT O
TfR NNP O
. . O

Studies NNS O
on IN O
cell NN O
- : O
associated VBN O
transferrin NN O
at IN O
37 CD O
degrees NNS O
C NNP O
suggest VBP O
that IN O
the DT O
overexpressed JJ O
wild JJ O
- : O
type NN O
HFE NNP O
protein NN O
decreases VBZ O
the DT O
affinity NN O
of IN O
the DT O
TfR NNP O
for IN O
transferrin NN O
. . O

The DT O
overexpressed JJ O
H63D NNP O
protein NN O
does VBZ O
not RB O
have VB O
this DT O
effect NN O
, , O
providing VBG O
the DT O
first JJ O
direct JJ O
evidence NN O
for IN O
a DT O
functional JJ O
consequence NN O
of IN O
the DT O
H63D NNP O
mutation NN O
. . O

Addition NN O
of IN O
soluble JJ O
wild JJ O
- : O
type NN O
HFE NNP O
/ NNP O
beta2m NN O
heterodimers NNS O
to TO O
cultured VB O
cells NNS O
also RB O
decreased VBD O
the DT O
apparent JJ O
affinity NN O
of IN O
the DT O
TfR NNP O
for IN O
its PRP$ O
ligand NN O
under IN O
steady JJ O
- : O
state NN O
conditions NNS O
, , O
both DT O
in IN O
293 CD O
cells NNS O
and CC O
in IN O
HeLa NNP O
cells NNS O
. . O

Furthermore RB O
, , O
at IN O
4 CD O
degrees NNS O
C NNP O
, , O
the DT O
added JJ O
soluble JJ O
complex NN O
of IN O
HFE NNP O
/ NNP O
beta2m NN O
inhibited VBD O
binding NN O
of IN O
transferrin NN O
to TO O
HeLa NNP O
cell NN O
TfR NNP O
in IN O
a DT O
concentration NN O
- : O
dependent JJ O
manner NN O
. . O

Scatchard NNP O
plots NNS O
of IN O
these DT O
data NNS O
indicate VBP O
that IN O
the DT O
added JJ O
heterodimer NN O
substantially RB O
reduced VBD O
the DT O
affinity NN O
of IN O
TfR NNP O
for IN O
transferrin NN O
. . O

These DT O
results NNS O
establish VB O
a DT O
molecular JJ O
link NN O
between IN O
HFE NNP O
and CC O
a DT O
key JJ O
protein NN O
involved VBN O
in IN O
iron NN O
transport NN O
, , O
the DT O
TfR NNP O
, , O
and CC O
raise VB O
the DT O
possibility NN O
that IN O
alterations NNS O
in IN O
this DT O
regulatory JJ O
mechanism NN O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
. . O
. . O

Genomic NNP O
organization NN O
of IN O
the DT O
UBE3A NNP O
/ NNP O
E6 NNP O
- : O
AP NNP O
gene NN O
and CC O
related JJ O
pseudogenes NNS O
. . O

The DT O
UBE3A NNP O
gene NN O
encodes VBZ O
the DT O
E6 NNP O
- : O
AP NNP O
ubiquitin JJ O
- : O
protein NN O
ligase NN O
and CC O
has VBZ O
recently RB O
been VBN O
shown VBN O
to TO O
be VB O
mutated VBN O
in IN O
Angelman NNP B-Disease
syndrome JJ I-Disease
patients NNS O
who WP O
lack VBP O
15q11 CD O
- : O
q13 NN O
deletions NNS O
or CC O
chromosome VB O
15 CD O
paternal JJ O
uniparental JJ B-Disease
disomy NN I-Disease
. . O

Previous JJ O
UBE3A NNP O
cDNA NN O
analysis NN O
has VBZ O
shown VBN O
a DT O
coding VBG O
region NN O
of IN O
approximately RB O
2 CD O
. . O

6 CD O
kb NN O
and CC O
a DT O
3 CD O
- : O
untranslated JJ O
region NN O
( ( O
UTR NNP O
) ) O
of IN O
< $ O
50 CD O
bp NN O
, , O
whereas JJ O
Northern NNP O
analysis NN O
has VBZ O
indicated VBN O
mRNA JJ O
sizes NNS O
of IN O
5 CD O
- : O
8 CD O
kb NN O
. . O

We PRP O
have VBP O
analyzed VBN O
additional JJ O
cDNA NN O
clones NNS O
and CC O
provide VB O
evidence NN O
for IN O
an DT O
additional JJ O
0 CD O
. . O

5 CD O
kb NN O
of IN O
5 CD O
- : O
UTR NN O
and CC O
> $ O
2 CD O
kb NN O
of IN O
3 CD O
- : O
UTR NN O
. . O

We PRP O
have VBP O
established VBN O
the DT O
genomic JJ O
organization NN O
of IN O
UBE3A NNP O
and CC O
the DT O
sequence NN O
of IN O
intron NN O
- : O
exon NN O
borders NNS O
. . O

We PRP O
have VBP O
also RB O
mapped VBN O
two CD O
highly RB O
homologous JJ O
processed VBN O
pseudogenes NNS O
, , O
UBE3AP1 NNP O
and CC O
UBE3AP2 NNP O
, , O
to TO O
chromosomes VB O
2 CD O
and CC O
21 CD O
, , O
respectively RB O
, , O
and CC O
determined VBD O
their PRP$ O
genomic JJ O
organization NN O
. . O

These DT O
results NNS O
will MD O
form VB O
the DT O
basis NN O
for IN O
studies NNS O
of IN O
mutation NN O
and CC O
imprinting NN O
of IN O
UBE3A NNP O
. . O

Mutation NNP O
spectrum NN O
and CC O
genotype NN O
- : O
phenotype NN O
analyses NNS O
in IN O
Cowden NNP B-Disease
disease NN I-Disease
and CC O
Bannayan NNP B-Disease
- : I-Disease
Zonana NNP I-Disease
syndrome NN I-Disease
, , O
two CD O
hamartoma NN B-Disease
syndromes NNS I-Disease
with IN O
germline NN O
PTEN NNP O
mutation NN O
. . O

The DT O
tumour NN B-Disease
suppressor NN O
gene NN O
PTEN NNP O
, , O
which WDT O
maps VBZ O
to TO O
10q23 CD O
. . O

3 CD O
and CC O
encodes VBZ O
a DT O
403 CD O
amino NN O
acid JJ O
dual JJ O
specificity NN O
phosphatase NN O
( ( O
protein JJ O
tyrosine NN O
phosphatase NN O
; : O
PTPase NNP O
) ) O
, , O
was VBD O
shown VBN O
recently RB O
to TO O
play VB O
a DT O
broad JJ O
role NN O
in IN O
human JJ O
malignancy NN B-Disease
. . O

Somatic JJ O
PTEN NNP O
deletions NNS O
and CC O
mutations NNS O
were VBD O
observed VBN O
in IN O
sporadic JJ B-Disease
breast NN I-Disease
, , I-Disease
brain NN I-Disease
, , I-Disease
prostate NN I-Disease
and CC I-Disease
kidney NN I-Disease
cancer NN I-Disease
cell NN O
lines NNS O
and CC O
in IN O
several JJ O
primary JJ O
tumours NNS B-Disease
such JJ O
as IN O
endometrial JJ B-Disease
carcinomas NN I-Disease
, , O
malignant JJ B-Disease
melanoma NN I-Disease
and CC O
thyroid JJ B-Disease
tumours NN I-Disease
. . O

In IN O
addition NN O
, , O
PTEN NNP O
was VBD O
identified VBN O
as IN O
the DT O
susceptibility NN O
gene NN O
for IN O
two CD O
hamartoma NN B-Disease
syndromes NNS I-Disease
Cowden NNP B-Disease
disease NN I-Disease
( ( O
CD NN B-Disease
; : O
MIM NNP O
158350 CD O
) ) O
and CC O
Bannayan NNP B-Disease
- : I-Disease
Zonana NNP I-Disease
( ( I-Disease
BZS NNP I-Disease
) ) I-Disease
or CC I-Disease
Ruvalcaba NNP I-Disease
- : I-Disease
Riley NNP I-Disease
- : I-Disease
Smith NNP I-Disease
syndrome NN I-Disease
( ( O
MIM NNP O
153480 CD O
) ) O
. . O

Constitutive JJ O
DNA NN O
from IN O
37 CD O
CD NN B-Disease
families NNS O
and CC O
seven CD O
BZS NNP B-Disease
families NNS O
was VBD O
screened VBN O
for IN O
germline NN O
PTEN NNP O
mutations NNS O
. . O

PTEN NNP O
mutations NNS O
were VBD O
identified VBN O
in IN O
30 CD O
of IN O
37 CD O
( ( O
81 CD O
% NN O
) ) O
CD NN B-Disease
families NNS O
, , O
including VBG O
missense NN O
and CC O
nonsense JJ O
point NN O
mutations NNS O
, , O
deletions NNS O
, , O
insertions NNS O
, , O
a DT O
deletion NN O
/ POS O
insertion NN O
and CC O
splice NN O
site NN O
mutations NNS O
. . O

These DT O
mutations NNS O
were VBD O
scattered VBN O
over IN O
the DT O
entire JJ O
length NN O
of IN O
PTEN NNP O
, , O
with IN O
the DT O
exception NN O
of IN O
the DT O
first JJ O
, , O
fourth JJ O
and CC O
last JJ O
exons NNS O
. . O

A DT O
hot JJ O
spot NN O
for IN O
PTEN NNP O
mutation NN O
in IN O
CD NN B-Disease
was VBD O
identified VBN O
in IN O
exon CC O
5 CD O
that WDT O
contains VBZ O
the DT O
PTPase NNP O
core NN O
motif NN O
, , O
with IN O
13 CD O
of IN O
30 CD O
( ( O
43 CD O
% NN O
) ) O
CD NN B-Disease
mutations NNS O
identified VBN O
in IN O
this DT O
exon NN O
. . O

Seven NNP O
of IN O
30 CD O
( ( O
23 CD O
% NN O
) ) O
were VBD O
within IN O
the DT O
core NN O
motif NN O
, , O
the DT O
majority NN O
( ( O
five CD O
of IN O
seven CD O
) ) O
of IN O
which WDT O
were VBD O
missense JJ O
mutations NNS O
, , O
possibly RB O
pointing VBG O
to TO O
the DT O
functional JJ O
significance NN O
of IN O
this DT O
region NN O
. . O

Germline NNP O
PTEN NNP O
mutations NNS O
were VBD O
identified VBN O
in IN O
four CD O
of IN O
seven CD O
( ( O
57 CD O
% NN O
) ) O
BZS NNP B-Disease
families NNS O
studied VBD O
. . O

Interestingly RB O
, , O
none NN O
of IN O
these DT O
mutations NNS O
was VBD O
observed VBN O
in IN O
the DT O
PTPase NNP O
core NN O
motif NN O
. . O

It PRP O
is VBZ O
also RB O
worthy JJ O
of IN O
note NN O
that IN O
a DT O
single JJ O
nonsense NN O
point NN O
mutation NN O
, , O
R233X NNP O
, , O
was VBD O
observed VBN O
in IN O
the DT O
germline NN O
DNA NN O
from IN O
two CD O
unrelated JJ O
CD NN B-Disease
families NNS O
and CC O
one CD O
BZS NNP B-Disease
family NN O
. . O

Genotype NNP O
- : O
phenotype NN O
studies NNS O
were VBD O
not RB O
performed VBN O
on IN O
this DT O
small JJ O
group NN O
of IN O
BZS NNP B-Disease
families NNS O
. . O

However RB O
, , O
genotype JJ O
- : O
phenotype NN O
analysis NN O
inthe NN O
group NN O
of IN O
CD NNP B-Disease
families NNS O
revealed VBD O
two CD O
possible JJ O
associations NNS O
worthy NN O
of IN O
follow JJ O
- : O
up RB O
in IN O
independent JJ O
analyses NNS O
. . O

The DT O
first JJ O
was VBD O
an DT O
association NN O
noted VBD O
in IN O
the DT O
group NN O
of IN O
CD NNP B-Disease
families NNS O
with IN O
breast NN B-Disease
disease NN I-Disease
. . O

A DT O
correlation NN O
was VBD O
observed VBN O
between IN O
the DT O
presence NN O
/ NNP O
absence NN O
of IN O
a DT O
PTEN NNP O
mutation NN O
and CC O
the DT O
type NN O
of IN O
breast NN O
involvement NN O
( ( O
unaffected JJ O
versus NN O
benign NN O
versus NN O
malignant NN O
) ) O
. . O

Specifically RB O
and CC O
more RBR O
directly RB O
, , O
an DT O
association NN O
was VBD O
also RB O
observed VBN O
between IN O
the DT O
presence NN O
of IN O
a DT O
PTEN NNP O
mutation NN O
and CC O
malignant JJ B-Disease
breast NN I-Disease
disease NN I-Disease
. . O

Secondly RB O
, , O
there EX O
appeared VBD O
to TO O
be VB O
an DT O
interdependent JJ O
association NN O
between IN O
mutations NNS O
upstream RB O
and CC O
within IN O
the DT O
PTPase NNP O
core NN O
motif NN O
, , O
the DT O
core NN O
motif NN O
containing VBG O
the DT O
majority NN O
of IN O
missense JJ O
mutations NNS O
, , O
and CC O
the DT O
involvement NN O
of IN O
all DT O
major JJ O
organ JJ O
systems NNS O
( ( O
central JJ O
nervous JJ O
system NN O
, , O
thyroid NN O
, , O
breast NN O
, , O
skin NN O
and CC O
gastrointestinal JJ O
tract NN O
) ) O
. . O

However RB O
, , O
these DT O
observations NNS O
would MD O
need VB O
to TO O
be VB O
confirmed VBN O
by IN O
studying VBG O
a DT O
larger JJR O
number NN O
of IN O
CD NNP B-Disease
families NNS O
. . O

Molecular JJ O
defects NNS O
leading VBG O
to TO O
human JJ O
complement NN B-Disease
component NN I-Disease
C6 NNP I-Disease
deficiency NN I-Disease
in IN O
an DT O
African JJ O
- : O
American JJ O
family NN O
. . O

Complement JJ B-Disease
component NN I-Disease
C6 NNP I-Disease
deficiency NN I-Disease
( ( O
C6D NNP B-Disease
) ) O
was VBD O
diagnosed VBN O
in IN O
a DT O
16 CD O
- : O
year NN O
- : O
old JJ O
African JJ O
- : O
American JJ O
male NN O
with IN O
meningococcal JJ B-Disease
meningitis NN I-Disease
. . O

The DT O
patients NNS O
father RB O
and CC O
two CD O
brothers NNS O
also RB O
had VBD O
C6D NNP B-Disease
, , O
but CC O
gave VBD O
no DT O
history NN O
of IN O
meningitis NN B-Disease
or CC O
other JJ O
neisserial JJ B-Disease
infection NN I-Disease
. . O

By IN O
using VBG O
exon JJ O
- : O
specific JJ O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
/ VBP O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
as IN O
a DT O
screening JJ O
step NN O
and CC O
nucleotide JJ O
sequencing NN O
of IN O
target NN O
exons NNS O
, , O
we PRP O
determined VBD O
that IN O
the DT O
proband NN O
was VBD O
a DT O
compound NN O
heterozygote NN O
for IN O
two CD O
C6 NNP O
gene NN O
mutations NNS O
. . O

The DT O
first JJ O
, , O
1195delC CD O
located VBN O
in IN O
exon JJ O
7 CD O
, , O
is VBZ O
a DT O
novel JJ O
mutation NN O
, , O
while IN O
the DT O
second JJ O
, , O
1936delG CD O
in IN O
exon NN O
12 CD O
, , O
has VBZ O
been VBN O
described VBN O
before IN O
to TO O
cause VB O
C6D NNP B-Disease
in IN O
an DT O
unrelated JJ O
African JJ O
- : O
American JJ O
individual NN O
. . O

Both DT O
mutations NNS O
result VBP O
in IN O
premature NN O
termination NN O
codons NNS O
and CC O
C6 NNP O
null JJ O
alleles NNS O
. . O

Allele NNP O
- : O
specific JJ O
PCR NNP O
indicated VBD O
that IN O
the DT O
probands NNS O
two CD O
brothers NNS O
also RB O
inherited VBD O
the DT O
1195delC CD O
mutation NN O
from IN O
their PRP$ O
heterozygous JJ O
mother NN O
and CC O
the DT O
1936delG CD O
mutation NN O
from IN O
their PRP$ O
homozygous JJ O
father NN O
. . O
. . O

PAX6 NNP O
mutations NNS O
reviewed VBD O
. . O

Mutations NNS O
in IN O
PAX6 NNP O
are VBP O
responsible JJ O
for IN O
human JJ O
aniridia NN B-Disease
and CC O
have VBP O
also RB O
been VBN O
found VBN O
in IN O
patients NNS O
with IN O
Peters NNP B-Disease
anomaly VBP I-Disease
, , O
with IN O
congenital JJ B-Disease
cataracts NNS I-Disease
, , O
with IN O
autosomal JJ B-Disease
dominant JJ I-Disease
keratitis NN I-Disease
, , O
and CC O
with IN O
isolated JJ B-Disease
foveal NN I-Disease
hypoplasia NN I-Disease
. . O

No DT O
locus NN O
other JJ O
than IN O
chromosome NN O
11p13 CD O
has VBZ O
been VBN O
implicated VBN O
in IN O
aniridia NN B-Disease
, , O
and CC O
PAX6 NNP O
is VBZ O
clearly RB O
the DT O
major JJ O
, , O
if IN O
not RB O
only RB O
, , O
gene NN O
responsible JJ O
. . O

Twenty NNP O
- : O
eight CD O
percent NN O
of IN O
identified JJ O
PAX6 NNP O
mutations NNS O
are VBP O
C NNP O
- : O
T NN O
changes NNS O
at IN O
CpG NNP O
dinucleotides NNS O
, , O
20 CD O
% NN O
are VBP O
splicing VBG O
errors NNS O
, , O
and CC O
more JJR O
than IN O
30 CD O
% NN O
are VBP O
deletion NN O
or CC O
insertion NN O
events NNS O
. . O

There EX O
is VBZ O
a DT O
noticeably RB O
elevated JJ O
level NN O
of IN O
mutation NN O
in IN O
the DT O
paired JJ O
domain NN O
compared VBN O
with IN O
the DT O
rest NN O
of IN O
the DT O
gene NN O
. . O

Increased VBN O
mutation NN O
in IN O
the DT O
homeodomain NN O
is VBZ O
accounted VBN O
for IN O
by IN O
the DT O
hypermutable JJ O
CpG NNP O
dinucleotide NN O
in IN O
codon NN O
240 CD O
. . O

Very RB O
nearly RB O
all DT O
mutations NNS O
appear VBP O
to TO O
cause VB O
loss NN O
of IN O
function NN O
of IN O
the DT O
mutant JJ O
allele NN O
, , O
and CC O
more JJR O
than IN O
80 CD O
% NN O
of IN O
exonic JJ O
substitutions NNS O
result VBP O
in IN O
nonsense JJ O
codons NNS O
. . O

In IN O
a DT O
gene NN O
with IN O
such JJ O
extraordinarily RB O
high JJ O
sequence NN O
conservation NN O
throughout IN O
evolution NN O
, , O
there EX O
are VBP O
presumed VBN O
undiscovered JJ O
missense NN O
mutations NNS O
, , O
these DT O
are VBP O
hypothesized VBN O
to TO O
exist VB O
in IN O
as IN O
- : O
yet RB O
unidentified JJ O
phenotypes NNS O
. . O
. . O

Genetic JJ O
heterogeneity NN O
and CC O
penetrance NN O
analysis NN O
of IN O
the DT O
BRCA1 NNP O
and CC O
BRCA2 NNP O
genes NNS O
in IN O
breast NN B-Disease
cancer NN I-Disease
families NNS O
. . O

The DT O
Breast NNP B-Disease
Cancer NNP I-Disease
Linkage NNP O
Consortium NNP O
. . O

The DT O
contribution NN O
of IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
to TO O
inherited VB B-Disease
breast NN I-Disease
cancer NN I-Disease
was VBD O
assessed VBN O
by IN O
linkage NN O
and CC O
mutation NN O
analysis NN O
in IN O
237 CD O
families NNS O
, , O
each DT O
with IN O
at IN O
least JJS O
four CD O
cases NNS O
of IN O
breast NN B-Disease
cancer NN I-Disease
, , O
collected VBN O
by IN O
the DT O
Breast NNP B-Disease
Cancer NNP I-Disease
Linkage NNP O
Consortium NNP O
. . O

Families NNS O
were VBD O
included VBN O
without IN O
regard NN O
to TO O
the DT O
occurrence NN O
of IN O
ovarian JJ B-Disease
or CC I-Disease
other JJ I-Disease
cancers NNS I-Disease
. . O

Overall JJ O
, , O
disease NN O
was VBD O
linked VBN O
to TO O
BRCA1 NNP O
in IN O
an DT O
estimated JJ O
52 CD O
% NN O
of IN O
families NNS O
, , O
to TO O
BRCA2 NNP O
in IN O
32 CD O
% NN O
of IN O
families NNS O
, , O
and CC O
to TO O
neither DT O
gene NN O
in IN O
16 CD O
% NN O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
[ NNP O
CI NNP O
] VBD O
6 CD O
% NN O
- : O
28 CD O
% NN O
) ) O
, , O
suggesting VBG O
other JJ O
predisposition NN O
genes NNS O
. . O

The DT O
majority NN O
( ( O
81 CD O
% NN O
) ) O
of IN O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
were VBD O
due JJ O
to TO O
BRCA1 NNP O
, , O
with IN O
most JJS O
others NNS O
( ( O
14 CD O
% NN O
) ) O
due JJ O
to TO O
BRCA2 NNP O
. . O

Conversely RB O
, , O
the DT O
majority NN O
of IN O
families NNS O
with IN O
male NN B-Disease
and CC I-Disease
female JJ I-Disease
breast NN I-Disease
cancer NN I-Disease
were VBD O
due JJ O
to TO O
BRCA2 NNP O
( ( O
76 CD O
% NN O
) ) O
. . O

The DT O
largest JJS O
proportion NN O
( ( O
67 CD O
% NN O
) ) O
of IN O
families NNS O
due JJ O
to TO O
other JJ O
genes NNS O
was VBD O
found VBN O
in IN O
families NNS O
with IN O
four CD O
or CC O
five CD O
cases NNS O
of IN O
female JJ O
breast NN B-Disease
cancer NN I-Disease
only RB O
. . O

These DT O
estimates NNS O
were VBD O
not RB O
substantially RB O
affected VBN O
either RB O
by IN O
changing VBG O
the DT O
assumed JJ O
penetrance NN O
model NN O
for IN O
BRCA1 NNP O
or CC O
by IN O
including VBG O
or CC O
excluding VBG O
BRCA1 NNP O
mutation NN O
data NNS O
. . O

Among IN O
those DT O
families NNS O
with IN O
disease NN O
due JJ O
to TO O
BRCA1 VB O
that WDT O
were VBD O
tested VBN O
by IN O
one CD O
of IN O
the DT O
standard JJ O
screening NN O
methods NNS O
, , O
mutations NNS O
were VBD O
detected VBN O
in IN O
the DT O
coding NN O
sequence NN O
or CC O
splice NN O
sites NNS O
in IN O
an DT O
estimated JJ O
63 CD O
% NN O
( ( O
95 CD O
% NN O
CI NNP O
51 CD O
% NN O
- : O
77 CD O
% NN O
) ) O
. . O

The DT O
estimated JJ O
sensitivity NN O
was VBD O
identical JJ O
for IN O
direct JJ O
sequencing NN O
and CC O
other JJ O
techniques NNS O
. . O

The DT O
penetrance NN O
of IN O
BRCA2 NNP O
was VBD O
estimated VBN O
by IN O
maximizing VBG O
the DT O
LOD NNP O
score NN O
in IN O
BRCA2 NNP O
- : O
mutation NN O
families NNS O
, , O
over IN O
all DT O
possible JJ O
penetrance NN O
functions NNS O
. . O

The DT O
estimated VBN O
cumulative JJ O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
reached VBD O
28 CD O
% NN O
( ( O
95 CD O
% NN O
CI NNP O
9 CD O
% NN O
- : O
44 CD O
% NN O
) ) O
by IN O
age NN O
50 CD O
years NNS O
and CC O
84 CD O
% NN O
( ( O
95 CD O
% NN O
CI NNP O
43 CD O
% NN O
- : O
95 CD O
% NN O
) ) O
by IN O
age NN O
70 CD O
years NNS O
. . O

The DT O
corresponding JJ O
ovarian JJ B-Disease
cancer NN I-Disease
risks NNS O
were VBD O
0 CD O
. . O

4 CD O
% NN O
( ( O
95 CD O
% NN O
CI NNP O
0 CD O
% NN O
- : O
1 CD O
% NN O
) ) O
by IN O
age NN O
50 CD O
years NNS O
and CC O
27 CD O
% NN O
( ( O
95 CD O
% NN O
CI NNP O
0 CD O
% NN O
- : O
47 CD O
% NN O
) ) O
by IN O
age NN O
70 CD O
years NNS O
. . O

The DT O
lifetime NN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
appears VBZ O
similar JJ O
to TO O
the DT O
risk NN O
in IN O
BRCA1 NNP O
carriers NNS O
, , O
but CC O
there EX O
was VBD O
some DT O
suggestion NN O
of IN O
a DT O
lower JJR O
risk NN O
in IN O
BRCA2 NNP O
carriers NNS O
< VBP O
50 CD O
years NNS O
of IN O
age NN O
. . O

Eye NNP B-Disease
movement NN I-Disease
abnormalities NNS I-Disease
correlate VBP O
with IN O
genotype NN O
in IN O
autosomal JJ O
dominant JJ O
cerebellar JJ B-Disease
ataxia NN I-Disease
type NN I-Disease
I PRP I-Disease
. . O

We PRP O
compared VBN O
horizontal JJ O
eye NN O
movements NNS O
( ( O
visually RB O
guided VBN O
saccades NNS O
, , O
antisaccades NNS O
, , O
and CC O
smooth VB O
pursuit NN O
) ) O
in IN O
control NN O
subjects NNS O
( ( O
n JJ O
= NNP O
14 CD O
) ) O
and CC O
patients NNS O
with IN O
three CD O
forms NNS O
of IN O
autosomal JJ O
dominant JJ O
cerebellar JJ B-Disease
ataxias NN I-Disease
type NN I-Disease
I PRP I-Disease
spinocerebellar VBP B-Disease
ataxias JJ I-Disease
1 CD I-Disease
and CC I-Disease
2 CD I-Disease
( ( O
SCA1 NNP B-Disease
, , O
n JJ O
= VBP O
11 CD O
; : O
SCA2 NNP B-Disease
, , O
n JJ O
= NNP O
10 CD O
) ) O
and CC O
SCA3 NNP B-Disease
/ NNP O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
( ( O
MJD NNP B-Disease
) ) O
( ( O
n JJ O
= NNP O
16 CD O
) ) O
. . O

In IN O
SCA1 NNP B-Disease
, , O
saccade VBD O
amplitude NN O
was VBD O
significantly RB O
increased VBN O
, , O
resulting VBG O
in IN O
hypermetria NN B-Disease
. . O

The DT O
smooth JJ O
pursuit NN O
gain NN O
was VBD O
decreased VBN O
. . O

In IN O
SCA2 NNP B-Disease
, , O
saccade VBD O
velocity NN O
was VBD O
markedly RB O
decreased VBN O
. . O

The DT O
percentage NN O
of IN O
errors NNS O
in IN O
antisaccades NNS O
was VBD O
greatly RB O
increased JJ O
and CC O
was VBD O
significantly RB O
correlated VBN O
with IN O
age NN O
at IN O
disease NN O
onset NN O
. . O

In IN O
addition NN O
, , O
a DT O
correlation NN O
between IN O
smooth JJ O
pursuit NN O
gain NN O
and CC O
the DT O
number NN O
of IN O
trinucleotide JJ O
repeats NNS O
was VBD O
found VBN O
. . O

In IN O
SCA3 NNP B-Disease
, , O
gaze SYM B-Disease
- : I-Disease
evoked JJ I-Disease
nystagmus NN I-Disease
was VBD O
often RB O
present JJ O
as IN O
was VBD O
saccade VBN O
hypometria NN O
and CC O
smooth JJ O
pursuit NN O
gain NN O
was VBD O
markedly RB O
decreased VBN O
. . O

Three CD O
major JJ O
criteria NNS O
, , O
saccade JJ O
amplitude NN O
, , O
saccade JJ O
velocity NN O
, , O
and CC O
presence NN O
of IN O
gaze JJ B-Disease
- : I-Disease
evoked JJ I-Disease
nystagmus NN I-Disease
, , O
permitted VBD O
the DT O
correct JJ O
assignment NN O
of IN O
90 CD O
% NN O
of IN O
the DT O
SCA1 NNP B-Disease
, , O
90 CD O
% NN O
of IN O
the DT O
SCA2 NNP B-Disease
, , O
and CC O
93 CD O
% NN O
of IN O
the DT O
patients NNS O
with IN O
SCA3 NNP B-Disease
to TO O
their PRP$ O
genetically RB O
confirmed VBN O
patient NN O
group NN O
and CC O
, , O
therefore RB O
, , O
may MD O
help VB O
orient VB O
diagnoses NNS O
of IN O
SCA1 NNP B-Disease
, , O
SCA2 NNP B-Disease
, , O
and CC O
SCA3 NNP B-Disease
at IN O
early RB O
clinical JJ O
stages NNS O
of IN O
the DT O
diseases NNS O
. . O
. . O

Genetic JJ O
basis NN O
and CC O
molecular JJ O
mechanism NN O
for IN O
idiopathic JJ B-Disease
ventricular JJ I-Disease
fibrillation NN I-Disease
. . O

Ventricular JJ B-Disease
fibrillation NN I-Disease
causes VBZ O
more JJR O
than IN O
300 CD O
, , O
0 CD O
sudden JJ O
deaths NNS O
each DT O
year NN O
in IN O
the DT O
USA NNP O
alone RB O
. . O

In IN O
approximately RB O
5 CD O
- : O
12 CD O
% NN O
of IN O
these DT O
cases NNS O
, , O
there EX O
are VBP O
no DT O
demonstrable JJ O
cardiac NN O
or CC O
non JJ O
- : O
cardiac JJ O
causes NNS O
to TO O
account VB O
for IN O
the DT O
episode NN O
, , O
which WDT O
is VBZ O
therefore RB O
classified JJ O
as IN O
idiopathic JJ B-Disease
ventricular JJ I-Disease
fibrillation NN I-Disease
( ( O
IVF NNP B-Disease
) ) O
. . O

A DT O
distinct JJ O
group NN O
of IN O
IVF NNP B-Disease
patients NNS O
has VBZ O
been VBN O
found VBN O
to TO O
present VB O
with IN O
a DT O
characteristic JJ O
electrocardiographic JJ O
pattern NN O
. . O

Because IN O
of IN O
the DT O
small JJ O
size NN O
of IN O
most JJS O
pedigrees NNS O
and CC O
the DT O
high JJ O
incidence NN O
of IN O
sudden JJ B-Disease
death NN I-Disease
, , O
however RB O
, , O
molecular JJ O
genetic JJ O
studies NNS O
of IN O
IVF NNP B-Disease
have VBP O
not RB O
yet RB O
been VBN O
done VBN O
. . O

Because IN O
IVF NNP B-Disease
causes VBZ O
cardiac JJ O
rhythm NN O
disturbance NN O
, , O
we PRP O
investigated VBD O
whether IN O
malfunction NN O
of IN O
ion NN O
channels NNS O
could MD O
cause VB O
the DT O
disorder NN O
by IN O
studying VBG O
mutations NNS O
in IN O
the DT O
cardiac JJ O
sodium NN O
channel NN O
gene NN O
SCN5A NNP O
. . O

We PRP O
have VBP O
now RB O
identified VBN O
a DT O
missense NN O
mutation NN O
, , O
a DT O
splice NN O
- : O
donor NN O
mutation NN O
, , O
and CC O
a DT O
frameshift JJ O
mutation NN O
in IN O
the DT O
coding JJ O
region NN O
of IN O
SCN5A NNP O
in IN O
three CD O
IVF NNP B-Disease
families NNS O
. . O

We PRP O
show VBP O
that IN O
sodium NN O
channels NNS O
with IN O
the DT O
missense NN O
mutation NN O
recover NN O
from IN O
inactivation NN O
more RBR O
rapidly RB O
than IN O
normal JJ O
and CC O
that IN O
the DT O
frameshift NN O
mutation NN O
causes VBZ O
the DT O
sodium NN O
channel NN O
to TO O
be VB O
non JJ O
- : O
functional NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
mutations NNS O
in IN O
cardiac JJ O
ion NN O
- : O
channel NN O
genes NNS O
contribute VBP O
to TO O
the DT O
risk NN O
of IN O
developing VBG O
IVF NNP B-Disease
. . O
. . O

Molecular JJ O
heterogeneity NN O
in IN O
mucopolysaccharidosis NN B-Disease
IVA NNP I-Disease
in IN O
Australia NNP O
and CC O
Northern NNP O
Ireland NNP O
: : O
nine CD O
novel JJ O
mutations NNS O
including VBG O
T312S NNP O
, , O
a DT O
common JJ O
allele NN O
that IN O
confers VBZ O
a DT O
mild JJ O
phenotype NN O
. . O

Mucopolysaccharidosis NN B-Disease
IVA NNP I-Disease
( ( O
MPS NNP B-Disease
IVA NNP I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive NN I-Disease
lysosomal JJ I-Disease
storage NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
genetic JJ B-Disease
defect NN I-Disease
in IN O
N NNP O
- : O
acetylgalactosamine NN O
- : O
6 CD O
- : O
sulfate NN O
sulfatase NN O
( ( O
GALNS NNP O
) ) O
. . O

Previous JJ O
studies NNS O
of IN O
patients NNS O
from IN O
a DT O
British JJ O
- : O
Irish JJ O
population NN O
showed VBD O
that IN O
the DT O
I113F NNP O
mutation NN O
is VBZ O
the DT O
most RBS O
common JJ O
single JJ O
mutation NN O
among IN O
MPS NNP B-Disease
IVA NNP I-Disease
patients NNS O
and CC O
produces VBZ O
a DT O
severe JJ O
clinical JJ O
phenotype NN O
. . O

We PRP O
studied VBD O
mutations NNS O
in IN O
the DT O
GALNS NNP O
gene NN O
from IN O
23 CD O
additional JJ O
MPS NNP B-Disease
IVA NNP I-Disease
patients NNS O
( ( O
15 CD O
from IN O
Australia NNP O
, , O
8 CD O
from IN O
Northern NNP O
Ireland NNP O
) ) O
, , O
with IN O
various JJ O
clinical JJ O
phenotypes NNS O
( ( O
severe JJ O
, , O
16 CD O
cases NNS O
; : O
intermediate VB O
, , O
4 CD O
cases NNS O
; : O
mild VB O
, , O
3 CD O
cases NNS O
) ) O
. . O

We PRP O
found VBD O
two CD O
common JJ O
mutations NNS O
that IN O
together RB O
accounted VBD O
for IN O
32 CD O
% NN O
of IN O
the DT O
44 CD O
unrelated JJ O
alleles NNS O
in IN O
these DT O
patients NNS O
. . O

One CD O
is VBZ O
the DT O
T312S NNP O
mutation NN O
, , O
a DT O
novel JJ O
mutation NN O
found VBD O
exclusively RB O
in IN O
milder NN O
patients NNS O
. . O

The DT O
other JJ O
is VBZ O
the DT O
previously RB O
described VBN O
I113F NNP O
that WDT O
produces VBZ O
a DT O
severe JJ O
phenotype NN O
. . O

The DT O
I113F NNP O
and CC O
T312S NNP O
mutations NNS O
accounted VBD O
for IN O
8 CD O
( ( O
18 CD O
% NN O
) ) O
and CC O
6 CD O
( ( O
14 CD O
% NN O
) ) O
of IN O
44 CD O
unrelated JJ O
alleles NNS O
, , O
respectively RB O
. . O

The DT O
relatively RB O
high JJ O
residual JJ O
GALNS NNP O
activity NN O
seen VBN O
when WRB O
the DT O
T312S NNP O
mutant NN O
cDNA NN O
is VBZ O
overexpressed VBN O
in IN O
mutant JJ O
cells NNS O
provides VBZ O
an DT O
explanation NN O
for IN O
the DT O
mild JJ O
phenotype NN O
in IN O
patients NNS O
with IN O
this DT O
mutation NN O
. . O

The DT O
distribution NN O
and CC O
relative JJ O
frequencies NNS O
of IN O
the DT O
I113F NNP O
and CC O
T312S NNP O
mutations NNS O
in IN O
Australia NNP O
corresponded VBD O
to TO O
those DT O
observed VBN O
in IN O
Northern NNP O
Ireland NNP O
and CC O
are VBP O
unique JJ O
to TO O
these DT O
two CD O
populations NNS O
, , O
suggesting VBG O
that IN O
both DT O
mutations NNS O
were VBD O
probably RB O
introduced VBN O
to TO O
Australia NNP O
by IN O
Irish JJ O
migrants NNS O
during IN O
the DT O
19th JJ O
century NN O
. . O

Haplotype NNP O
analysis NN O
using VBG O
6 CD O
RFLPs NNP O
provides VBZ O
additional JJ O
data NNS O
that IN O
the DT O
I113F NNP O
mutation NN O
originated VBD O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

The DT O
other JJ O
9 CD O
novel JJ O
mutations NNS O
identified VBN O
in IN O
these DT O
23 CD O
patients NNS O
were VBD O
each DT O
limited VBN O
to TO O
a DT O
single JJ O
family NN O
. . O

These DT O
data NNS O
provide VBP O
further JJ O
evidence NN O
for IN O
extensive JJ O
allelic JJ O
heterogeneity NN O
in IN O
MPS NNP B-Disease
IVA NNP I-Disease
in IN O
British NNP O
- : O
Irish JJ O
patients NNS O
and CC O
provide VB O
evidence NN O
for IN O
their PRP$ O
transmission NN O
to TO O
Australia NNP O
by IN O
British NNP O
- : O
Irish JJ O
migrants NNS O
. . O
. . O

Identification NN O
of IN O
constitutional JJ O
WT1 NNP O
mutations NNS O
, , O
in IN O
patients NNS O
with IN O
isolated JJ O
diffuse NN B-Disease
mesangial JJ I-Disease
sclerosis NN I-Disease
, , O
and CC O
analysis NN O
of IN O
genotype NN O
/ NNP O
phenotype NN O
correlations NNS O
by IN O
use NN O
of IN O
a DT O
computerized JJ O
mutation NN O
database NN O
. . O

Constitutional JJ O
mutations NNS O
of IN O
the DT O
WT1 NNP O
gene NN O
, , O
encoding VBG O
a DT O
zinc NN O
- : O
finger NN O
transcription NN O
factor NN O
involved VBN O
in IN O
renal JJ O
and CC O
gonadal JJ O
development NN O
, , O
are VBP O
found VBN O
in IN O
most JJS O
patients NNS O
with IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
( ( O
DDS NNP B-Disease
) ) O
, , O
or CC O
diffuse VB B-Disease
mesangial JJ I-Disease
sclerosis NN I-Disease
( ( O
DMS NNP B-Disease
) ) O
associated VBN O
with IN O
pseudohermaphroditism NN B-Disease
and CC O
/ NN O
or CC O
Wilms NNP B-Disease
tumor NN I-Disease
( ( O
WT NNP B-Disease
) ) O
. . O

Most JJS O
mutations NNS O
in IN O
DDS NNP B-Disease
patients NNS O
lie VBP O
in IN O
exon $ O
8 CD O
or CC O
exon VB O
9 CD O
, , O
encoding VBG O
zinc NN O
finger NN O
2 CD O
or CC O
zinc VB O
finger JJR O
3 CD O
, , O
respectively RB O
, , O
with IN O
a DT O
hot JJ O
spot NN O
( ( O
R394W NNP O
) ) O
in IN O
exon $ O
9 CD O
. . O

We PRP O
analyzed VBD O
a DT O
series NN O
of IN O
24 CD O
patients NNS O
, , O
10 CD O
with IN O
isolated JJ B-Disease
DMS NNP I-Disease
( ( O
IDMS NNP B-Disease
) ) O
, , O
10 CD O
with IN O
DDS NNP B-Disease
, , O
and CC O
4 CD O
with IN O
urogenital JJ B-Disease
abnormalities NNS I-Disease
and CC O
/ NN O
or CC O
WT NNP B-Disease
. . O

We PRP O
report VBP O
WT1 NNP O
heterozygous JJ O
mutations NNS O
in IN O
16 CD O
patients NNS O
, , O
4 CD O
of IN O
whom WP O
presented VBN O
with IN O
IDMS NNP B-Disease
. . O

One CD O
male NN O
and CC O
two CD O
female JJ O
IDMS NNP B-Disease
patients NNS O
with IN O
WT1 NNP O
mutations NNS O
underwent JJ O
normal JJ O
puberty NN O
. . O

Two CD O
mutations NNS O
associated VBN O
with IN O
IDMS NNP B-Disease
are VBP O
different JJ O
from IN O
those DT O
described VBN O
in IN O
DDS NNP B-Disease
patients NNS O
. . O

No DT O
WT1 NNP O
mutations NNS O
were VBD O
detected VBN O
in IN O
the DT O
six CD O
other JJ O
IDMS NNP B-Disease
patients NNS O
, , O
suggesting VBG O
genetic JJ O
heterogeneity NN O
of IN O
this DT O
disease NN O
. . O

We PRP O
analyzed VBD O
genotype JJ O
/ NNP O
phenotype NN O
correlations NNS O
, , O
on IN O
the DT O
basis NN O
of IN O
the DT O
constitution NN O
of IN O
a DT O
WT1 NNP O
mutation NN O
database NN O
of IN O
84 CD O
germ JJ O
- : O
line NN O
mutations NNS O
, , O
to TO O
compare VB O
the DT O
distribution NN O
and CC O
type NN O
of IN O
mutations NNS O
, , O
according VBG O
to TO O
the DT O
different JJ O
symptoms NNS O
. . O

This DT O
demonstrated VBD O
( ( O
1 CD O
) ) O
the DT O
association NN O
between IN O
mutations NNS O
in IN O
exons NNS O
8 CD O
and CC O
9 CD O
and CC O
DMS NNP B-Disease
; : O
( ( O
2 CD O
) ) O
among IN O
patients NNS O
with IN O
DMS NNP B-Disease
, , O
a DT O
higher JJR O
frequency NN O
of IN O
exon $ O
8 CD O
mutations NNS O
among IN O
46 CD O
, , O
XY NN O
patients NNS O
with IN O
female JJ O
phenotype NN O
than IN O
among IN O
46 CD O
, , O
XY NN O
patients NNS O
with IN O
sexual JJ O
ambiguity NN O
or CC O
male JJ O
phenotype NN O
; : O
and CC O
( ( O
3 CD O
) ) O
statistically RB O
significant JJ O
evidence NN O
that IN O
mutations NNS O
in IN O
exons NNS O
8 CD O
and CC O
9 CD O
preferentially RB O
affect JJ O
amino NN O
acids NNS O
with IN O
different JJ O
functions NNS O
. . O
. . O

The DT O
185delAG CD O
BRCA1 NNP O
mutation NN O
originated VBD O
before IN O
the DT O
dispersion NN O
of IN O
Jews NNP O
in IN O
the DT O
diaspora NN O
and CC O
is VBZ O
not RB O
limited VBN O
to TO O
Ashkenazim NNP O
. . O

The DT O
185delAG CD O
mutation NN O
in IN O
BRCA1 NNP O
is VBZ O
detected VBN O
in IN O
Ashkenazi NNP O
Jews NNP O
both DT O
in IN O
familial JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
and CC O
in IN O
the DT O
general JJ O
population NN O
. . O

All DT O
tested VBD O
Ashkenazi NNP O
mutation NN O
carriers NNS O
share NN O
the DT O
same JJ O
allelic JJ O
pattern NN O
at IN O
the DT O
BRCA1 NNP O
locus NN O
. . O

Our PRP$ O
previous JJ O
study NN O
showed VBD O
that IN O
this DT O
Ashkenazi NNP O
mutation NN O
also RB O
occurs VBZ O
in IN O
Iraqi NNP O
Jews NNP O
with IN O
a DT O
similar JJ O
allelic JJ O
pattern NN O
. . O

We PRP O
extended VBD O
our PRP$ O
analysis NN O
to TO O
other JJ O
non JJ O
- : O
Ashkenazi NNP O
subsets VBZ O
354 CD O
of IN O
Moroccan NNP O
origin NN O
, , O
200 CD O
Yemenites NNS O
and CC O
150 CD O
Iranian JJ O
Jews NNPS O
. . O

Heteroduplex NNP O
analysis NN O
complemented VBN O
by IN O
direct JJ O
DNA NNP O
sequencing NN O
of IN O
abnormally RB O
migrating VBG O
bands NNS O
were VBD O
employed VBN O
. . O

Four CD O
of IN O
Moroccan NNP O
origin NN O
( ( O
1 CD O
. . O
1 CD O
% NN O
) ) O
and CC O
none NN O
of IN O
the DT O
Yemenites NNS O
or CC O
Iranians NNP O
was VBD O
a DT O
carrier NN O
of IN O
the DT O
185delAG CD O
mutation NN O
. . O

BRCA1 NNP O
allelic JJ O
patterns NNS O
were VBD O
determined VBN O
for IN O
four CD O
of IN O
these DT O
individuals NNS O
and CC O
for IN O
12 CD O
additional JJ O
non NN O
- : O
Ashkenazi $ O
185delAG CD O
mutation NN O
carriers NNS O
who WP O
had VBD O
breast VBN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Six NNP O
non SYM O
- : O
Ashkenazi JJ O
individuals NNS O
shared VBD O
the DT O
common JJ O
Ashkenazi NNP O
haplotype NN O
, , O
four CD O
had VBD O
a DT O
closely RB O
related JJ O
pattern NN O
, , O
and CC O
the DT O
rest NN O
( ( O
n JJ O
= NNP O
6 CD O
) ) O
displayed VBD O
a DT O
distinct JJ O
BRCA1 NNP O
allelic NN O
pattern NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
185delAG CD O
BRCA1 NNP O
mutation NN O
occurs VBZ O
in IN O
some DT O
non JJ O
- : O
Ashkenazi JJ O
populations NNS O
at IN O
rates NNS O
comparable JJ O
with IN O
that DT O
of IN O
Ashkenazim NNP O
. . O

The DT O
majority NN O
of IN O
Jewish JJ O
185delAG CD O
mutation NN O
carriers NNS O
have VBP O
a DT O
common JJ O
allelic JJ O
pattern NN O
, , O
supporting VBG O
the DT O
founder NN O
effect NN O
notion NN O
, , O
but CC O
dating VBG O
the DT O
mutations NNS O
origin VBP O
to TO O
an DT O
earlier JJR O
date NN O
than IN O
currently RB O
estimated VBN O
. . O

However RB O
, , O
the DT O
different JJ O
allelic JJ O
pattern NN O
at IN O
the DT O
BRCA1 NNP O
locus VBD O
even RB O
in IN O
some DT O
Jewish JJ O
mutation NN O
carriers NNS O
, , O
might MD O
suggest VB O
that IN O
the DT O
mutation NN O
arose VBD O
independently RB O
. . O
. . O

Crystal JJ O
structure NN O
of IN O
the DT O
hemochromatosis NN B-Disease
protein NN O
HFE NNP O
and CC O
characterization NN O
of IN O
its PRP$ O
interaction NN O
with IN O
transferrin JJ O
receptor NN O
. . O

HFE NNP O
is VBZ O
an DT O
MHC NNP O
- : O
related JJ O
protein NN O
that WDT O
is VBZ O
mutated VBN O
in IN O
the DT O
iron NN B-Disease
- : I-Disease
overload NN I-Disease
disease NN I-Disease
hereditary JJ B-Disease
hemochromatosis NN I-Disease
. . O

HFE NNP O
binds VBZ O
to TO O
transferrin VB O
receptor NN O
( ( O
TfR NNP O
) ) O
and CC O
reduces VBZ O
its PRP$ O
affinity NN O
for IN O
iron NN O
- : O
loaded JJ O
transferrin NN O
, , O
implicating VBG O
HFE NNP O
in IN O
iron NN O
metabolism NN O
. . O

The DT O
2 CD O
. . O

6 CD O
A NNP O
crystal JJ O
structure NN O
of IN O
HFE NNP O
reveals VBZ O
the DT O
locations NNS O
of IN O
hemochromatosis NN B-Disease
mutations NNS O
and CC O
a DT O
patch NN O
of IN O
histidines NNS O
that WDT O
could MD O
be VB O
involved VBN O
in IN O
pH JJ O
- : O
dependent JJ O
interactions NNS O
. . O

We PRP O
also RB O
demonstrate VBP O
that IN O
soluble JJ O
TfR NNP O
and CC O
HFE NNP O
bind VBP O
tightly RB O
at IN O
the DT O
basic JJ O
pH NN O
of IN O
the DT O
cell NN O
surface NN O
, , O
but CC O
not RB O
at IN O
the DT O
acidic JJ O
pH NN O
of IN O
intracellular JJ O
vesicles NNS O
. . O

TfR NNP O
HFE NNP O
stoichiometry NN O
( ( O
2 CD O
1 CD O
) ) O
differs NNS O
from IN O
TfR NNP O
transferrin NN O
stoichiometry NN O
( ( O
2 CD O
2 CD O
) ) O
, , O
implying VBG O
a DT O
different JJ O
mode NN O
of IN O
binding VBG O
for IN O
HFE NNP O
and CC O
transferrin NN O
to TO O
TfR NNP O
, , O
consistent NN O
with IN O
our PRP$ O
demonstration NN O
that IN O
HFE NNP O
, , O
transferrin NN O
, , O
and CC O
TfR NNP O
form VBP O
a DT O
ternary JJ O
complex NN O
. . O

Identification NN O
of IN O
three CD O
novel JJ O
mutations NNS O
and CC O
a DT O
high JJ O
frequency NN O
of IN O
the DT O
Arg778Leu NNP O
mutation NN O
in IN O
Korean JJ O
patients NNS O
with IN O
Wilson NNP B-Disease
disease NN I-Disease
. . O

Four CD O
mutations NNS O
- : O
- : O
R778L NN O
, , O
A874V NNP O
, , O
L1083F NNP O
, , O
and CC O
2304delC CD O
- : O
- : O
in IN O
the DT O
copper NN O
- : O
transporting NN O
enzyme NN O
, , O
P NNP O
- : O
type NN O
ATPase NNP O
( ( O
ATP7B NNP O
) ) O
, , O
were VBD O
identified VBN O
in IN O
Korean JJ O
Patients NNS O
with IN O
Wilson NNP B-Disease
disease NN I-Disease
. . O

Arg778Leu NNP O
, , O
the DT O
most RBS O
frequently RB O
reported VBN O
mutation NN O
of IN O
this DT O
enzyme NN O
, , O
was VBD O
found VBN O
in IN O
six CD O
of IN O
eight CD O
unrelated JJ O
patients NNS O
studied VBN O
, , O
an DT O
allele JJ O
frequency NN O
of IN O
37 CD O
. . O

5 CD O
% NN O
, , O
which WDT O
is VBZ O
considerably RB O
higher JJR O
than IN O
those DT O
in IN O
other JJ O
Asian JJ O
populations NNS O
. . O

The DT O
novel JJ O
single JJ O
nucleotide NN O
deletion NN O
, , O
2304delC CD O
, , O
was VBD O
found VBN O
in IN O
one CD O
patient NN O
. . O

Since IN O
a DT O
mutation NN O
at IN O
cDNA NN O
nucleotide NN O
2302 CD O
( ( O
2302insC CD O
) ) O
had VBD O
been VBN O
previously RB O
described VBN O
, , O
this DT O
region NN O
of IN O
the DT O
ATP7B NNP O
gene NN O
may MD O
be VB O
susceptible JJ O
to TO O
gene NN O
rearrangements NNS O
causing VBG O
Wilson NNP B-Disease
disease NN I-Disease
. . O

Disruption NN O
of IN O
splicing VBG O
regulated VBN O
by IN O
a DT O
CUG NNP O
- : O
binding VBG O
protein NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
a DT O
CTG NNP O
expansion NN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
the DT O
DM NNP B-Disease
gene NN O
. . O

One CD O
model NN O
of IN O
DM NNP B-Disease
pathogenesis NN O
suggests VBZ O
that IN O
RNAs NNP O
from IN O
the DT O
expanded VBN O
allele NN O
create VB O
a DT O
gain NN O
- : O
of IN O
- : O
function NN O
mutation NN O
by IN O
the DT O
inappropriate JJ O
binding NN O
of IN O
proteins NNS O
to TO O
the DT O
CUG NNP O
repeats NNS O
. . O

Data NNS O
presented VBN O
here RB O
indicate VBP O
that IN O
the DT O
conserved VBN O
heterogeneous JJ O
nuclear JJ O
ribonucleoprotein NN O
, , O
CUG NNP O
- : O
binding NN O
protein NN O
( ( O
CUG NNP O
- : O
BP NNP O
) ) O
, , O
may MD O
mediate VB O
the DT O
trans NNS O
- : O
dominant JJ O
effect NN O
of IN O
the DT O
RNA NNP O
. . O

CUG NNP O
- : O
BP NNP O
was VBD O
found VBN O
to TO O
bind VB O
to TO O
the DT O
human JJ O
cardiac JJ O
troponin NN O
T NNP O
( ( O
cTNT NN O
) ) O
pre VBZ O
- : O
messenger NN O
RNA NNP O
and CC O
regulate VB O
its PRP$ O
alternative JJ O
splicing NN O
. . O

Splicing VBG O
of IN O
cTNT NN O
was VBD O
disrupted VBN O
in IN O
DM NNP B-Disease
striated VBD O
muscle NN O
and CC O
in IN O
normal JJ O
cells NNS O
expressing VBG O
transcripts NNS O
that WDT O
contain VBP O
CUG NNP O
repeats NNS O
. . O

Altered NNP O
expression NN O
of IN O
genes NNS O
regulated VBN O
posttranscriptionally RB O
by IN O
CUG NNP O
- : O
BP NNP O
therefore NN O
may MD O
contribute VB O
to TO O
DM NNP B-Disease
pathogenesis NN O
. . O
. . O

Identification NN O
of IN O
a DT O
novel JJ O
nonsense JJ O
mutation NN O
and CC O
a DT O
missense JJ O
substitution NN O
in IN O
the DT O
vasopressin NN O
- : O
neurophysin NN O
II NNP O
gene NN O
in IN O
two CD O
Spanish JJ O
kindreds NNS O
with IN O
familial JJ B-Disease
neurohypophyseal NN I-Disease
diabetes VBZ I-Disease
insipidus NN I-Disease
. . O

Familial JJ B-Disease
neurohypophyseal NN I-Disease
diabetes NNS I-Disease
insipidus VBP I-Disease
( ( O
FNDI NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disease NN I-Disease
caused VBN O
by IN O
deficiency NN O
in IN O
the DT O
antidiuretic JJ O
hormone NN O
arginine NN O
vasopressin NN O
( ( O
AVP NNP O
) ) O
encoded VBN O
by IN O
the DT O
AVP NNP O
- : O
neurophysin NN O
II NNP O
( ( O
AVP NNP O
- : O
NPII NN O
) ) O
gene NN O
on IN O
chromosome NN O
20p13 CD O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
analyzed VBD O
two CD O
families NNS O
with IN O
FNDI NNP B-Disease
using VBG O
direct JJ O
automated VBN O
fluorescent NN O
, , O
solid JJ O
phase NN O
, , O
single JJ O
- : O
stranded VBD O
DNA NNP O
sequencing NN O
of IN O
PCR NNP O
- : O
amplified VBD O
AVP NNP O
- : O
NPII NNP O
DNA NNP O
. . O

In IN O
one CD O
of IN O
the DT O
families NNS O
, , O
affected JJ O
individuals NNS O
presented VBD O
a DT O
novel JJ O
nonsense JJ O
mutation NN O
in IN O
exon JJ O
3 CD O
of IN O
the DT O
gene NN O
, , O
consisting VBG O
in IN O
a DT O
G NNP O
to TO O
T VB O
transition NN O
at IN O
nucleotide JJ O
2101 CD O
, , O
which WDT O
produces VBZ O
a DT O
stop JJ O
signal NN O
in IN O
codon NN O
82 CD O
( ( O
Glu NNP O
) ) O
of IN O
NPII NNP O
. . O

The DT O
premature NN O
termination NN O
eliminates VBZ O
part NN O
of IN O
the DT O
C NNP O
- : O
terminal JJ O
domain NN O
of IN O
NPII NNP O
, , O
including VBG O
a DT O
cysteine NN O
residue NN O
in IN O
position NN O
85 CD O
, , O
which WDT O
could MD O
be VB O
involved VBN O
in IN O
the DT O
correct JJ O
folding NN O
of IN O
the DT O
prohormone NN O
. . O

In IN O
the DT O
second JJ O
family NN O
, , O
a DT O
G279A NNP O
substitution NN O
at IN O
position NN O
- : O
1 CD O
of IN O
the DT O
signal JJ O
peptide NN O
was VBD O
observed VBN O
in IN O
all DT O
affected JJ O
individuals NNS O
. . O

This DT O
missense NN O
mutation NN O
, , O
which WDT O
replaces VBZ O
Ala NNP O
with IN O
Thr NNP O
, , O
is VBZ O
frequent JJ O
among IN O
FNDI JJ B-Disease
patients NNS O
and CC O
is VBZ O
thought VBN O
to TO O
reduce VB O
the DT O
efficiency NN O
of IN O
cleavage NN O
by IN O
signal JJ O
peptidases NNS O
. . O
. . O

Genetic JJ O
heterogeneity NN O
of IN O
Saethre NNP B-Disease
- : I-Disease
Chotzen NNP I-Disease
syndrome NN I-Disease
, , O
due JJ O
to TO O
TWIST NNP O
and CC O
FGFR NNP O
mutations NNS O
. . O

Thirty SYM O
- : O
two CD O
unrelated JJ O
patients NNS O
with IN O
features NNS O
of IN O
Saethre NNP B-Disease
- : I-Disease
Chotzen NNP I-Disease
syndrome NN I-Disease
, , O
a DT O
common JJ O
autosomal JJ B-Disease
dominant JJ I-Disease
condition NN I-Disease
of IN O
craniosynostosis NN B-Disease
and CC O
limb NN B-Disease
anomalies NNS I-Disease
, , O
were VBD O
screened VBN O
for IN O
mutations NNS O
in IN O
TWIST NNP O
, , O
FGFR2 NNP O
, , O
and CC O
FGFR3 NNP O
. . O

Nine NNP O
novel NN O
and CC O
three CD O
recurrent NN O
TWIST NNP O
mutations NNS O
were VBD O
found VBN O
in IN O
12 CD O
families NNS O
. . O

Seven JJ O
families NNS O
were VBD O
found VBN O
to TO O
have VB O
the DT O
FGFR3 NNP O
P250R NNP O
mutation NN O
, , O
and CC O
one CD O
individual NN O
was VBD O
found VBN O
to TO O
have VB O
an DT O
FGFR2 NNP O
VV269 NNP O
- : O
270 CD O
deletion NN O
. . O

To TO O
date NN O
, , O
our PRP$ O
detection NN O
rate NN O
for IN O
TWIST NNP O
or CC O
FGFR NNP O
mutations NNS O
is VBZ O
68 CD O
% NN O
in IN O
our PRP$ O
Saethre NNP B-Disease
- : I-Disease
Chotzen NNP I-Disease
syndrome NN I-Disease
patients NNS O
, , O
including VBG O
our PRP$ O
five CD O
patients NNS O
elsewhere RB O
reported VBN O
with IN O
TWIST NNP O
mutations NNS O
. . O

More JJR O
than IN O
35 CD O
different JJ O
TWIST NNP O
mutations NNS O
are VBP O
now RB O
known VBN O
in IN O
the DT O
literature NN O
. . O

The DT O
most RBS O
common JJ O
phenotypic NN O
features NNS O
, , O
present JJ O
in IN O
more JJR O
than IN O
a DT O
third JJ O
of IN O
our PRP$ O
patients NNS O
with IN O
TWIST NNP O
mutations NNS O
, , O
are VBP O
coronal JJ B-Disease
synostosis NN I-Disease
, , O
brachycephaly NN B-Disease
, , O
low JJ B-Disease
frontal JJ I-Disease
hairline NN I-Disease
, , O
facial JJ B-Disease
asymmetry NN I-Disease
, , O
ptosis NN B-Disease
, , O
hypertelorism NN B-Disease
, , O
broad JJ B-Disease
great JJ I-Disease
toes NNS I-Disease
, , O
and CC O
clinodactyly NN B-Disease
. . O

Significant JJ O
intra JJ O
- : O
and CC O
interfamilial JJ O
phenotypic NN O
variability NN O
is VBZ O
present JJ O
for IN O
either DT O
TWIST NNP O
mutations NNS O
or CC O
FGFR NNP O
mutations NNS O
. . O

The DT O
overlap NN O
in IN O
clinical JJ O
features NNS O
and CC O
the DT O
presence NN O
, , O
in IN O
the DT O
same JJ O
genes NNS O
, , O
of IN O
mutations NNS O
for IN O
more JJR O
than IN O
one CD O
craniosynostotic JJ B-Disease
condition NN I-Disease
- : O
such JJ O
as IN O
Saethre NNP B-Disease
- : I-Disease
Chotzen NNP I-Disease
, , I-Disease
Crouzon NNP I-Disease
, , I-Disease
and CC I-Disease
Pfeiffer NNP I-Disease
syndromes VBZ I-Disease
- : O
support NN O
the DT O
hypothesis NN O
that WDT O
TWIST NNP O
and CC O
FGFRs NNP O
are VBP O
components NNS O
of IN O
the DT O
same JJ O
molecular JJ O
pathway NN O
involved VBN O
in IN O
the DT O
modulation NN O
of IN O
craniofacial JJ O
and CC O
limb JJ O
development NN O
in IN O
humans NNS O
. . O
. . O

Mutation NNP O
analysis NN O
of IN O
UBE3A NNP O
in IN O
Angelman NNP B-Disease
syndrome NN I-Disease
patients NNS O
. . O

Angelman NNP B-Disease
syndrome NN I-Disease
( ( O
AS IN B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
chromosome NN O
15q11 CD O
- : O
q13 NN O
deletions NNS O
of IN O
maternal JJ O
origin NN O
, , O
by IN O
paternal JJ O
uniparental JJ B-Disease
disomy NN I-Disease
( ( O
UPD NNP B-Disease
) ) O
15 CD O
, , O
by IN O
imprinting VBG O
defects NNS O
, , O
and CC O
by IN O
mutations NNS O
in IN O
the DT O
UBE3A NNP O
gene NN O
. . O

UBE3A NNP O
encodes VBZ O
a DT O
ubiquitin JJ O
- : O
protein NN O
ligase NN O
and CC O
shows VBZ O
brain NN O
- : O
specific JJ O
imprinting NN O
. . O

Here RB O
we PRP O
describe VBP O
UBE3A NNP O
coding VBG O
- : O
region NN O
mutations NNS O
detected VBN O
by IN O
SSCP NNP O
analysis NN O
in IN O
13 CD O
AS IN B-Disease
individuals NNS O
or CC O
families NNS O
. . O

Two CD O
identical JJ O
de FW O
novo FW O
5 CD O
- : O
bp NN O
duplications NNS O
in IN O
exon JJ O
16 CD O
were VBD O
found VBN O
. . O

Among IN O
the DT O
other JJ O
11 CD O
unique JJ O
mutations NNS O
, , O
8 CD O
were VBD O
small JJ O
deletions NNS O
or CC O
insertions NNS O
predicted VBN O
to TO O
cause VB O
frameshifts NNS O
, , O
1 CD O
was VBD O
a DT O
mutation NN O
to TO O
a DT O
stop NN O
codon NN O
, , O
1 CD O
was VBD O
a DT O
missense JJ O
mutation NN O
, , O
and CC O
1 CD O
was VBD O
predicted VBN O
to TO O
cause VB O
insertion NN O
of IN O
an DT O
isoleucine NN O
in IN O
the DT O
hect NN O
domain NN O
of IN O
the DT O
UBE3A NNP O
protein NN O
, , O
which WDT O
functions NNS O
in IN O
E2 NNP O
binding NN O
and CC O
ubiquitin JJ O
transfer NN O
. . O

Eight CD O
of IN O
the DT O
cases NNS O
were VBD O
familial JJ O
, , O
and CC O
five CD O
were VBD O
sporadic NNS O
. . O

In IN O
two CD O
familial JJ O
cases NNS O
and CC O
one CD O
sporadic JJ O
case NN O
, , O
mosaicism NN O
for IN O
UBE3A NNP O
mutations NNS O
was VBD O
detected VBN O
in IN O
the DT O
mother NN O
of IN O
three CD O
AS IN B-Disease
sons NNS O
, , O
in IN O
the DT O
maternal JJ O
grandfather NN O
of IN O
two CD O
AS IN B-Disease
first JJ O
cousins NNS O
, , O
and CC O
in IN O
the DT O
mother NN O
of IN O
an DT O
AS NNP B-Disease
daughter NN O
. . O

The DT O
frequencies NNS O
with IN O
which WDT O
we PRP O
detected VBD O
mutations NNS O
were VBD O
5 CD O
( ( O
14 CD O
% NN O
) ) O
of IN O
35 CD O
in IN O
sporadic JJ O
cases NNS O
and CC O
8 CD O
( ( O
80 CD O
% NN O
) ) O
of IN O
10 CD O
in IN O
familial JJ O
cases NNS O
. . O
. . O

The DT O
hemochromatosis NN B-Disease
845 CD O
G NNP O
- : O
- : O
> VB O
A DT O
and CC O
187 CD O
C NNP O
- : O
- : O
> NN O
G NNP O
mutations NNS O
: : O
prevalence NN O
in IN O
non JJ O
- : O
Caucasian JJ O
populations NNS O
. . O

Hemochromatosis NN B-Disease
, , O
the DT O
inherited JJ B-Disease
disorder NN I-Disease
of IN I-Disease
iron NN I-Disease
metabolism NN I-Disease
, , O
leads VBZ O
, , O
if IN O
untreated VBN O
, , O
to TO O
progressive VB O
iron NN B-Disease
overload NN I-Disease
and CC O
premature JJ B-Disease
death NN I-Disease
. . O

The DT O
hemochromatosis NN B-Disease
gene NN O
, , O
HFE NNP O
, , O
recently RB O
has VBZ O
been VBN O
identified VBN O
, , O
and CC O
characterization NN O
of IN O
this DT O
gene NN O
has VBZ O
shown VBN O
that IN O
it PRP O
contains VBZ O
two CD O
mutations NNS O
that WDT O
result VBP O
in IN O
amino NN O
acid NN O
substitutions NNS O
- : O
cDNA NN O
nucleotides VBZ O
845 CD O
G NNP O
- : O
- : O
> VB O
A NNP O
( ( O
C282Y NNP O
) ) O
and CC O
187 CD O
C NNP O
- : O
- : O
> NN O
G NNP O
( ( O
H63D NNP O
) ) O
. . O

Although IN O
hemochromatosis NN B-Disease
is VBZ O
common JJ O
in IN O
Caucasians NNPS O
, , O
affecting VBG O
> JJ O
= $ O
1 CD O
/ $ O
300 CD O
individuals NNS O
of IN O
northern JJ O
European JJ O
origin NN O
, , O
it PRP O
has VBZ O
not RB O
been VBN O
recognized VBN O
in IN O
other JJ O
populations NNS O
. . O

The DT O
present JJ O
study NN O
used VBN O
PCR NNP O
and CC O
restriction NN O
- : O
enzyme NN O
digestion NN O
to TO O
analyze VB O
the DT O
frequency NN O
of IN O
the DT O
845 CD O
G NNP O
- : O
- : O
> VB O
A DT O
and CC O
187 CD O
C NNP O
- : O
- : O
> NN O
G NNP O
mutations NNS O
in IN O
HLA NNP O
- : O
typed VBD O
samples NNS O
from IN O
non JJ O
- : O
Caucasian JJ O
populations NNS O
, , O
comprising VBG O
Australian JJ O
Aboriginal NNP O
, , O
Chinese NNP O
, , O
and CC O
Pacific NNP O
Islanders NNP O
. . O

Results NNS O
showed VBD O
that IN O
the DT O
845 CD O
G NNP O
- : O
- : O
> VB O
A DT O
mutation NN O
was VBD O
present JJ O
in IN O
these DT O
populations NNS O
( ( O
allele JJ O
frequency NN O
0 CD O
. . O
32 CD O
% NN O
) ) O
, , O
and CC O
, , O
furthermore RB O
, , O
it PRP O
was VBD O
always RB O
seen VBN O
in IN O
conjunction NN O
with IN O
HLA NNP O
haplotypes NNS O
common JJ O
in IN O
Caucasians NNPS O
, , O
suggesting VBG O
that IN O
845 CD O
G NNP O
- : O
- : O
> VB O
A DT O
may MD O
have VB O
been VBN O
introduced VBN O
into IN O
these DT O
populations NNS O
by IN O
Caucasian JJ O
admixture NN O
. . O

187 CD O
C NNP O
- : O
- : O
> NN O
G NNP O
was VBD O
present JJ O
at IN O
an DT O
allele JJ O
frequency NN O
of IN O
2 CD O
. . O

68 CD O
% NN O
in IN O
the DT O
two CD O
populations NNS O
analyzed VBN O
( ( O
Australian JJ O
Aboriginal NNP O
and CC O
Chinese NNP O
) ) O
. . O

In IN O
the DT O
Australian JJ O
Aboriginal NNP O
samples NNS O
, , O
187 CD O
C NNP O
- : O
- : O
> NN O
G NNP O
was VBD O
found VBN O
to TO O
be VB O
associated VBN O
with IN O
HLA NNP O
haplotypes NNS O
common JJ O
in IN O
Caucasians NNPS O
, , O
suggesting VBG O
that IN O
it PRP O
was VBD O
introduced VBN O
by IN O
recent JJ O
admixture NN O
. . O

In IN O
the DT O
Chinese JJ O
samples NNS O
analyzed VBN O
, , O
187 CD O
C NNP O
- : O
- : O
> NN O
G NNP O
was VBD O
present JJ O
in IN O
association NN O
with IN O
a DT O
wide JJ O
variety NN O
of IN O
HLA NNP O
haplotypes NNS O
, , O
showing VBG O
this DT O
mutation NN O
to TO O
be VB O
widespread JJ O
and CC O
likely JJ O
to TO O
predate VB O
the DT O
more RBR O
genetically RB O
restricted VBN O
845 CD O
G NNP O
- : O
- : O
> VB O
A DT O
mutation NN O
. . O

Genotype NNP O
- : O
phenotype NN O
correlations NNS O
in IN O
attenuated JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
. . O

Germ NNP O
- : O
line NN O
mutations NNS O
of IN O
the DT O
tumor NN B-Disease
suppressor NN O
APC NNP O
are VBP O
implicated VBN O
in IN O
attenuated JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
AAPC NNP B-Disease
) ) O
, , O
a DT O
variant NN O
of IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
. . O

AAPC NNP B-Disease
is VBZ O
recognized VBN O
by IN O
the DT O
occurrence NN O
of IN O
< $ O
100 CD O
colonic JJ B-Disease
adenomas NN I-Disease
and CC O
a DT O
later JJ O
onset NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
( ( O
age NN O
> VBZ O
40 CD O
years NNS O
) ) O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
assess VB O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
in IN O
AAPC NNP B-Disease
families NNS O
. . O

By IN O
protein SYM O
- : O
truncation NN O
test NN O
( ( O
PTT NNP O
) ) O
assay VBP O
, , O
the DT O
entire JJ O
coding NN O
region NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
was VBD O
screened VBN O
in IN O
affected JJ O
individuals NNS O
from IN O
11 CD O
AAPC NNP B-Disease
kindreds NNS O
, , O
and CC O
their PRP$ O
phenotypic NN O
differences NNS O
were VBD O
examined VBN O
. . O

Five CD O
novel JJ O
germ NN O
- : O
line NN O
APC NNP B-Disease
mutations NNS O
were VBD O
identified VBN O
in IN O
seven CD O
kindreds NNS O
. . O

Mutations NNS O
were VBD O
located VBN O
in IN O
three CD O
different JJ O
regions NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
( ( O
1 CD O
) ) O
at IN O
the DT O
5 CD O
end NN O
spanning VBG O
exons NNS O
4 CD O
and CC O
5 CD O
, , O
( ( O
2 CD O
) ) O
within IN O
exon $ O
9 CD O
, , O
and CC O
( ( O
3 CD O
) ) O
at IN O
the DT O
3 CD O
distal JJ O
end NN O
of IN O
the DT O
gene NN O
. . O

Variability NN O
in IN O
the DT O
number NN O
of IN O
colorectal JJ B-Disease
adenomas NN I-Disease
was VBD O
most RBS O
apparent JJ O
in IN O
individuals NNS O
with IN O
mutations NNS O
in IN O
region NN O
1 CD O
, , O
and CC O
upper JJ O
- : O
gastrointestinal JJ O
manifestations NNS O
were VBD O
more RBR O
severe JJ O
in IN O
them PRP O
. . O

In IN O
individuals NNS O
with IN O
mutations NNS O
in IN O
either DT O
region NN O
2 CD O
or CC O
region NN O
3 CD O
, , O
the DT O
average JJ O
number NN O
of IN O
adenomas NN B-Disease
tended VBN O
to TO O
be VB O
lower JJR O
than IN O
those DT O
in IN O
individuals NNS O
with IN O
mutations NNS O
in IN O
region NN O
1 CD O
, , O
although IN O
age NN O
at IN O
diagnosis NN O
was VBD O
similar JJ O
. . O

In IN O
all DT O
AAPC NNP B-Disease
kindreds NNS O
, , O
a DT O
predominance NN O
of IN O
right JJ O
- : O
sided VBD O
colorectal JJ B-Disease
adenomas NN I-Disease
and CC O
rectal JJ B-Disease
polyp NN I-Disease
sparing NN O
was VBD O
observed VBN O
. . O

No DT O
desmoid JJ B-Disease
tumors NNS I-Disease
were VBD O
found VBN O
in IN O
these DT O
kindreds NNS O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
, , O
in IN O
AAPC NNP B-Disease
families NNS O
, , O
the DT O
location NN O
of IN O
the DT O
APC NNP B-Disease
mutation NN O
may MD O
partially RB O
predict VB O
specific JJ O
phenotypic NN O
expression NN O
. . O

This DT O
should MD O
help VB O
in IN O
the DT O
design NN O
of IN O
tailored JJ O
clinical JJ O
- : O
management NN O
protocols NNS O
in IN O
this DT O
subset NN O
of IN O
FAP NNP B-Disease
patients NNS O
. . O
. . O

Wilms NNP B-Disease
' POS I-Disease
tumor NN I-Disease
1 CD O
and CC O
Dax NNP O
- : O
1 CD O
modulate NN O
the DT O
orphan JJ O
nuclear JJ O
receptor NN O
SF NNP O
- : O
1 CD O
in IN O
sex NN O
- : O
specific JJ O
gene NN O
expression NN O
. . O

Products NNS O
of IN O
steroidogenic JJ O
factor NN O
1 CD O
( ( O
SF NNP O
- : O
1 CD O
) ) O
and CC O
Wilms NNP B-Disease
tumor NN I-Disease
1 CD O
( ( O
WT1 NNP O
) ) O
genes NNS O
are VBP O
essential JJ O
for IN O
mammalian JJ O
gonadogenesis NN O
prior RB O
to TO O
sexual JJ O
differentiation NN O
. . O

In IN O
males NNS O
, , O
SF NNP O
- : O
1 CD O
participates NNS O
in IN O
sexual JJ O
development NN O
by IN O
regulating VBG O
expression NN O
of IN O
the DT O
polypeptide NN O
hormone NN O
Mullerian JJ O
inhibiting NN O
substance NN O
( ( O
MIS NNP O
) ) O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
WT1 NNP O
- : O
KTS NNP O
isoforms NNS O
associate VBP O
and CC O
synergize VBP O
with IN O
SF NNP O
- : O
1 CD O
to TO O
promote VB O
MIS NNP O
expression NN O
. . O

In IN O
contrast NN O
, , O
WT1 NNP O
missense NN O
mutations NNS O
, , O
associated VBN O
with IN O
male JJ B-Disease
pseudohermaphroditism NN I-Disease
in IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
, , O
fail VBP O
to TO O
synergize VB O
with IN O
SF NNP O
- : O
1 CD O
. . O

Additionally RB O
, , O
the DT O
X NNP O
- : O
linked VBN O
, , O
candidate JJ O
dosage NN O
- : O
sensitive JJ O
sex NN O
- : O
reversal NN O
gene NN O
, , O
Dax NNP O
- : O
1 CD O
, , O
antagonizes VBZ O
synergy NN O
between IN O
SF NNP O
- : O
1 CD O
and CC O
WT1 NNP O
, , O
most JJS O
likely RB O
through IN O
a DT O
direct JJ O
interaction NN O
with IN O
SF NNP O
- : O
1 CD O
. . O

We PRP O
propose VBP O
that IN O
WT1 NNP O
and CC O
Dax NNP O
- : O
1 CD O
functionally RB O
oppose VBP O
each DT O
other JJ O
in IN O
testis NN O
development NN O
by IN O
modulating VBG O
SF NNP O
- : O
1 CD O
- : O
mediated VBN O
transactivation NN O
. . O
. . O

A DT O
mouse NN O
model NN O
for IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome VBP I-Disease
imprinting VBG O
- : O
centre NN O
mutations NNS O
. . O

Imprinting VBG O
in IN O
the DT O
15q11 CD O
- : O
q13 JJ O
region NN O
involves VBZ O
an DT O
imprinting NN O
centre NN O
( ( O
IC NNP O
) ) O
, , O
mapping VBG O
in IN O
part NN O
to TO O
the DT O
promoter NN O
and CC O
first JJ O
exon NN O
of IN O
SNRPN NNP O
. . O

Deletion NN O
of IN O
this DT O
IC NNP O
abolishes VBZ O
local JJ O
paternally RB O
derived VBN O
gene NN O
expression NN O
and CC O
results NNS O
in IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

We PRP O
have VBP O
created VBN O
two CD O
deletion NN O
mutations NNS O
in IN O
mice NN O
to TO O
understand VB O
PWS NNP B-Disease
and CC O
the DT O
mechanism NN O
of IN O
this DT O
IC NNP O
. . O

Mice NNP O
harbouring VBG O
an DT O
intragenic JJ O
deletion NN O
in IN O
Snrpn NNP O
are VBP O
phenotypically RB O
normal JJ O
, , O
suggesting VBG O
that IN O
mutations NNS O
of IN O
SNRPN NNP O
are VBP O
not RB O
sufficient JJ O
to TO O
induce VB O
PWS NNP B-Disease
. . O

Mice NNP O
with IN O
a DT O
larger JJR O
deletion NN O
involving VBG O
both DT O
Snrpn NNP O
and CC O
the DT O
putative JJ O
PWS NNP O
- : O
IC NNP O
lack VBP O
expression NN O
of IN O
the DT O
imprinted JJ O
genes NNS O
Zfp127 NNP O
( ( O
mouse IN O
homologue NN O
of IN O
ZNF127 NNP O
) ) O
, , O
Ndn NNP O
and CC O
Ipw NNP O
, , O
and CC O
manifest JJS O
several JJ O
phenotypes NNS O
common JJ O
to TO O
PWS NNP B-Disease
infants NNS O
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
both CC O
the DT O
position NN O
of IN O
the DT O
IC NNP O
and CC O
its PRP$ O
role NN O
in IN O
the DT O
coordinate JJ O
expression NN O
of IN O
genes NNS O
is VBZ O
conserved VBN O
between IN O
mouse NN O
and CC O
human NN O
, , O
and CC O
indicate VBP O
that IN O
the DT O
mouse NN O
is VBZ O
a DT O
suitable JJ O
model NN O
system NN O
in IN O
which WDT O
to TO O
investigate VB O
the DT O
molecular JJ O
mechanisms NN O
of IN O
imprinting VBG O
in IN O
this DT O
region NN O
of IN O
the DT O
genome NN O
. . O
. . O

Mutations NNS O
of IN O
the DT O
ATM NNP O
gene NN O
detected VBD O
in IN O
Japanese JJ O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
patients NNS O
: : O
possible JJ O
preponderance NN O
of IN O
the DT O
two CD O
founder NN O
mutations NNS O
4612del165 CD O
and CC O
7883del5 CD O
. . O

The DT O
ATM NNP O
( ( O
A NNP O
- : O
T NN O
, , O
mutated VBN O
) ) O
gene NN O
on IN O
human JJ O
chromosome NN O
11q22 CD O
. . O

3 CD O
has VBZ O
recently RB O
been VBN O
identified VBN O
as IN O
the DT O
gene NN O
responsible JJ O
for IN O
the DT O
human JJ O
recessive JJ B-Disease
disease NN I-Disease
ataxia SYM B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
. . O

In IN O
order NN O
to TO O
define VB O
the DT O
types NNS O
of IN O
disease NN O
- : O
causing NN O
ATM NNP O
mutations NNS O
in IN O
Japanese JJ O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
as RB O
well RB O
as IN O
to TO O
look VB O
for IN O
possible JJ O
mutational JJ O
hotspots NNS O
, , O
reverse VB O
- : O
transcribed NN O
RNA NNP O
derived VBD O
from IN O
ten JJ O
patients NNS O
belonging VBG O
to TO O
eight CD O
unrelated JJ O
Japanese PDT O
A DT B-Disease
- : I-Disease
T NN I-Disease
families NNS O
was VBD O
analyzed VBN O
for IN O
mutations NNS O
by IN O
the DT O
restriction NN O
endonuclease NN O
fingerprinting VBG O
method NN O
. . O

As IN O
has VBZ O
been VBN O
reported VBN O
by IN O
others NNS O
, , O
mutations NNS O
that WDT O
lead VBP O
to TO O
exon VB O
skipping VBG O
or CC O
premature JJ O
protein JJ O
truncation NN O
were VBD O
also RB O
predominant JJ O
in IN O
our PRP$ O
mutants NNS O
. . O

Six CD O
different JJ O
mutations NNS O
were VBD O
identified VBN O
on IN O
12 CD O
of IN O
the DT O
16 CD O
alleles NNS O
examined VBN O
. . O

Four CD O
were VBD O
deletions NNS O
involving VBG O
a DT O
loss NN O
of IN O
a DT O
single JJ O
exon NN O
exon VBD O
7 CD O
, , O
exon RB O
16 CD O
, , O
exon VBZ O
33 CD O
or CC O
exon VB O
35 CD O
. . O

The DT O
others NNS O
were VBD O
minute JJ O
deletions NNS O
, , O
4649delA CD O
in IN O
exon JJ O
33 CD O
and CC O
7883del5 CD O
in IN O
exon JJ O
55 CD O
. . O

The DT O
mutations NNS O
4612del165 CD O
and CC O
7883del5 CD O
were VBD O
found VBN O
in IN O
more JJR O
than IN O
two CD O
unrelated JJ O
families NNS O
; : O
44 CD O
% NN O
( ( O
7 CD O
of IN O
16 CD O
) ) O
of IN O
the DT O
mutant JJ O
alleles NNS O
had VBD O
one CD O
of IN O
the DT O
two CD O
mutations NNS O
. . O

The DT O
4612del165 CD O
mutations NNS O
in IN O
three CD O
different JJ O
families NNS O
were VBD O
all DT O
ascribed VBN O
to TO O
the DT O
same JJ O
T NNP O
- : O
- : O
> VB O
A DT O
substitution NN O
at IN O
the DT O
splice NN O
donor NN O
site NN O
in IN O
intron NN O
33 CD O
. . O

Microsatellite NNP O
genotyping VBG O
around IN O
the DT O
ATM NNP O
locus NN O
also RB O
indicated VBD O
that IN O
a DT O
common JJ O
haplotype NN O
was VBD O
shared VBN O
by IN O
the DT O
mutant JJ O
alleles NNS O
in IN O
both DT O
mutations NNS O
. . O

This DT O
suggests VBZ O
that IN O
these DT O
two CD O
founder NN O
mutations NNS O
may MD O
be VB O
predominant JJ O
among IN O
Japanese JJ O
ATM NNP O
mutant JJ O
alleles NNS O
. . O

W474C NNP O
amino NN O
acid NN O
substitution NN O
affects VBZ O
early JJ O
processing NN O
of IN O
the DT O
alpha JJ O
- : O
subunit NN O
of IN O
beta NN O
- : O
hexosaminidase NN O
A DT O
and CC O
is VBZ O
associated VBN O
with IN O
subacute NN O
G NNP B-Disease
( ( I-Disease
M2 NNP I-Disease
) ) I-Disease
gangliosidosis NN I-Disease
. . O

Mutations NNS O
in IN O
the DT O
HEXA NNP O
gene NN O
, , O
encoding VBG O
the DT O
alpha NN O
- : O
subunit NN O
of IN O
beta NN O
- : O
hexosaminidase NN O
A NNP O
( ( O
Hex NNP O
A NNP O
) ) O
, , O
that IN O
abolish JJ O
Hex NNP O
A NNP O
enzyme NN O
activity NN O
cause NN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
, , O
the DT O
fatal JJ O
infantile JJ B-Disease
form NN I-Disease
of IN I-Disease
G NNP I-Disease
( ( I-Disease
M2 NNP I-Disease
) ) I-Disease
gangliosidosis NN I-Disease
, , I-Disease
Type NNP I-Disease
1 CD I-Disease
. . O

Less RBR O
severe JJ O
, , O
subacute JJ O
( ( O
juvenile JJ O
- : O
onset NN O
) ) O
and CC O
chronic JJ O
( ( O
adult JJ O
- : O
onset NN O
) ) O
variants NNS O
are VBP O
characterized VBN O
by IN O
a DT O
broad JJ O
spectrum NN O
of IN O
clinical JJ O
manifestations NNS O
and CC O
are VBP O
associated VBN O
with IN O
residual JJ O
levels NNS O
of IN O
Hex NNP O
A NNP O
enzyme NN O
activity NN O
. . O

We PRP O
identified VBD O
a DT O
1422 CD O
G NNP O
- : O
- : O
> NN O
C NNP O
( ( O
amino JJ O
acid VBP O
W474C NNP O
) ) O
substitution NN O
in IN O
the DT O
first JJ O
position NN O
of IN O
exon JJ O
13 CD O
of IN O
HEXA NNP O
of IN O
a DT O
non JJ O
- : O
Jewish JJ O
proband NN O
who WP O
manifested VBD O
a DT O
subacute JJ O
variant NN O
of IN O
G NNP B-Disease
( ( I-Disease
M2 NNP I-Disease
) ) I-Disease
gangliosidosis NN I-Disease
. . O

On IN O
the DT O
second JJ O
maternally RB O
inherited VBN O
allele RB O
, , O
we PRP O
identified VBD O
the DT O
common JJ O
infantile NN O
disease NN O
- : O
causing VBG O
4 CD O
- : O
bp NN O
insertion NN O
, , O
+ NNP O
TATC NNP O
1278 CD O
, , O
in IN O
exon JJ O
11 CD O
. . O

Pulse NNP O
- : O
chase NN O
analysis NN O
using VBG O
proband NN O
fibroblasts NNS O
revealed VBD O
that IN O
the DT O
W474C NNP O
- : O
containing VBG O
alpha JJ O
- : O
subunit NN O
precursor NN O
was VBD O
normally RB O
synthesized VBN O
, , O
but CC O
not RB O
phosphorylated VBD O
or CC O
secreted VBN O
, , O
and CC O
the DT O
mature NN O
lysosomal JJ O
alpha SYM O
- : O
subunit NN O
was VBD O
not RB O
detected VBN O
. . O

When WRB O
the DT O
W474C NNP O
- : O
containing VBG O
alpha JJ O
- : O
subunit NN O
was VBD O
transiently RB O
co JJ O
- : O
expressed VBN O
with IN O
the DT O
beta NN O
- : O
subunit NN O
to TO O
produce VB O
Hex NNP O
A NNP O
( ( O
alphabeta NN O
) ) O
in IN O
COS NNP O
- : O
7 CD O
cells NNS O
, , O
the DT O
mature NN O
alpha SYM O
- : O
subunit NN O
was VBD O
present JJ O
, , O
but CC O
its PRP$ O
level NN O
was VBD O
much RB O
lower JJR O
than IN O
that DT O
from IN O
normal JJ O
alpha JJ O
- : O
subunit NN O
transfections NNS O
, , O
although IN O
higher JJR O
than IN O
in IN O
those DT O
cells NNS O
transfected VBN O
with IN O
an DT O
alpha JJ O
- : O
subunit NN O
associated VBN O
with IN O
infantile JJ O
TSD NNP B-Disease
. . O

Furthermore RB O
, , O
the DT O
precursor NN O
level NN O
of IN O
the DT O
W474C NNP O
alpha SYM O
- : O
subunit NN O
was VBD O
found VBN O
to TO O
accumulate VB O
in IN O
comparison NN O
to TO O
the DT O
normal JJ O
alpha JJ O
- : O
subunit NN O
precursor NN O
levels NNS O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
1422 CD O
G NNP O
- : O
- : O
> NN O
C NNP O
mutation NN O
is VBZ O
the DT O
cause NN O
of IN O
Hex NNP B-Disease
A NNP I-Disease
enzyme JJ I-Disease
deficiency NN I-Disease
in IN O
the DT O
proband NN O
. . O

The DT O
resulting VBG O
W474C NNP O
substitution NN O
clearly RB O
interferes VBZ O
with IN O
alpha JJ O
- : O
subunit NN O
processing NN O
, , O
but CC O
because IN O
the DT O
base NN O
substitution NN O
falls VBZ O
at IN O
the DT O
first JJ O
position NN O
of IN O
exon JJ O
13 CD O
, , O
aberrant JJ O
splicing NN O
may MD O
also RB O
contribute VB O
to TO O
Hex VB B-Disease
A DT I-Disease
deficiency NN I-Disease
in IN O
this DT O
proband NN O
. . O
. . O

Two CD O
frequent JJ O
missense NN O
mutations NNS O
in IN O
Pendred NNP B-Disease
syndrome NN I-Disease
. . O

Pendred NNP B-Disease
syndrome NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
early JJ O
childhood NN O
deafness NN B-Disease
and CC O
goiter NN B-Disease
. . O

A DT O
century NN O
after IN O
its PRP$ O
recognition NN O
as IN O
a DT O
syndrome NN O
by IN O
Vaughan NNP O
Pendred NNP O
, , O
the DT O
disease NN O
gene NN O
( ( O
PDS NNP O
) ) O
was VBD O
mapped VBN O
to TO O
chromosome VB O
7q22 CD O
- : O
q31 NN O
. . O

1 CD O
and CC O
, , O
recently RB O
, , O
found VBD O
to TO O
encode VB O
a DT O
putative JJ O
sulfate NN O
transporter NN O
. . O

We PRP O
performed VBD O
mutation NN O
analysis NN O
of IN O
the DT O
PDS NNP B-Disease
gene NN O
in IN O
patients NNS O
from IN O
14 CD O
Pendred NNP B-Disease
families NNS O
originating VBG O
from IN O
seven CD O
countries NNS O
and CC O
identified VBD O
all DT O
mutations NNS O
. . O

The DT O
mutations NNS O
include VBP O
three CD O
single JJ O
base NN O
deletions NNS O
, , O
one CD O
splice NN O
site NN O
mutation NN O
and CC O
10 CD O
missense NN O
mutations NNS O
. . O

One CD O
missense NN O
mutation NN O
( ( O
L236P NNP O
) ) O
was VBD O
found VBN O
in IN O
a DT O
homozygous JJ O
state NN O
in IN O
two CD O
consanguineous JJ O
families NNS O
and CC O
in IN O
a DT O
heterozygous JJ O
state NN O
in IN O
five CD O
additional JJ O
non NN O
- : O
consanguineous JJ O
families NNS O
. . O

Another DT O
missense NN O
mutation NN O
( ( O
T416P NNP O
) ) O
was VBD O
found VBN O
in IN O
a DT O
homozygous JJ O
state NN O
in IN O
one CD O
family NN O
and CC O
in IN O
a DT O
heterozygous JJ O
state NN O
in IN O
four CD O
families NNS O
. . O

Pendred JJ B-Disease
patients NNS O
in IN O
three CD O
non SYM O
- : O
consanguineous JJ O
families NNS O
were VBD O
shown VBN O
to TO O
be VB O
compound VBN O
heterozygotes NNS O
for IN O
L236P NNP O
and CC O
T416P NNP O
. . O

In IN O
total JJ O
, , O
one CD O
or CC O
both DT O
of IN O
these DT O
mutations NNS O
were VBD O
found VBN O
in IN O
nine CD O
of IN O
the DT O
14 CD O
families NNS O
analyzed VBN O
. . O

The DT O
identification NN O
of IN O
two CD O
frequent JJ O
PDS NNP B-Disease
mutations NNS O
will MD O
facilitate VB O
the DT O
molecular JJ O
diagnosis NN O
of IN O
Pendred NNP B-Disease
syndrome NN I-Disease
. . O

Insertional JJ O
mutation NN O
by IN O
transposable JJ O
element NN O
, , O
L1 NNP O
, , O
in IN O
the DT O
DMD NNP B-Disease
gene NN O
results NNS O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
dilated JJ I-Disease
cardiomyopathy NN I-Disease
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
dilated VBN I-Disease
cardiomyopathy NN I-Disease
( ( O
XLDCM NNP B-Disease
) ) O
is VBZ O
a DT O
clinical JJ O
phenotype NN O
of IN O
dystrophinopathy NN B-Disease
which WDT O
is VBZ O
characterized VBN O
by IN O
preferential JJ O
myocardial JJ B-Disease
involvement NN I-Disease
without IN O
any DT O
overt JJ O
clinical JJ O
signs NNS O
of IN O
skeletal JJ B-Disease
myopathy NN I-Disease
. . O

To TO O
date NN O
, , O
several JJ O
mutations NNS O
in IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
gene NN O
, , O
DMD NNP O
, , O
have VBP O
been VBN O
identified VBN O
in IN O
patients NNS O
with IN O
XLDCM NNP B-Disease
, , O
but CC O
a DT O
pathogenic JJ O
correlation NN O
of IN O
these DT O
cardiospecific JJ O
mutations NNS O
in IN O
DMD NNP O
with IN O
the DT O
XLDCM NNP B-Disease
phenotype NN O
has VBZ O
remained VBN O
to TO O
be VB O
elucidated VBN O
. . O

We PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
a DT O
unique JJ O
de FW O
novo FW O
L1 NNP O
insertion NN O
in IN O
the DT O
muscle NN O
exon VBD O
1 CD O
in IN O
DMD NNP O
in IN O
three CD O
XLDCM NN B-Disease
patients NNS O
from IN O
two CD O
unrelated JJ O
Japanese JJ O
families NNS O
. . O

The DT O
insertion NN O
was VBD O
a DT O
5 CD O
- : O
truncated JJ O
form NN O
of IN O
human JJ O
L1 NNP O
inversely RB O
integrated VBD O
in IN O
the DT O
5 CD O
- : O
untranslated JJ O
region NN O
in IN O
the DT O
muscle NN O
exon VBZ O
1 CD O
, , O
which WDT O
affected VBD O
the DT O
transcription NN O
or CC O
the DT O
stability NN O
of IN O
the DT O
muscle NN O
form NN O
of IN O
dystrophin JJ O
transcripts NNS O
but CC O
not RB O
that IN O
of IN O
the DT O
brain NN O
or CC O
Purkinje NNP O
cell NN O
form NN O
, , O
probably RB O
due JJ O
to TO O
its PRP$ O
unique JJ O
site NN O
of IN O
integration NN O
. . O

We PRP O
speculate VBP O
that IN O
this DT O
insertion NN O
of IN O
an DT O
L1 NNP O
sequence NN O
in IN O
DMD NNP O
is VBZ O
responsible JJ O
for IN O
some DT O
of IN O
the DT O
population NN O
of IN O
Japanese JJ O
patients NNS O
with IN O
XLDCM NNP B-Disease
. . O
. . O

Severe RB O
early JJ O
- : O
onset NN O
obesity NN B-Disease
, , O
adrenal JJ B-Disease
insufficiency NN I-Disease
and CC O
red JJ O
hair NN O
pigmentation NN O
caused VBN O
by IN O
POMC NNP O
mutations NNS O
in IN O
humans NNS O
. . O

Sequential JJ O
cleavage NN O
of IN O
the DT O
precursor NN O
protein NN O
pre SYM O
- : O
pro JJ O
- : O
opiomelanocortin NN O
( ( O
POMC NNP O
) ) O
generates VBZ O
the DT O
melanocortin NN O
peptides NNS O
adrenocorticotrophin VBP O
( ( O
ACTH NNP O
) ) O
, , O
melanocyte SYM O
- : O
stimulating NN O
hormones NNS O
( ( O
MSH NNP O
) ) O
alpha NN O
, , O
beta NN O
and CC O
gamma NN O
as RB O
well RB O
as IN O
the DT O
opioid JJ O
- : O
receptor NN O
ligand NN O
beta SYM O
- : O
endorphin NN O
. . O

While IN O
a DT O
few JJ O
cases NNS O
of IN O
isolated JJ O
ACTH NNP B-Disease
deficiency NN I-Disease
have VBP O
been VBN O
reported VBN O
( ( O
OMIM NNP O
201400 CD O
) ) O
, , O
an DT O
inherited JJ O
POMC NNP O
defect NN O
has VBZ O
not RB O
been VBN O
described VBN O
so RB O
far RB O
. . O

Recent JJ O
studies NNS O
in IN O
animal JJ O
models NNS O
elucidated VBD O
a DT O
central JJ O
role NN O
of IN O
alpha JJ O
- : O
MSH NN O
in IN O
the DT O
regulation NN O
of IN O
food NN O
intake NN O
by IN O
activation NN O
of IN O
the DT O
brain NN O
melanocortin SYM O
- : O
4 CD O
- : O
receptor NN O
( ( O
MC4 NNP O
- : O
R NN O
; : O
refs CC O
3 CD O
- : O
5 CD O
) ) O
and CC O
the DT O
linkage NN O
of IN O
human JJ O
obesity NN B-Disease
to TO O
chromosome VB O
2 CD O
in IN O
close JJ O
proximity NN O
to TO O
the DT O
POMC NNP O
locus NN O
, , O
led VBN O
to TO O
the DT O
proposal NN O
of IN O
an DT O
association NN O
of IN O
POMC NNP O
with IN O
human JJ O
obesity NN B-Disease
. . O

The DT O
dual JJ O
role NN O
of IN O
alpha JJ O
- : O
MSH NN O
in IN O
regulating VBG O
food NN O
intake NN O
and CC O
influencing VBG O
hair NN O
pigmentation NN O
predicts VBZ O
that IN O
the DT O
phenotype NN O
associated VBN O
with IN O
a DT O
defect NN O
in IN O
POMC NNP O
function NN O
would MD O
include VB O
obesity NN B-Disease
, , O
alteration NN O
in IN O
pigmentation NN O
and CC O
ACTH NNP B-Disease
deficiency NN I-Disease
. . O

The DT O
observation NN O
of IN O
these DT O
symptoms NNS O
in IN O
two CD O
probands NNS O
prompted VBD O
us PRP O
to TO O
search VB O
for IN O
mutations NNS O
within IN O
their PRP$ O
POMC NNP O
genes NNS O
. . O

Patient JJ O
1 CD O
was VBD O
found VBN O
to TO O
be VB O
a DT O
compound NN O
heterozygote NN O
for IN O
two CD O
mutations NNS O
in IN O
exon JJ O
3 CD O
( ( O
G7013T NNP O
, , O
C7133delta NNP O
) ) O
which WDT O
interfere VBP O
with IN O
appropriate JJ O
synthesis NN O
of IN O
ACTH NNP O
and CC O
alpha SYM O
- : O
MSH NN O
. . O

Patient JJ O
2 CD O
was VBD O
homozygous JJ O
for IN O
a DT O
mutation NN O
in IN O
exon JJ O
2 CD O
( ( O
C3804A NNP O
) ) O
which WDT O
abolishes VBZ O
POMC NNP O
translation NN O
. . O

These DT O
findings NNS O
represent VBP O
the DT O
first JJ O
examples NNS O
of IN O
a DT O
genetic JJ B-Disease
defect NN I-Disease
within IN O
the DT O
POMC NNP O
gene NN O
and CC O
define VB O
a DT O
new JJ O
monogenic JJ B-Disease
endocrine NN I-Disease
disorder NN I-Disease
resulting VBG O
in IN O
early JJ O
- : O
onset NN O
obesity NN B-Disease
, , O
adrenal JJ B-Disease
insufficiency NN I-Disease
and CC O
red JJ O
hair NN O
pigmentation NN O
. . O
. . O

A DT O
European JJ O
multicenter NN O
study NN O
of IN O
phenylalanine JJ B-Disease
hydroxylase NN I-Disease
deficiency NN I-Disease
: : O
classification NN O
of IN O
105 CD O
mutations NNS O
and CC O
a DT O
general JJ O
system NN O
for IN O
genotype NN O
- : O
based VBN O
prediction NN O
of IN O
metabolic JJ O
phenotype NN O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
and CC O
mild JJ B-Disease
hyperphenylalaninemia NN I-Disease
( ( O
MHP NNP B-Disease
) ) O
are VBP O
allelic JJ B-Disease
disorders NNS I-Disease
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
gene NN O
encoding VBG O
phenylalanine JJ O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
. . O

Previous JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
the DT O
highly RB O
variable JJ O
metabolic JJ O
phenotypes NNS O
of IN O
PAH NNP B-Disease
deficiency NN I-Disease
correlate NN O
with IN O
PAH NNP O
genotypes NNS O
. . O

We PRP O
identified VBD O
both DT O
causative JJ O
mutations NNS O
in IN O
686 CD O
patients NNS O
from IN O
seven CD O
European JJ O
centers NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
the DT O
phenotypic NN O
characteristics NNS O
of IN O
297 CD O
functionally RB O
hemizygous JJ O
patients NNS O
, , O
105 CD O
of IN O
the DT O
mutations NNS O
were VBD O
assigned VBN O
to TO O
one CD O
of IN O
four CD O
arbitrary JJ O
phenotype NN O
categories NNS O
. . O

We PRP O
proposed VBD O
and CC O
tested VBD O
a DT O
simple JJ O
model NN O
for IN O
correlation NN O
between IN O
genotype NN O
and CC O
phenotypic NN O
outcome NN O
. . O

The DT O
observed JJ O
phenotype NN O
matched VBD O
the DT O
predicted JJ O
phenotype NN O
in IN O
79 CD O
% NN O
of IN O
the DT O
cases NNS O
, , O
and CC O
in IN O
only RB O
5 CD O
of IN O
184 CD O
patients NNS O
was VBD O
the DT O
observed JJ O
phenotype NN O
more JJR O
than IN O
one CD O
category NN O
away RB O
from IN O
that DT O
expected VBN O
. . O

Among IN O
the DT O
seven CD O
contributing NN O
centers NNS O
, , O
the DT O
proportion NN O
of IN O
patients NNS O
for IN O
whom WP O
the DT O
observed JJ O
phenotype NN O
did VBD O
not RB O
match VB O
the DT O
predicted JJ O
phenotype NN O
was VBD O
4 CD O
% NN O
- : O
23 CD O
% NN O
( ( O
P NNP O
< NNP O
. . O
1 CD O
) ) O
, , O
suggesting VBG O
that IN O
differences NNS O
in IN O
methods NNS O
used VBN O
for IN O
mutation NN O
detection NN O
or CC O
phenotype JJ O
classification NN O
may MD O
account VB O
for IN O
a DT O
considerable JJ O
proportion NN O
of IN O
genotype JJ O
- : O
phenotype NN O
inconsistencies NNS O
. . O

Our PRP$ O
data NNS O
indicate VBP O
that IN O
the DT O
PAH NNP O
- : O
mutation NN O
genotype NN O
is VBZ O
the DT O
main JJ O
determinant NN O
of IN O
metabolic JJ O
phenotype NN O
in IN O
most JJS O
patients NNS O
with IN O
PAH NNP B-Disease
deficiency NN I-Disease
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
the DT O
classification NN O
of IN O
105 CD O
PAH NNP O
mutations NNS O
may MD O
allow VB O
the DT O
prediction NN O
of IN O
the DT O
biochemical JJ O
phenotype NN O
in IN O
> JJ O
10 CD O
, , O
0 CD O
genotypes NNS O
, , O
which WDT O
may MD O
be VB O
useful JJ O
for IN O
the DT O
management NN O
of IN O
hyperphenylalaninemia NN B-Disease
in IN O
newborns NNS O
. . O

Somatic JJ O
instability NN O
of IN O
the DT O
CTG NNP O
repeat NN O
in IN O
mice NN O
transgenic NN O
for IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
region NN O
is VBZ O
age NN O
dependent JJ O
but CC O
not RB O
correlated VBN O
to TO O
the DT O
relative JJ O
intertissue NN O
transcription NN O
levels NNS O
and CC O
proliferative JJ O
capacities NNS O
. . O

A DT O
( ( O
CTG NNP O
) ) O
nexpansion NN O
in IN O
the DT O
3 CD O
- : O
untranslated JJ O
region NN O
( ( O
UTR NNP O
) ) O
of IN O
the DT O
DM NNP O
protein NN O
kinase NN O
gene NN O
( ( O
DMPK NNP O
) ) O
is VBZ O
responsible JJ O
for IN O
causing VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
. . O

Major JJ O
instability NN O
, , O
with IN O
very RB O
large JJ O
expansions NNS O
between IN O
generations NNS O
and CC O
high JJ O
levels NNS O
of IN O
somatic JJ O
mosaicism NN O
, , O
is VBZ O
observed VBN O
in IN O
patients NNS O
. . O

There EX O
is VBZ O
a DT O
good JJ O
correlation NN O
between IN O
repeat NN O
size NN O
( ( O
at IN O
least JJS O
in IN O
leucocytes NNS O
) ) O
, , O
clinical JJ O
severity NN O
and CC O
age NN O
of IN O
onset NN O
. . O

The DT O
trinucleotide JJ O
repeat NN O
instability NN O
mechanisms NNS O
involved VBN O
in IN O
DM NNP B-Disease
and CC O
other JJ O
human JJ O
genetic JJ B-Disease
diseases NNS I-Disease
are VBP O
unknown JJ O
. . O

We PRP O
studied VBD O
somatic JJ O
instability NN O
by IN O
measuring VBG O
the DT O
CTG NNP O
repeat NN O
length NN O
at IN O
several JJ O
ages NNS O
in IN O
various JJ O
tissues NNS O
of IN O
transgenic JJ O
mice NN O
carrying VBG O
a DT O
( ( O
CTG NNP O
) ) O
55expansion CD O
surrounded VBN O
by IN O
45 CD O
kb NNS O
of IN O
the DT O
human JJ O
DM NNP B-Disease
region NN O
, , O
using VBG O
small JJ O
- : O
pool NN O
PCR NNP O
. . O

These DT O
mice NNS O
have VBP O
been VBN O
shown VBN O
to TO O
reproduce VB O
the DT O
intergenerational JJ O
and CC O
somatic JJ O
instability NN O
of IN O
the DT O
55 CD O
CTG NNP O
repeat NN O
suggesting VBG O
that IN O
surrounding VBG O
sequences NNS O
and CC O
the DT O
chromatin NN O
environment NN O
are VBP O
involved VBN O
in IN O
instability NN O
mechanisms NNS O
. . O

As IN O
observed VBN O
in IN O
some DT O
of IN O
the DT O
tissues NNS O
of IN O
DM NNP B-Disease
patients NNS O
, , O
there EX O
is VBZ O
a DT O
tendency NN O
for IN O
repeat NN O
length NN O
and CC O
somatic JJ O
mosaicism NN O
to TO O
increase VB O
with IN O
the DT O
age NN O
of IN O
the DT O
mouse NN O
. . O

Furthermore RB O
, , O
we PRP O
observed VBD O
no DT O
correlation NN O
between IN O
the DT O
somatic JJ O
mutation NN O
rate NN O
and CC O
tissue NN O
proliferation NN O
capacity NN O
. . O

The DT O
somatic JJ O
mutation NN O
rates NNS O
in IN O
different JJ O
tissues NNS O
were VBD O
also RB O
not RB O
correlated VBN O
to TO O
the DT O
relative JJ O
inter NN O
- : O
tissue NN O
difference NN O
in IN O
transcriptional JJ O
levels NNS O
of IN O
the DT O
three CD O
genes NNS O
( ( O
DMAHP NNP O
, , O
DMPK NNP O
and CC O
59 CD O
) ) O
surrounding VBG O
the DT O
repeat NN O
. . O
. . O

A DT O
novel JJ O
missense NN O
mutation NN O
in IN O
patients NNS O
from IN O
a DT O
retinoblastoma NN B-Disease
pedigree NN O
showing VBG O
only RB O
mild JJ O
expression NN O
of IN O
the DT O
tumor NN B-Disease
phenotype NN O
. . O

We PRP O
have VBP O
used VBN O
single JJ O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
to TO O
study VB O
the DT O
27 CD O
exons NNS O
of IN O
the DT O
RB1 NNP O
gene NN O
in IN O
individuals NNS O
from IN O
a DT O
family NN O
showing VBG O
mild JJ O
expression NN O
of IN O
the DT O
retinoblastoma NN B-Disease
phenotype NN O
. . O

In IN O
this DT O
family NN O
affected VBD O
individuals NNS O
developed VBD O
unilateral JJ B-Disease
tumors NNS I-Disease
and CC O
, , O
as IN O
a DT O
result NN O
of IN O
linkage NN O
analysis NN O
, , O
unaffected JJ O
mutation NN O
carriers NNS O
were VBD O
also RB O
identified VBN O
within IN O
the DT O
pedigree NN O
. . O

A DT O
single JJ O
band NN O
shift NN O
using VBG O
SSCP NNP O
was VBD O
identified VBN O
in IN O
exon NN O
21 CD O
which WDT O
resulted VBD O
in IN O
a DT O
missense JJ O
mutation NN O
converting VBG O
a DT O
cys NN O
- : O
- : O
> NN O
arg NN O
at IN O
nucleotide JJ O
position NN O
28 CD O
in IN O
the DT O
exon NN O
. . O

The DT O
mutation NN O
destroyed VBD O
an DT O
NdeI NNP O
restriction NN O
enzyme NN O
site NN O
. . O

Analysis NN O
of IN O
all DT O
family NN O
members NNS O
demonstrated VBD O
that IN O
the DT O
missense NN O
mutation NN O
co SYM O
- : O
segregated VBN O
with IN O
patients NNS O
with IN O
tumors NNS B-Disease
or CC O
who WP O
, , O
as IN O
a DT O
result NN O
of IN O
linkage NN O
analysis NN O
had VBD O
been VBN O
predicted VBN O
to TO O
carry VB O
the DT O
predisposing NN O
mutation NN O
. . O

These DT O
observations NNS O
point NN O
to TO O
another DT O
region NN O
of IN O
the DT O
RB1 NNP O
gene NN O
where WRB O
mutations NNS O
only RB O
modify VBP O
the DT O
function NN O
of IN O
the DT O
gene NN O
and CC O
raise VB O
important JJ O
questions NNS O
for IN O
genetic JJ O
counseling NN O
in IN O
families NNS O
with IN O
these DT O
distinctive JJ O
phenotypes NNS O
. . O
. . O

Maternal JJ B-Disease
disomy NN I-Disease
and CC O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome JJ I-Disease
consistent NN O
with IN O
gamete JJ O
complementation NN O
in IN O
a DT O
case NN O
of IN O
familial JJ O
translocation NN O
( ( O
3 CD O
; : O
15 CD O
) ) O
( ( O
p25 NN O
; : O
q11 NN O
. . O
2 CD O
) ) O
. . O

Maternal NNP B-Disease
uniparental JJ I-Disease
disomy NN I-Disease
( ( I-Disease
UPD NNP I-Disease
) ) I-Disease
for IN I-Disease
chromosome NN I-Disease
15 CD I-Disease
is VBZ O
responsible JJ O
for IN O
an DT O
estimated JJ O
30 CD O
% NN O
of IN O
cases NNS O
of IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

We PRP O
report VBP O
on IN O
an DT O
unusual JJ O
case NN O
of IN O
maternal JJ B-Disease
disomy NN I-Disease
15 CD I-Disease
in IN O
PWS NNP B-Disease
that WDT O
is VBZ O
most RBS O
consistent JJ O
with IN O
adjacent JJ O
- : O
1 CD O
segregation NN O
of IN O
a DT O
paternal JJ O
t NN O
( ( O
3 CD O
; : O
15 CD O
) ) O
( ( O
p25 NN O
; : O
q11 NN O
. . O
2 CD O
) ) O
with IN O
simultaneous JJ O
maternal JJ O
meiotic JJ O
nondisjunction NN O
for IN O
chromosome NN O
15 CD O
. . O

The DT O
patient NN O
( ( O
J NNP O
. . O
B NNP O
. . O
) ) O
, , O
a DT O
17 CD O
- : O
year NN O
- : O
old JJ O
white JJ O
male NN O
with IN O
PWS NNP B-Disease
, , O
was VBD O
found VBN O
to TO O
have VB O
47 CD O
chromosomes NNS O
with IN O
a DT O
supernumerary JJ O
, , O
paternal JJ O
der NN O
( ( O
15 CD O
) ) O
consisting NN O
of IN O
the DT O
short JJ O
arm NN O
and CC O
the DT O
proximal JJ O
long JJ O
arm NN O
of IN O
chromosome NN O
15 CD O
, , O
and CC O
distal JJ O
chromosome NN O
arm NN O
3p CD O
. . O

The DT O
t NN O
( ( O
3 CD O
; : O
15 CD O
) ) O
was VBD O
present JJ O
in IN O
the DT O
balanced JJ O
state NN O
in IN O
the DT O
patients NNS O
father NN O
and CC O
a DT O
sister NN O
. . O

Fluorescent NN O
in IN O
situ JJ O
hybridization NN O
analysis NN O
demonstrated VBD O
that IN O
the DT O
PWS NNP B-Disease
critical JJ O
region NN O
resided VBD O
on IN O
the DT O
derivative JJ O
chromosome NN O
3 CD O
and CC O
that IN O
there EX O
was VBD O
no DT O
deletion NN O
of IN O
the DT O
PWS NNP B-Disease
region NN O
on IN O
the DT O
normal JJ O
pair NN O
of IN O
15s CD O
present JJ O
in IN O
J NNP O
. . O

B NNP O
. . O

Methylation NN O
analysis NN O
at IN O
exon JJ O
alpha NN O
of IN O
the DT O
small JJ O
nuclear JJ O
ribonucleoprotein NN O
- : O
associated VBN O
polypeptide IN O
N NNP O
( ( O
SNRPN NNP O
) ) O
gene NN O
showed VBD O
a DT O
pattern JJ O
characteristic NN O
of IN O
only RB O
the DT O
maternal JJ O
chromosome NN O
15 CD O
in IN O
J NNP O
. . O

B NNP O
. . O

Maternal JJ B-Disease
disomy NN I-Disease
was VBD O
confirmed VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
analysis NN O
of IN O
microsatellite JJ O
repeats NNS O
at IN O
the DT O
gamma NN O
- : O
aminobutyric JJ O
acid NN O
receptor NN O
beta3 NN O
subunit NN O
( ( O
GABRB3 NNP O
) ) O
locus NN O
. . O

A DT O
niece NN O
( ( O
B NNP O
. . O
B NNP O
. . O
) ) O
with IN O
45 CD O
chromosomes NNS O
and CC O
the DT O
derivative JJ O
3 CD O
but CC O
without IN O
the DT O
der NN O
( ( O
15 CD O
) ) O
demonstrated VBD O
a DT O
phenotype JJ O
consistent NN O
with IN O
that DT O
reported VBD O
for IN O
haploinsufficiency NN O
of IN O
distal JJ O
3 CD O
p NN O
. . O

Uniparental JJ B-Disease
disomy NN I-Disease
associated VBN O
with IN O
unbalanced JJ O
segregation NN O
of IN O
non JJ O
- : O
Robertsonian JJ O
translocations NNS O
has VBZ O
been VBN O
reported VBN O
previously RB O
but CC O
has VBZ O
not RB O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
been VBN O
observed VBN O
in IN O
a DT O
case NN O
of IN O
PWS NNP B-Disease
. . O

Furthermore RB O
, , O
our PRP$ O
findings NNS O
are VBP O
best RB O
interpreted VBN O
as IN O
true JJ O
gamete JJ O
complementation NN O
resulting VBG O
in IN O
maternal JJ B-Disease
UPD NNP I-Disease
15 CD I-Disease
and CC O
PWS NNP B-Disease

Schwartz NNP B-Disease
- : I-Disease
Jampel NNP I-Disease
syndrome VBD I-Disease
type JJ I-Disease
2 CD I-Disease
and CC O
Stuve NNP B-Disease
- : I-Disease
Wiedemann JJ I-Disease
syndrome NN I-Disease
: : O
a DT O
case NN O
for IN O
"""" NNP O
lumping VBG O
"""" NN O
. . O

Recent JJ O
studies NNS O
demonstrated VBD O
the DT O
existence NN O
of IN O
a DT O
genetically RB O
distinct JJ O
, , O
usually RB O
lethal JJ O
form NN O
of IN O
the DT O
Schwartz NNP B-Disease
- : I-Disease
Jampel NNP I-Disease
syndrome NN I-Disease
( ( O
SJS NNP B-Disease
) ) O
of IN O
myotonia NN B-Disease
and CC O
skeletal JJ B-Disease
dysplasia NN I-Disease
, , O
which WDT O
we PRP O
called VBD O
SJS NNP B-Disease
type NN I-Disease
2 CD I-Disease
. . O

This DT O
disorder NN O
is VBZ O
reminiscent JJ O
of IN O
another DT O
rare JJ O
condition NN O
, , O
the DT O
Stuve NNP B-Disease
- : I-Disease
Wiedemann NNP I-Disease
syndrome NN I-Disease
( ( O
SWS NNP B-Disease
) ) O
, , O
which WDT O
comprises VBZ O
campomelia NN B-Disease
at IN O
birth NN O
with IN O
skeletal JJ B-Disease
dysplasia NN I-Disease
, , O
contractures NNS B-Disease
, , O
and CC O
early JJ B-Disease
death NN I-Disease
. . O

To TO O
test VB O
for IN O
possible JJ O
nosologic JJ O
identity NN O
between IN O
these DT O
disorders NNS O
, , O
we PRP O
reviewed VBD O
the DT O
literature NN O
and CC O
obtained VBD O
a DT O
follow JJ O
- : O
up IN O
of IN O
the DT O
only JJ O
two CD O
surviving VBG O
patients NNS O
, , O
one CD O
with IN O
SJS NNP B-Disease
type NN I-Disease
2 CD I-Disease
at IN O
age NN O
10 CD O
years NNS O
and CC O
another DT O
with IN O
SWS NNP B-Disease
at IN O
age NN O
7 CD O
years NNS O
. . O

Patients NNS O
reported VBD O
as IN O
having VBG O
either CC O
neonatal JJ O
SJS NNP B-Disease
or CC O
SWS NNP B-Disease
presented VBD O
a DT O
combination NN O
of IN O
a DT O
severe JJ O
, , O
prenatal JJ O
- : O
onset NN O
neuromuscular JJ B-Disease
disorder NN I-Disease
( ( O
with IN O
congenital JJ B-Disease
joint NN I-Disease
contractures NNS I-Disease
, , O
respiratory NN O
and CC O
feeding NN O
difficulties NNS O
, , O
tendency NN O
to TO O
hyperthermia VB B-Disease
, , O
and CC O
frequent JJ O
death NN O
in IN O
infancy NN O
) ) O
with IN O
a DT O
distinct JJ O
campomelic JJ B-Disease
- : I-Disease
metaphyseal NN I-Disease
skeletal JJ I-Disease
dysplasia NN I-Disease
. . O

The DT O
similarity NN O
of IN O
the DT O
clinical JJ O
and CC O
radiographic JJ O
findings NNS O
is VBZ O
so RB O
extensive JJ O
that IN O
these DT O
disorders NNS O
appear VBP O
to TO O
be VB O
a DT O
single JJ O
entity NN O
. . O

The DT O
follow NN O
- : O
up IN O
observation NN O
of IN O
an DT O
identical JJ O
and CC O
unique JJ O
pattern NN O
of IN O
progressive JJ O
bone NN B-Disease
dysplasia NN I-Disease
in IN O
the DT O
two CD O
patients NNS O
( ( O
one CD O
with IN O
SJS NNP B-Disease
type NN I-Disease
2 CD I-Disease
, , O
one CD O
with IN O
SWS NNP B-Disease
) ) O
surviving VBG O
beyond IN O
infancy NN O
adds VBZ O
to TO O
the DT O
evidence NN O
in IN O
favor NN O
of IN O
identity NN O
. . O

The DT O
hypothesis NN O
that WDT O
SWS NNP B-Disease
and CC O
SJS NNP B-Disease
type NN I-Disease
2 CD I-Disease
are VBP O
the DT O
same JJ O
disorder NN O
should MD O
be VB O
testable JJ O
by IN O
molecular JJ O
methods NNS O
. . O
. . O

A DT O
mouse NN O
model NN O
of IN O
severe JJ O
von NN B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
: : O
defects NNS O
in IN O
hemostasis NN O
and CC O
thrombosis NN B-Disease
. . O

von NN B-Disease
Willebrand NNP I-Disease
factor NN I-Disease
( ( I-Disease
vWf NN I-Disease
) ) I-Disease
deficiency NN I-Disease
causes VBZ O
severe JJ O
von NN B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
in IN O
humans NNS O
. . O

We PRP O
generated VBD O
a DT O
mouse NN O
model NN O
for IN O
this DT O
disease NN O
by IN O
using VBG O
gene NN O
targeting VBG O
. . O

vWf SYM B-Disease
- : I-Disease
deficient NN I-Disease
mice RB O
appeared VBD O
normal JJ O
at IN O
birth NN O
; : O
they PRP O
were VBD O
viable JJ O
and CC O
fertile JJ O
. . O

Neither DT O
vWf NN O
nor CC O
vWf JJ O
propolypeptide NN O
( ( O
von JJ B-Disease
Willebrand NNP I-Disease
antigen NN O
II NNP O
) ) O
were VBD O
detectable JJ O
in IN O
plasma NN O
, , O
platelets NNS O
, , O
or CC O
endothelial JJ O
cells NNS O
of IN O
the DT O
homozygous JJ O
mutant JJ O
mice NN O
. . O

The DT O
mutant JJ O
mice NN O
exhibited VBD O
defects NNS O
in IN O
hemostasis NN O
with IN O
a DT O
highly RB O
prolonged JJ O
bleeding NN O
time NN O
and CC O
spontaneous JJ O
bleeding VBG O
events NNS O
in IN O
approximately RB O
10 CD O
% NN O
of IN O
neonates NNS O
. . O

As IN O
in IN O
the DT O
human JJ O
disease NN O
, , O
the DT O
factor NN O
VIII NNP O
level NN O
in IN O
these DT O
mice NN O
was VBD O
reduced VBN O
strongly RB O
as IN O
a DT O
result NN O
of IN O
the DT O
lack NN O
of IN O
protection NN O
provided VBN O
by IN O
vWf NN O
. . O

Defective JJ O
thrombosis NN B-Disease
in IN O
mutant JJ O
mice NN O
was VBD O
also RB O
evident JJ O
in IN O
an DT O
in IN O
vivo JJ O
model NN O
of IN O
vascular JJ B-Disease
injury NN I-Disease
. . O

In IN O
this DT O
model NN O
, , O
the DT O
exteriorized JJ O
mesentery NN O
was VBD O
superfused VBN O
with IN O
ferric JJ O
chloride NN O
and CC O
the DT O
accumulation NN O
of IN O
fluorescently RB O
labeled VBN O
platelets NNS O
was VBD O
observed VBN O
by IN O
intravital JJ O
microscopy NN O
. . O

We PRP O
conclude VBP O
that IN O
these DT O
mice NNS O
very RB O
closely RB O
mimic JJ O
severe JJ O
human JJ O
von NN B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
and CC O
will MD O
be VB O
very RB O
useful JJ O
for IN O
investigating VBG O
the DT O
role NN O
of IN O
vWf NN O
in IN O
normal JJ O
physiology NN O
and CC O
in IN O
disease NN O
models NNS O
. . O
. . O

Oral JJ O
contraceptives NNS O
and CC O
the DT O
risk NN O
of IN O
hereditary JJ B-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Hereditary JJ B-Disease
Ovarian JJ I-Disease
Cancer NNP I-Disease
Clinical NNP O
Study NNP O
Group NNP O
. . O

BACKGROUND NNP O
Women NNP O
with IN O
mutations NNS O
in IN O
either CC O
the DT O
BRCA1 NNP O
or CC O
the DT O
BRCA2 NNP O
gene NN O
have VBP O
a DT O
high JJ O
lifetime NN O
risk NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

Oral JJ O
contraceptives NNS O
protect VBP O
against IN O
ovarian JJ B-Disease
cancer NN I-Disease
in IN O
general JJ O
, , O
but CC O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
they PRP O
also RB O
protect VBP O
against IN O
hereditary JJ B-Disease
forms NNS I-Disease
of IN I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

METHODS NNP O
We PRP O
enrolled VBD O
207 CD O
women NNS O
with IN O
hereditary JJ B-Disease
ovarian JJ I-Disease
cancer NN I-Disease
and CC O
161 CD O
of IN O
their PRP$ O
sisters NNS O
as IN O
controls NNS O
in IN O
a DT O
case NN O
- : O
control NN O
study NN O
. . O

All PDT O
the DT O
patients NNS O
carried VBD O
a DT O
pathogenic JJ O
mutation NN O
in IN O
either DT O
BRCA1 NNP O
( ( O
179 CD O
women NNS O
) ) O
or CC O
BRCA2 NNP O
( ( O
28 CD O
women NNS O
) ) O
. . O

The DT O
control NN O
women NNS O
were VBD O
enrolled JJ O
regardless NN O
of IN O
whether IN O
or CC O
not RB O
they PRP O
had VBD O
either DT O
mutation NN O
. . O

Lifetime NNP O
histories NNS O
of IN O
oral JJ O
- : O
contraceptive NN O
use NN O
were VBD O
obtained VBN O
by IN O
interview NN O
or CC O
by IN O
written VBN O
questionnaire NN O
and CC O
were VBD O
compared VBN O
between IN O
patients NNS O
and CC O
control VB O
women NNS O
, , O
after IN O
adjustment NN O
for IN O
year NN O
of IN O
birth NN O
and CC O
parity NN O
. . O

RESULTS VB O
The DT O
adjusted JJ O
odds NNS O
ratio NN O
for IN O
ovarian JJ B-Disease
cancer NN I-Disease
associated VBN O
with IN O
any DT O
past JJ O
use NN O
of IN O
oral JJ O
contraceptives NNS O
was VBD O
0 CD O
. . O

5 CD O
( ( O
95 CD O
percent NN O
confidence NN O
interval NN O
, , O
0 CD O
. . O
3 CD O
to TO O
0 CD O
. . O
8 CD O
) ) O
. . O

The DT O
risk NN O
decreased VBD O
with IN O
increasing VBG O
duration NN O
of IN O
use NN O
( ( O
P NNP O
for IN O
trend NN O
, , O
< RB O
0 CD O
. . O
1 CD O
) ) O
; : O
use NN O
for IN O
six CD O
or CC O
more JJR O
years NNS O
was VBD O
associated VBN O
with IN O
a DT O
60 CD O
percent NN O
reduction NN O
in IN O
risk NN O
. . O

Oral NNP O
- : O
contraceptive NN O
use NN O
protected VBN O
against IN O
ovarian JJ B-Disease
cancer NN I-Disease
both DT O
for IN O
carriers NNS O
of IN O
the DT O
BRCA1 NNP O
mutation NN O
( ( O
odds NNS O
ratio NN O
, , O
0 CD O
. . O
5 CD O
; : O
95 CD O
percent NN O
confidence NN O
interval NN O
, , O
0 CD O
. . O
3 CD O
to TO O
0 CD O
. . O
9 CD O
) ) O
and CC O
for IN O
carriers NNS O
of IN O
the DT O
BRCA2 NNP O
mutation NN O
( ( O
odds NNS O
ratio NN O
, , O
0 CD O
. . O
4 CD O
; : O
95 CD O
percent NN O
confidence NN O
interval NN O
, , O
0 CD O
. . O
2 CD O
to TO O
1 CD O
. . O
1 CD O
) ) O
. . O

CONCLUSIONS NNP O
Oral NNP O
- : O
contraceptive NN O
use NN O
may MD O
reduce VB O
the DT O
risk NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
in IN O
women NNS O
with IN O
pathogenic JJ O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
or CC O
BRCA2 NNP O
gene NN O

A DT O
Japanese JJ O
family NN O
with IN O
adrenoleukodystrophy NN B-Disease
with IN O
a DT O
codon NN O
291 CD O
deletion NN O
: : O
a DT O
clinical JJ O
, , O
biochemical JJ O
, , O
pathological JJ O
, , O
and CC O
genetic JJ O
report NN O
. . O

We PRP O
report VBP O
a DT O
Japanese JJ O
family NN O
with IN O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
with IN O
a DT O
three CD O
base NN O
pair NN O
deletion NN O
( ( O
delGAG JJ O
291 CD O
) ) O
in IN O
the DT O
ALD NNP B-Disease
gene NN O
. . O

A DT O
variety NN O
of IN O
phenotypes NNS O
were VBD O
observed VBN O
within IN O
this DT O
family NN O
. . O

While IN O
the DT O
proband NN O
( ( O
patient JJ O
1 CD O
) ) O
was VBD O
classified VBN O
as IN O
having VBG O
a DT O
rare JJ O
intermediate JJ O
type NN O
of IN O
adult JJ O
cerebral JJ O
and CC O
cerebello JJ O
- : O
brain NN O
stem NN O
forms NNS O
, , O
his PRP$ O
younger JJR O
brother NN O
( ( O
patient JJ O
2 CD O
) ) O
and CC O
nephew $ O
( ( O
patient JJ O
3 CD O
) ) O
had VBD O
a DT O
childhood NN O
ALD NNP B-Disease
type NN O
. . O

Another DT O
nephew NN O
( ( O
patient JJ O
4 CD O
) ) O
of IN O
patient NN O
1 CD O
was VBD O
classified VBN O
as IN O
having VBG O
an DT O
adolescent JJ O
form NN O
. . O

The DT O
tau JJ O
level NN O
in IN O
the DT O
cerebrospinal JJ O
fluid NN O
( ( O
CSF NNP O
) ) O
in IN O
patient NN O
1 CD O
was VBD O
as RB O
high JJ O
as IN O
that DT O
of IN O
patients NNS O
with IN O
Alzheimers NNP B-Disease
disease NN I-Disease
( ( O
AD NNP B-Disease
) ) O
. . O

His PRP$ O
brain NN O
magnetic JJ O
resonance NN O
image NN O
( ( O
MRI NNP O
) ) O
showed VBD O
abnormalities NNS B-Disease
in IN I-Disease
the DT I-Disease
bilateral JJ I-Disease
cerebellar NN I-Disease
hemispheres NNS I-Disease
and CC O
brain NN O
stem NN O
, , O
but CC O
not RB O
in IN O
the DT O
cerebral JJ O
white JJ O
matter NN O
, , O
where WRB O
marked JJ O
reductions NNS O
of IN O
the DT O
cerebral JJ O
blood NN O
flow NN O
and CC O
oxygen NN O
metabolism NN O
were VBD O
clearly RB O
demonstrated VBN O
by IN O
positron NN O
emission NN O
tomography NN O
( ( O
PET NNP O
) ) O
. . O

In IN O
patients NNS O
2 CD O
and CC O
3 CD O
, , O
the DT O
autopsy NN O
findings NNS O
showed VBD O
massive JJ O
demyelination NN B-Disease
of IN I-Disease
the DT I-Disease
cerebral JJ I-Disease
white JJ I-Disease
matter NN I-Disease
with IN O
sparing NN O
of IN O
the DT O
U NNP O
- : O
fibers NNS O
, , O
compatible JJ O
with IN O
the DT O
findings NNS O
of IN O
childhood NN O
ALD NNP B-Disease
. . O

Oleic NNP O
and CC O
erucic JJ O
acids NNS O
( ( O
Lorenzos NNP O
Oil NNP O
) ) O
were VBD O
administered VBN O
to TO O
patients NNS O
1 CD O
and CC O
4 CD O
, , O
but CC O
sufficient JJ O
effectiveness NN O
was VBD O
not RB O
obtained VBN O
. . O

The DT O
findings NNS O
in IN O
this DT O
family NN O
suggest VBP O
that IN O
delGAG291 NN O
is VBZ O
part NN O
of IN O
the DT O
cause NN O
of IN O
Japanese JJ O
ALD NNP B-Disease
with IN O
phenotypic JJ O
variations NNS O
. . O

Moreover RB O
, , O
although IN O
the DT O
scale NN O
of IN O
the DT O
study NN O
is VBZ O
limited VBN O
, , O
there EX O
is VBZ O
a DT O
possibility NN O
that IN O
PET NNP O
can MD O
detect VB O
an DT O
insidious JJ B-Disease
lesion NN I-Disease
which WDT O
is VBZ O
undetectable JJ O
by IN O
computed JJ O
tomogram NN O
( ( O
CT NNP O
) ) O
or CC O
MRI NNP O
analysis NN O
, , O
and CC O
that IN O
the DT O
higher JJR O
level NN O
of IN O
tau NN O
reflects VBZ O
the DT O
process NN O
of IN O
neuronal JJ B-Disease
degeneration NN I-Disease
in IN O
ALD NNP B-Disease
. . O

Lorenzos NNP O
Oil NNP O
should MD O
be VB O
given VBN O
in IN O
the DT O
early JJ O
stage NN O
. . O
. . O

Nonsense NNP O
mutation NN O
in IN O
exon JJ O
4 CD O
of IN O
human JJ O
complement NN O
C9 NNP O
gene NN O
is VBZ O
the DT O
major JJ O
cause NN O
of IN O
Japanese JJ O
complement NN B-Disease
C9 NNP I-Disease
deficiency NN I-Disease
. . O

Deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
ninth JJ I-Disease
component NN I-Disease
of IN I-Disease
human JJ I-Disease
complement NN I-Disease
( ( O
C9 NNP O
) ) O
is VBZ O
the DT O
most RBS O
common JJ O
complement NN B-Disease
deficiency NN I-Disease
in IN O
Japan NNP O
but CC O
is VBZ O
rare JJ O
in IN O
other JJ O
countries NNS O
. . O

We PRP O
studied VBD O
the DT O
molecular JJ O
basis NN O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
in IN O
four CD O
Japanese JJ O
C9 NNP B-Disease
- : I-Disease
deficient NN I-Disease
patients NNS O
who WP O
had VBD O
suffered VBN O
from IN O
meningococcal JJ B-Disease
meningitis NN I-Disease
. . O

Direct JJ O
sequencing NN O
of IN O
amplified JJ O
C9 NNP O
cDNA NN O
and CC O
DNA NNP O
revealed VBD O
a DT O
nonsense JJ O
substitution NN O
( ( O
CGA NNP O
- : O
- : O
> NN O
TGA NNP O
) ) O
at IN O
codon $ O
95 CD O
in IN O
exon JJ O
4 CD O
in IN O
the DT O
four CD O
C9 NNP B-Disease
- : I-Disease
deficient NN I-Disease
individuals NNS O
. . O

An DT O
allele JJ O
- : O
specific JJ O
polymerase NN O
chain NN O
reaction NN O
system NN O
designed VBN O
to TO O
detect VB O
exclusively RB O
only RB O
one CD O
of IN O
the DT O
normal JJ O
and CC O
mutant JJ O
alleles NNS O
indicated VBD O
that IN O
all PDT O
the DT O
four CD O
patients NNS O
were VBD O
homozygous JJ O
for IN O
the DT O
mutation NN O
in IN O
exon CC O
4 CD O
and CC O
that IN O
the DT O
parents NNS O
of IN O
patient JJ O
2 CD O
were VBD O
heterozygous JJ O
. . O

The DT O
common JJ O
mutation NN O
at IN O
codon NN O
95 CD O
in IN O
exon JJ O
4 CD O
might MD O
be VB O
responsible JJ O
for IN O
most JJS O
Japanese JJ O
C9 NNP B-Disease
deficiency NN I-Disease
. . O
. . O

BRCA1 NNP O
required VBD O
for IN O
transcription NN O
- : O
coupled VBN O
repair NN O
of IN O
oxidative JJ O
DNA NNP O
damage NN O
. . O

The DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
BRCA1 NNP O
encodes VBZ O
a DT O
zinc NN O
finger NN O
protein NN O
of IN O
unknown JJ O
function NN O
. . O

Association NNP O
of IN O
the DT O
BRCA1 NNP O
protein NN O
with IN O
the DT O
DNA NNP O
repair NN O
protein NN O
Rad51 NNP O
and CC O
changes NNS O
in IN O
the DT O
phosphorylation NN O
and CC O
cellular JJ O
localization NN O
of IN O
the DT O
protein NN O
after IN O
exposure NN O
to TO O
DNA NNP O
- : O
damaging NN O
agents NNS O
are VBP O
consistent JJ O
with IN O
a DT O
role NN O
for IN O
BRCA1 NNP O
in IN O
DNA NNP O
repair NN O
. . O

Here RB O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
mouse NN O
embryonic JJ O
stem NN O
cells NNS O
deficient NN B-Disease
in IN I-Disease
BRCA1 NNP I-Disease
are VBP O
defective JJ O
in IN O
the DT O
ability NN O
to TO O
carry VB O
out RP O
transcription NN O
- : O
coupled VBN O
repair NN O
of IN O
oxidative JJ O
DNA NNP O
damage NN O
, , O
and CC O
are VBP O
hypersensitive JJ O
to TO O
ionizing VBG O
radiation NN O
and CC O
hydrogen NN O
peroxide NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
BRCA1 NNP O
participates NNS O
, , O
directly RB O
or CC O
indirectly RB O
, , O
in IN O
transcription NN O
- : O
coupled VBN O
repair NN O
of IN O
oxidative JJ O
DNA NNP O
damage NN O
. . O
. . O

Truncation NN O
mutations NNS O
in IN O
the DT O
transactivation NN O
region NN O
of IN O
PAX6 NNP O
result NN O
in IN O
dominant JJ O
- : O
negative JJ O
mutants NNS O
. . O

PAX6 NNP O
is VBZ O
a DT O
transcription NN O
factor NN O
with IN O
two CD O
DNA NNP O
- : O
binding NN O
domains NNS O
( ( O
paired VBN O
box NN O
and CC O
homeobox NN O
) ) O
and CC O
a DT O
proline JJ O
- : O
serine NN O
- : O
threonine NN O
( ( O
PST NNP O
) ) O
- : O
rich JJ O
transactivation NN O
domain NN O
. . O

PAX6 NNP O
regulates VBZ O
eye NN O
development NN O
in IN O
animals NNS O
ranging VBG O
from IN O
jellyfish NN O
to TO O
Drosophila NNP O
to TO O
humans NNS O
. . O

Heterozygous JJ O
mutations NNS O
in IN O
the DT O
human JJ O
PAX6 NNP O
gene NN O
result NN O
in IN O
various JJ O
phenotypes NNS O
, , O
including VBG O
aniridia NN B-Disease
, , O
Peters NNP B-Disease
anomaly VBP I-Disease
, , O
autosomal JJ B-Disease
dominant JJ I-Disease
keratitis NN I-Disease
, , O
and CC O
familial JJ B-Disease
foveal NN I-Disease
dysplasia NN I-Disease
. . O

It PRP O
is VBZ O
believed VBN O
that IN O
the DT O
mutated JJ O
allele NN O
of IN O
PAX6 NNP O
produces VBZ O
an DT O
inactive JJ O
protein NN O
and CC O
aniridia NN B-Disease
is VBZ O
caused VBN O
due JJ O
to TO O
genetic JJ O
haploinsufficiency NN O
. . O

However RB O
, , O
several JJ O
truncation NN O
mutations NNS O
have VBP O
been VBN O
found VBN O
to TO O
occur VB O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
half NN O
of IN O
PAX6 NNP O
in IN O
patients NNS O
with IN O
Aniridia NNP B-Disease
resulting VBG O
in IN O
mutant JJ O
proteins NNS O
that WDT O
retain VBP O
the DT O
DNA NNP O
- : O
binding NN O
domains NNS O
but CC O
have VBP O
lost VBN O
most JJS O
of IN O
the DT O
transactivation NN O
domain NN O
. . O

It PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
such JJ O
mutants NNS O
really RB O
behave VBP O
as IN O
loss NN O
- : O
of IN O
- : O
function NN O
mutants NNS O
as IN O
predicted VBN O
by IN O
haploinsufficiency NN O
. . O

Contrary JJ O
to TO O
this DT O
theory NN O
, , O
our PRP$ O
data NNS O
showed VBD O
that IN O
these DT O
mutants NNS O
are VBP O
dominant JJ O
- : O
negative JJ O
in IN O
transient JJ O
transfection NN O
assays NNS O
when WRB O
they PRP O
are VBP O
coexpressed VBN O
with IN O
wild JJ O
- : O
type NN O
PAX6 NNP O
. . O

We PRP O
found VBD O
that IN O
the DT O
dominant JJ O
- : O
negative JJ O
effects NNS O
result VBP O
from IN O
the DT O
enhanced JJ O
DNA NNP O
binding VBG O
ability NN O
of IN O
these DT O
mutants NNS O
. . O

Kinetic JJ O
studies NNS O
of IN O
binding NN O
and CC O
dissociation NN O
revealed VBD O
that IN O
various JJ O
truncation NN O
mutants NNS O
have VBP O
3 CD O
- : O
5 CD O
- : O
fold NN O
higher JJR O
affinity NN O
to TO O
various JJ O
DNA NNP O
- : O
binding NN O
sites NNS O
when WRB O
compared VBN O
with IN O
the DT O
wild JJ O
- : O
type NN O
PAX6 NNP O
. . O

These DT O
results NNS O
provide VBP O
a DT O
new JJ O
insight NN O
into IN O
the DT O
role NN O
of IN O
mutant JJ O
PAX6 NNP O
in IN O
causing VBG O
aniridia NN B-Disease
. . O
. . O

Reversal NNP O
of IN O
severe JJ O
hypertrophic JJ B-Disease
cardiomyopathy NN I-Disease
and CC O
excellent JJ O
neuropsychologic JJ O
outcome NN O
in IN O
very RB B-Disease
- : I-Disease
long JJ I-Disease
- : I-Disease
chain NN I-Disease
acyl IN I-Disease
- : I-Disease
coenzyme NN I-Disease
A DT I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
. . O

Very RB B-Disease
- : I-Disease
long JJ I-Disease
- : I-Disease
chain NN I-Disease
acyl IN I-Disease
- : I-Disease
coenzyme NN I-Disease
A DT I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
VLCAD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
is VBZ O
a DT O
disorder NN O
of IN O
fatty JJ O
acid JJ O
beta NN O
oxidation NN O
that WDT O
reportedly RB O
has VBZ O
high JJ O
rates NNS O
of IN O
morbidity NN O
and CC O
mortality NN O
. . O

We PRP O
describe VBP O
the DT O
outcome NN O
of IN O
a DT O
5 CD O
- : O
year NN O
- : O
old JJ O
girl NN O
with IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
who WP O
was VBD O
first RB O
seen VBN O
at IN O
5 CD O
months NNS O
of IN O
age NN O
with IN O
severe JJ O
hypertrophic JJ B-Disease
cardiomyopathy NN I-Disease
, , O
hepatomegaly NN B-Disease
, , O
encephalopathy NN B-Disease
, , O
and CC O
hypotonia NN B-Disease
. . O

Biochemical JJ O
studies NNS O
indicated VBD O
VLCAD NNP B-Disease
deficiency NN I-Disease
caused VBN O
by IN O
a DT O
stable JJ O
yet RB O
inactive JJ O
enzyme NN O
. . O

Molecular JJ O
genetic JJ O
analysis NN O
of IN O
her PRP$ O
VLCAD NNP O
gene NN O
revealed VBD O
a DT O
T1372C NNP O
( ( O
F458L NNP O
) ) O
missense NN O
mutation NN O
and CC O
a DT O
1668 CD O
ACAG NNP O
1669 CD O
splice NN O
site NN O
mutation NN O
. . O

After IN O
initial JJ O
treatment NN O
with IN O
intravenous JJ O
glucose NNS O
and CC O
carnitine NN O
, , O
the DT O
patient NN O
has VBZ O
thrived VBN O
on IN O
a DT O
low JJ O
- : O
fat NN O
diet JJ O
supplemented VBN O
with IN O
medium NN O
- : O
chain NN O
triglyceride JJ O
oil NN O
and CC O
carnitine NN O
and CC O
avoidance NN O
of IN O
fasting NN O
. . O

Her PRP$ O
ventricular JJ O
hypertrophy NN O
resolved VBD O
significantly RB O
over IN O
1 CD O
year NN O
, , O
and CC O
cognitively RB O
, , O
she PRP O
is VBZ O
in IN O
the DT O
superior JJ O
range NN O
for IN O
age NN O
. . O

Clinical JJ O
recognition NN O
of IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
is VBZ O
important JJ O
because IN O
it PRP O
is VBZ O
one CD O
of IN O
the DT O
few JJ O
directly RB O
treatable JJ O
causes NNS O
of IN O
cardiomyopathy NN B-Disease
in IN O
children NNS O
. . O
. . O

Cloning NN O
of IN O
a DT O
novel JJ O
member NN O
of IN O
the DT O
low JJ O
- : O
density NN O
lipoprotein NN O
receptor NN O
family NN O
. . O

A DT O
gene NN O
encoding VBG O
a DT O
novel JJ O
transmembrane NN O
protein NN O
was VBD O
identified VBN O
by IN O
DNA NNP O
sequence NN O
analysis NN O
within IN O
the DT O
insulin NN B-Disease
- : I-Disease
dependent NN I-Disease
diabetes VBZ I-Disease
mellitus NNS I-Disease
( ( O
IDDM NNP B-Disease
) ) O
locus VBZ O
IDDM4 NNP O
on IN O
chromosome NN O
11q13 CD O
. . O

Based VBN O
on IN O
its PRP$ O
chromosomal JJ O
position NN O
, , O
this DT O
gene NN O
is VBZ O
a DT O
candidate NN O
for IN O
conferring VBG O
susceptibility NN O
to TO O
diabetes NNS B-Disease
. . O

The DT O
gene NN O
, , O
termed VBD O
low JJ O
- : O
density NN O
lipoprotein VBZ O
receptor NN O
related JJ O
protein NN O
5 CD O
( ( O
LRP5 NNP O
) ) O
, , O
encodes VBZ O
a DT O
protein NN O
of IN O
1615 CD O
amino NN O
acids NNS O
that WDT O
contains VBZ O
conserved VBN O
modules NNS O
which WDT O
are VBP O
characteristic JJ O
of IN O
the DT O
low JJ O
- : O
density NN O
lipoprotein NN O
( ( O
LDL NNP O
) ) O
receptor NN O
family NN O
. . O

These DT O
modules NNS O
include VBP O
a DT O
putative JJ O
signal NN O
peptide NN O
for IN O
protein NN O
export NN O
, , O
four CD O
epidermal JJ O
growth NN O
factor NN O
( ( O
EGF NNP O
) ) O
repeats VBZ O
with IN O
associated JJ O
spacer NN O
domains NNS O
, , O
three CD O
LDL NNP O
- : O
receptor NN O
( ( O
LDLR NNP O
) ) O
repeats VBZ O
, , O
a DT O
single JJ O
transmembrane NN O
spanning VBG O
domain NN O
, , O
and CC O
a DT O
cytoplasmic JJ O
domain NN O
. . O

The DT O
encoded JJ O
protein NN O
has VBZ O
a DT O
unique JJ O
organization NN O
of IN O
EGF NNP O
and CC O
LDLR NNP O
repeats NNS O
; : O
therefore RB O
, , O
LRP5 NNP O
likely JJ O
represents VBZ O
a DT O
new JJ O
category NN O
of IN O
the DT O
LDLR NNP O
family NN O
. . O

Both DT O
human JJ O
and CC O
mouse NN O
LRP5 NNP O
cDNAs NN O
have VBP O
been VBN O
isolated VBN O
and CC O
the DT O
encoded JJ O
mature NN O
proteins NNS O
are VBP O
95 CD O
% NN O
identical JJ O
, , O
indicating VBG O
a DT O
high JJ O
degree NN O
of IN O
evolutionary JJ O
conservation NN O
. . O
. . O

The DT O
APC NNP B-Disease
variants NNS O
I1307K NNP O
and CC O
E1317Q NNP O
are VBP O
associated VBN O
with IN O
colorectal JJ B-Disease
tumors NNS I-Disease
, , O
but CC O
not RB O
always RB O
with IN O
a DT O
family NN O
history NN O
. . O

Classical JJ O
familial NN B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
is VBZ O
a DT O
high JJ O
- : O
penetrance NN O
autosomal JJ B-Disease
dominant JJ I-Disease
disease NN I-Disease
that WDT O
predisposes VBZ O
to TO O
hundreds NNS O
or CC O
thousands NNS O
of IN O
colorectal JJ B-Disease
adenomas NN I-Disease
and CC I-Disease
carcinoma NN I-Disease
and CC O
that IN O
results NNS O
from IN O
truncating VBG O
mutations NNS O
in IN O
the DT O
APC NNP B-Disease
gene NN O
. . O

A DT O
variant NN O
of IN O
FAP NNP B-Disease
is VBZ O
attenuated VBN B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
, , O
which WDT O
results NNS O
from IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
5 CD O
and CC O
3 CD O
regions NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
. . O

Attenuated NNP B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
patients NNS O
have VBP O
"""" VBN O
multiple JJ O
"""" NNP O
colorectal NN B-Disease
adenomas NN I-Disease
( ( O
typically RB O
fewer JJR O
than IN O
100 CD O
) ) O
without IN O
the DT O
florid JJ O
phenotype NN O
of IN O
classical JJ O
FAP NNP B-Disease
. . O

Another DT O
group NN O
of IN O
patients NNS O
with IN O
multiple JJ O
adenomas NN B-Disease
has VBZ O
no DT O
mutations NNS O
in IN O
the DT O
APC NNP B-Disease
gene NN O
, , O
and CC O
their PRP$ O
phenotype NN O
probably RB O
results NNS O
from IN O
variation NN O
at IN O
a DT O
locus NN O
, , O
or CC O
loci NN O
, , O
elsewhere RB O
in IN O
the DT O
genome NN O
. . O

Recently RB O
, , O
however RB O
, , O
a DT O
missense NN O
variant NN O
of IN O
APC NNP B-Disease
( ( O
I1307K NNP O
) ) O
was VBD O
described VBN O
that IN O
confers NNS O
an DT O
increased VBN O
risk NN O
of IN O
colorectal JJ B-Disease
tumors NNS I-Disease
, , O
including VBG O
multiple JJ O
adenomas NN B-Disease
, , O
in IN O
Ashkenazim NNP O
. . O

We PRP O
have VBP O
studied VBN O
a DT O
set NN O
of IN O
164 CD O
patients NNS O
with IN O
multiple JJ O
colorectal JJ B-Disease
adenomas NN I-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
carcinoma NN I-Disease
and CC O
analyzed VBD O
codons NNS O
1263 CD O
- : O
1377 CD O
( ( O
exon VB O
15G CD O
) ) O
of IN O
the DT O
APC NNP B-Disease
gene NN O
for IN O
germ JJ O
- : O
line NN O
variants NNS O
. . O

Three CD O
patients NNS O
with IN O
the DT O
I1307K NNP O
allele NN O
were VBD O
detected VBN O
, , O
each DT O
of IN O
Ashkenazi NNP O
descent NN O
. . O

Four CD O
patients NNS O
had VBD O
a DT O
germ JJ O
- : O
line NN O
E1317Q NNP O
missense NN O
variant NN O
of IN O
APC NNP O
that WDT O
was VBD O
not RB O
present JJ O
in IN O
controls NNS O
; : O
one CD O
of IN O
these DT O
individuals NNS O
had VBD O
an DT O
unusually RB O
large JJ O
number NN O
of IN O
metaplastic JJ B-Disease
polyps NNS I-Disease
of IN I-Disease
the DT I-Disease
colorectum NN I-Disease
. . O

There EX O
is VBZ O
increasing VBG O
evidence NN O
that IN O
there EX O
exist VBP O
germ SYM O
- : O
line NN O
variants NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
that WDT O
predispose VBP O
to TO O
the DT O
development NN O
of IN O
multiple JJ O
colorectal JJ B-Disease
adenomas NN I-Disease
and CC I-Disease
carcinoma NN I-Disease
, , O
but CC O
without IN O
the DT O
florid JJ O
phenotype NN O
of IN O
classical JJ O
FAP NNP B-Disease
, , O
and CC O
possibly RB O
with IN O
importance NN O
for IN O
colorectal JJ B-Disease
cancer NN I-Disease
risk NN O
in IN O
the DT O
general JJ O
population NN O
. . O
. . O

Genomic NNP O
structure NN O
of IN O
the DT O
human JJ O
congenital JJ B-Disease
chloride NN I-Disease
diarrhea NN I-Disease
( ( O
CLD NNP B-Disease
) ) O
gene NN O
. . O

Congenital NNP B-Disease
chloride NN I-Disease
diarrhea NN I-Disease
( ( O
CLD NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
a DT O
gene NN O
which WDT O
encodes VBZ O
an DT O
intestinal JJ O
anion NN O
transporter NN O
. . O

We PRP O
report VBP O
here RB O
the DT O
complete JJ O
genomic JJ O
organization NN O
of IN O
the DT O
human JJ O
CLD NNP B-Disease
gene NN O
which WDT O
spans VBZ O
approximately RB O
39kb CD O
, , O
and CC O
comprises VBZ O
21 CD O
exons NNS O
. . O

All DT O
exon VBP O
/ NNP O
intron NN O
boundaries NNS O
conform VBP O
to TO O
the DT O
GT NNP O
/ NNP O
AG NNP O
rule NN O
. . O

An DT O
analysis NN O
of IN O
the DT O
putative JJ O
promoter NN O
region NN O
sequence NN O
shows VBZ O
a DT O
putative JJ O
TATA NNP O
box NN O
and CC O
predicts VBZ O
multiple JJ O
transcription NN O
factor NN O
binding VBG O
sites NNS O
. . O

The DT O
genomic JJ O
structure NN O
was VBD O
determined VBN O
using VBG O
DNA NN O
from IN O
several JJ O
sources NNS O
including VBG O
multiple JJ O
large JJ O
- : O
insert NN O
libaries NNS O
and CC O
genomic JJ O
DNA NN O
from IN O
Finnish JJ O
CLD NNP B-Disease
patients NNS O
and CC O
controls NNS O
. . O

Exon NNP O
- : O
specific JJ O
primers NNS O
developed VBD O
in IN O
this DT O
study NN O
will MD O
facilitate VB O
mutation NN O
screening VBG O
studies NNS O
of IN O
patients NNS O
with IN O
the DT O
disease NN O
. . O

Genomic NNP O
sequencing NN O
of IN O
a DT O
BAC NNP O
clone NN O
H NNP O
_ NNP O
RG364P16 NNP O
revealed VBD O
the DT O
presence NN O
of IN O
another DT O
, , O
highly RB O
homologous JJ O
gene NN O
3 CD O
of IN O
the DT O
CLD NNP B-Disease
gene NN O
, , O
with IN O
a DT O
similar JJ O
genomic JJ O
structure NN O
, , O
recently RB O
identified VBN O
as IN O
the DT O
Pendred NNP B-Disease
syndrome JJ I-Disease
gene NN O
( ( O
PDS NNP B-Disease
) ) O
. . O
. . O

The DT O
APCI1307K NNP O
allele NN O
and CC O
cancer NN B-Disease
risk NN O
in IN O
a DT O
community NN O
- : O
based VBN O
study NN O
of IN O
Ashkenazi NNP O
Jews NNP O
. . O

Mutations NNS O
in IN O
APC NNP O
are VBP O
classically RB O
associated VBN O
with IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
, , O
a DT O
highly RB O
penetrant JJ O
autosomal JJ B-Disease
dominant JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
multiple JJ O
intestinal JJ O
polyps NNS B-Disease
and CC O
, , O
without IN O
surgical JJ O
intervention NN O
, , O
the DT O
development NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
( ( O
CRC NNP B-Disease
) ) O
. . O

APC NNP B-Disease
is VBZ O
a DT O
tumour JJ O
- : O
suppressor NN O
gene NN O
, , O
and CC O
somatic JJ O
loss NN O
occurs VBZ O
in IN O
tumours NNS B-Disease
. . O

The DT O
germline NN O
T NNP O
- : O
to TO O
- : O
A DT O
transversion NN O
responsible JJ O
for IN O
the DT O
APC NNP O
I1307K NNP O
allele NN O
converts VBZ O
the DT O
wild JJ O
- : O
type NN O
sequence NN O
to TO O
a DT O
homopolymer NN O
tract NN O
( ( O
A8 NNP O
) ) O
that WDT O
is VBZ O
genetically RB O
unstable JJ O
and CC O
prone NN O
to TO O
somatic JJ O
mutation NN O
. . O

The DT O
I1307K NNP O
allele NN O
was VBD O
found VBN O
in IN O
6 CD O
. . O

1 CD O
% NN O
of IN O
unselected JJ O
Ashkenazi NNP O
Jews NNPS O
and CC O
higher JJR O
proportions NNS O
of IN O
Ashkenazim NNP O
with IN O
family NN O
or CC O
personal JJ O
histories NNS O
of IN O
CRC NNP B-Disease
( ( O
ref NN O
. . O
2 CD O
) ) O
. . O

To TO O
evaluate VB O
the DT O
role NN O
of IN O
I1307K NNP O
in IN O
cancer NN B-Disease
, , O
we PRP O
genotyped VBD O
5 CD O
, , O
81 CD O
Ashkenazi NNP O
volunteers NNS O
in IN O
a DT O
community NN O
survey NN O
. . O

Risk NN O
of IN O
developing VBG O
colorectal JJ B-Disease
, , I-Disease
breast NN I-Disease
and CC I-Disease
other JJ I-Disease
cancers NNS I-Disease
were VBD O
compared VBN O
between IN O
genotyped VBN O
I1307K NNP O
carriers NNS O
and CC O
non SYM O
- : O
carriers NNS O
and CC O
their PRP$ O
first JJ O
- : O
degree NN O
relatives NNS O
. . O

Sperm NNP O
DNA NNP O
analysis NN O
in IN O
a DT O
Friedreich NNP B-Disease
ataxia NN I-Disease
premutation NN O
carrier NN O
suggests VBZ O
both DT O
meiotic JJ O
and CC O
mitotic JJ O
expansion NN O
in IN O
the DT O
FRDA NNP B-Disease
gene NN O
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
is VBZ O
usually RB O
caused VBN O
by IN O
an DT O
expansion NN O
of IN O
a DT O
GAA NNP O
trinucleotide NN O
repeat NN O
in IN O
intron NN O
1 CD O
of IN O
the DT O
FRDA NNP B-Disease
gene NN O
. . O

Occasionally RB O
, , O
a DT O
fully RB O
expanded VBN O
allele NN O
has VBZ O
been VBN O
found VBN O
to TO O
arise VB O
from IN O
a DT O
premutation NN O
of IN O
100 CD O
or CC O
less JJR O
triplet JJ O
repeats NNS O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
sperm JJ O
DNA NNP O
of IN O
a DT O
premutation NN O
carrier NN O
. . O

This DT O
mans VBZ O
leucocyte JJ O
DNA NN O
showed VBD O
one CD O
normal JJ O
allele NN O
and CC O
one CD O
allele NN O
of IN O
approximately RB O
100 CD O
repeats NNS O
. . O

His PRP$ O
sperm NN O
showed VBD O
an DT O
expanded VBN O
allele NN O
in IN O
a DT O
tight JJ O
range NN O
centering VBG O
on IN O
a DT O
size NN O
of IN O
approximately RB O
320 CD O
trinucleotide JJ O
repeats NNS O
. . O

His PRP$ O
affected JJ O
son NN O
has VBZ O
repeat NN O
sizes NNS O
of IN O
1040 CD O
and CC O
540 CD O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
expansion NN O
occurs NNS O
in IN O
two CD O
stages NNS O
, , O
the DT O
first JJ O
during IN O
meiosis NN O
followed VBN O
by IN O
a DT O
second JJ O
mitotic JJ O
expansion NN O
. . O

We PRP O
also RB O
show VBP O
that IN O
in IN O
all DT O
informative JJ O
carrier NN O
father NN O
to TO O
affected JJ O
child NN O
transmissions NNS O
, , O
with IN O
the DT O
notable JJ O
exception NN O
of IN O
the DT O
premutation NN O
carrier NN O
, , O
the DT O
expansion NN O
size NN O
decreases NNS O
. . O
. . O

The DT O
R496H NNP O
mutation NN O
of IN O
arylsulfatase NN O
A NNP O
does VBZ O
not RB O
cause VB O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
. . O

Deficiency NN B-Disease
of IN I-Disease
arylsulfatase NN I-Disease
A NNP I-Disease
( ( O
ARSA NNP O
) ) O
enzyme VBP O
activity NN O
causes VBZ O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
. . O

A DT O
number NN O
of IN O
ARSA NNP O
gene NN O
mutations NNS O
responsible JJ O
for IN O
MLD NNP B-Disease
have VBP O
been VBN O
identified VBN O
. . O

Recently RB O
, , O
the DT O
R496H NNP O
mutation NN O
of IN O
ARSA NNP O
was VBD O
proposed VBN O
to TO O
be VB O
a DT O
cause NN O
of IN O
MLD NNP B-Disease
( ( O
Draghia NNP O
et RB O
al RB O
. . O
, , O
1997 CD O
) ) O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
R496H NNP O
mutation NN O
and CC O
found VBD O
this DT O
mutation NN O
at IN O
a DT O
relatively RB O
high JJ O
frequency NN O
in IN O
an DT O
African JJ O
American JJ O
population NN O
( ( O
f JJ O
= NN O
0 CD O
. . O
9 CD O
, , O
n RB O
= VBZ O
61 CD O
subjects NNS O
) ) O
. . O

The DT O
ARSA NNP O
enzyme NN O
activity NN O
in IN O
subjects NNS O
with IN O
and CC O
without IN O
the DT O
R496H NNP O
mutation NN O
was VBD O
determined VBN O
and CC O
found VBN O
to TO O
be VB O
normal JJ O
. . O

It PRP O
is VBZ O
therefore RB O
concluded VBD O
that IN O
the DT O
R496H NNP O
mutation NN O
of IN O
ARSA NNP O
does VBZ O
not RB O
negatively RB O
influence VB O
the DT O
activity NN O
of IN O
ARSA NNP O
and CC O
is VBZ O
not RB O
a DT O
cause NN O
of IN O
MLD NNP B-Disease

Down NNP O
- : O
regulation NN O
of IN O
transmembrane NN O
carbonic JJ O
anhydrases NNS O
in IN O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
cell NN O
lines NNS O
by IN O
wild JJ O
- : O
type NN O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
transgenes NNS O
. . O

To TO O
discover VB O
genes NNS O
involved VBN O
in IN O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( O
VHL NNP B-Disease
) ) O
- : O
mediated VBN O
carcinogenesis NN O
, , O
we PRP O
used VBD O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
cell NN O
lines NNS O
stably RB O
transfected VBN O
with IN O
wild JJ O
- : O
type NN O
VHL NNP O
- : O
expressing VBG O
transgenes NNS O
. . O

Large JJ O
- : O
scale NN O
RNA NNP O
differential JJ O
display NN O
technology NN O
applied VBN O
to TO O
these DT O
cell NN O
lines NNS O
identified VBD O
several JJ O
differentially RB O
expressed VBN O
genes NNS O
, , O
including VBG O
an DT O
alpha NN O
carbonic JJ O
anhydrase NN O
gene NN O
, , O
termed VBD O
CA12 NNP O
. . O

The DT O
deduced JJ O
protein NN O
sequence NN O
was VBD O
classified VBN O
as IN O
a DT O
one CD O
- : O
pass NN O
transmembrane NN O
CA NNP O
possessing VBG O
an DT O
apparently RB O
intact JJ O
catalytic JJ O
domain NN O
in IN O
the DT O
extracellular JJ O
CA NNP O
module NN O
. . O

Reintroduced NNP O
wild SYM O
- : O
type NN O
VHL NNP B-Disease
strongly RB O
inhibited VBD O
the DT O
overexpression NN O
of IN O
the DT O
CA12 NNP O
gene NN O
in IN O
the DT O
parental JJ O
renal NN B-Disease
cell NN I-Disease
carcinoma NN I-Disease
cell NN O
lines NNS O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
with IN O
CA9 NNP O
, , O
encoding VBG O
another DT O
transmembrane NN O
CA NNP O
with IN O
an DT O
intact JJ O
catalytic JJ O
domain NN O
. . O

Although IN O
both DT O
domains NNS O
of IN O
the DT O
VHL NNP B-Disease
protein NN O
contribute NN O
to TO O
regulation NN O
of IN O
CA12 NNP O
expression NN O
, , O
the DT O
elongin NN O
binding VBG O
domain NN O
alone RB O
could MD O
effectively RB O
regulate VB O
CA9 NNP O
expression NN O
. . O

We PRP O
mapped VBD O
CA12 NNP O
and CC O
CA9 NNP O
loci VBP O
to TO O
chromosome VB O
bands NNS O
15q22 CD O
and CC O
17q21 CD O
. . O

2 CD O
respectively RB O
, , O
regions NNS O
prone VBP O
to TO O
amplification NN O
in IN O
some DT O
human JJ O
cancers NNS B-Disease
. . O

Additional JJ O
experiments NNS O
are VBP O
needed VBN O
to TO O
define VB O
the DT O
role NN O
of IN O
CA NNP O
IX NNP O
and CC O
CA NNP O
XII NNP O
enzymes VBZ O
in IN O
the DT O
regulation NN O
of IN O
pH NN O
in IN O
the DT O
extracellular JJ O
microenvironment NN O
and CC O
its PRP$ O
potential JJ O
impact NN O
on IN O
cancer NN B-Disease
cell NN O
growth NN O
. . O

A DT O
gene NN O
encoding VBG O
a DT O
transmembrane NN O
protein NN O
is VBZ O
mutated VBN O
in IN O
patients NNS O
with IN O
diabetes NNS B-Disease
mellitus NNS I-Disease
and CC O
optic JJ B-Disease
atrophy NN I-Disease
( ( O
Wolfram NNP B-Disease
syndrome NN I-Disease
) ) O
. . O

Wolfram NNP B-Disease
syndrome NN I-Disease
( ( O
WFS NNP B-Disease
; : O
OMIM NNP O
222300 CD O
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
neurodegenerative JJ I-Disease
disorder NN I-Disease
defined VBN O
by IN O
young JJ O
- : O
onset NN O
non SYM O
- : O
immune JJ O
insulin NN B-Disease
- : I-Disease
dependent NN I-Disease
diabetes VBZ I-Disease
mellitus NNS I-Disease
and CC O
progressive JJ O
optic JJ B-Disease
atrophy NN I-Disease
. . O

Linkage NN O
to TO O
markers NNS O
on IN O
chromosome NN O
4p CD O
was VBD O
confirmed VBN O
in IN O
five CD O
families NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
meiotic JJ O
recombinants NNS O
and CC O
disease VB O
- : O
associated VBN O
haplotypes NNS O
, , O
the DT O
WFS NNP B-Disease
gene NN O
was VBD O
localized VBN O
to TO O
a DT O
BAC NNP O
/ NNP O
P1 NNP O
contig NN O
of IN O
less JJR O
than IN O
250 CD O
kb NN O
. . O

Mutations NNS O
in IN O
a DT O
novel JJ O
gene NN O
( ( O
WFS1 NNP O
) ) O
encoding VBG O
a DT O
putative JJ O
transmembrane NN O
protein NN O
were VBD O
found VBN O
in IN O
all DT O
affected JJ O
individuals NNS O
in IN O
six CD O
WFS NNP B-Disease
families NNS O
, , O
and CC O
these DT O
mutations NNS O
were VBD O
associated VBN O
with IN O
the DT O
disease NN O
phenotype NN O
. . O

WFS1 NNP O
appears VBZ O
to TO O
function VB O
in IN O
survival NN O
of IN O
islet NN O
beta SYM O
- : O
cells NNS O
and CC O
neurons NNS O
. . O
. . O

Stable JJ O
interaction NN O
between IN O
the DT O
products NNS O
of IN O
the DT O
BRCA1 NNP O
and CC O
BRCA2 NNP O
tumor NN B-Disease
suppressor NN O
genes NNS O
in IN O
mitotic JJ O
and CC O
meiotic JJ O
cells NNS O
. . O

BRCA1 NNP O
and CC O
BRCA2 NNP O
account NN O
for IN O
most JJS O
cases NNS O
of IN O
familial JJ O
, , O
early JJ O
onset VBN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
and CC O
encode NN O
products NNS O
that IN O
each DT O
interact NN O
with IN O
hRAD51 NN O
. . O

Results NNS O
presented VBD O
here RB O
show VBP O
that IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
coexist NN O
in IN O
a DT O
biochemical JJ O
complex NN O
and CC O
colocalize NN O
in IN O
subnuclear JJ O
foci NN O
in IN O
somatic JJ O
cells NNS O
and CC O
on IN O
the DT O
axial JJ O
elements NNS O
of IN O
developing VBG O
synaptonemal JJ O
complexes NNS O
. . O

Like IN O
BRCA1 NNP O
and CC O
RAD51 NNP O
, , O
BRCA2 NNP O
relocates VBZ O
to TO O
PCNA NNP O
+ NNP O
replication NN O
sites NNS O
following VBG O
exposure NN O
of IN O
S NNP O
phase NN O
cells NNS O
to TO O
hydroxyurea VB O
or CC O
UV NNP O
irradiation NN O
. . O

Thus RB O
, , O
BRCA1 NNP O
and CC O
BRCA2 NNP O
participate VB O
, , O
together RB O
, , O
in IN O
a DT O
pathway NN O
( ( O
s PRP O
) ) O
associated VBN O
with IN O
the DT O
activation NN O
of IN O
double JJ O
- : O
strand NN O
break NN O
repair NN O
and CC O
/ NN O
or CC O
homologous JJ O
recombination NN O
. . O

Dysfunction NN O
of IN O
this DT O
pathway NN O
may MD O
be VB O
a DT O
general JJ O
phenomenon NN O
in IN O
the DT O
majority NN O
of IN O
cases NNS O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O
. . O

A DT O
novel JJ O
Arg362Ser NNP O
mutation NN O
in IN O
the DT O
sterol NN O
27 CD O
- : O
hydroxylase NN O
gene NN O
( ( O
CYP27 NNP O
) ) O
: : O
its PRP$ O
effects NNS O
on IN O
pre NN O
- : O
mRNA NN O
splicing NN O
and CC O
enzyme JJ O
activity NN O
. . O

A DT O
novel JJ O
C NNP O
to TO O
A DT O
mutation NN O
in IN O
the DT O
sterol NN O
27 CD O
- : O
hydroxylase NN O
gene NN O
( ( O
CYP27 NNP O
) ) O
was VBD O
identified VBN O
by IN O
sequencing VBG O
amplified VBN O
CYP27 NNP O
gene NN O
products NNS O
from IN O
a DT O
patient NN O
with IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
. . O

The DT O
mutation NN O
changed VBD O
the DT O
adrenodoxin NN O
cofactor NN O
binding VBG O
residue JJ O
362Arg CD O
to TO O
362Ser CD O
( ( O
CGT NNP O
362Arg CD O
to TO O
AGT NNP O
362Ser CD O
) ) O
, , O
and CC O
was VBD O
responsible JJ O
for IN O
deficiency NN O
in IN O
the DT O
sterol NN O
27 CD O
- : O
hydroxylase NN O
activity NN O
, , O
as IN O
confirmed VBN O
by IN O
expression NN O
of IN O
mutant JJ O
cDNA NN O
into IN O
COS NNP O
- : O
1 CD O
cells NNS O
. . O

Quantitative JJ O
analysis NN O
showed VBD O
that IN O
the DT O
expression NN O
of IN O
CYP27 NNP O
gene NN O
mRNA NN O
in IN O
the DT O
patient NN O
represented VBD O
52 CD O
. . O

5 CD O
% NN O
of IN O
the DT O
normal JJ O
level NN O
. . O

As IN O
the DT O
mutation NN O
occurred VBD O
at IN O
the DT O
penultimate NN O
nucleotide NN O
of IN O
exon $ O
6 CD O
( ( O
- : O
2 CD O
position NN O
of IN O
exon $ O
6 CD O
- : O
intron NN O
6 CD O
splice NN O
site NN O
) ) O
of IN O
the DT O
gene NN O
, , O
we PRP O
hypothesized VBD O
that IN O
the DT O
mutation NN O
may MD O
partially RB O
affect VB O
the DT O
normal JJ O
splicing JJ O
efficiency NN O
in IN O
exon CC O
6 CD O
and CC O
cause VB O
alternative JJ O
splicing NN O
elsewhere RB O
, , O
which WDT O
resulted VBD O
in IN O
decreased JJ O
transcript NN O
in IN O
the DT O
patient NN O
. . O

Transfection NN O
of IN O
constructed JJ O
minigenes NNS O
, , O
with IN O
or CC O
without IN O
the DT O
mutation NN O
, , O
into IN O
COS NNP O
- : O
1 CD O
cells NNS O
confirmed VBD O
that IN O
the DT O
mutant JJ O
minigene NN O
was VBD O
responsible JJ O
for IN O
a DT O
mRNA NN O
species VBZ O
alternatively RB O
spliced VBN O
at IN O
an DT O
activated JJ O
cryptic JJ O
5 CD O
splice NN O
site NN O
88 CD O
bp NN O
upstream NN O
from IN O
the DT O
3 CD O
end NN O
of IN O
exon JJ O
6 CD O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
C NNP O
to TO O
A DT O
mutation NN O
at IN O
the DT O
penultimate NN O
nucleotide NN O
of IN O
exon JJ O
6 CD O
of IN O
the DT O
CYP27 NNP O
gene NN O
not RB O
only RB O
causes VBZ O
the DT O
deficiency NN B-Disease
in IN I-Disease
the DT I-Disease
sterol NN I-Disease
27 CD I-Disease
- : I-Disease
hydroxylase NN I-Disease
activity NN I-Disease
, , O
but CC O
also RB O
partially RB O
leads VBZ O
to TO O
alternative VB O
pre JJ O
- : O
mRNA NN O
splicing NN O
of IN O
the DT O
gene NN O
. . O

To TO O
our PRP$ O
knowledge NN O
, , O
this DT O
is VBZ O
the DT O
first JJ O
report NN O
regarding VBG O
effects NNS O
on IN O
pre NN O
- : O
mRNA NN O
splicing NN O
of IN O
a DT O
mutation NN O
at IN O
the DT O
- : O
2 CD O
position NN O
of IN O
a DT O
5 CD O
splice NN O
site NN O
. . O

ATM NNP O
germline NN O
mutations NNS O
in IN O
classical JJ O
ataxia NN B-Disease
- : I-Disease
telangiectasia NN I-Disease
patients NNS O
in IN O
the DT O
Dutch JJ O
population NN O
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
are VBP O
responsible JJ O
for IN O
the DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
ataxia SYM B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
. . O

In IN O
our PRP$ O
study NN O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
ATM NNP O
mutation NN O
spectrum NN O
in IN O
19 CD O
classical JJ O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
, , O
including VBG O
some DT O
immigrant JJ O
populations NNS O
, , O
as RB O
well RB O
as IN O
12 CD O
of IN O
Dutch NNP O
ethnic JJ O
origin NN O
. . O

Both DT O
the DT O
protein NN O
truncation NN O
test NN O
( ( O
PTT NNP O
) ) O
and CC O
the DT O
restriction NN O
endonuclease NN O
fingerprinting NN O
( ( O
REF NNP O
) ) O
method NN O
were VBD O
used VBN O
and CC O
compared VBN O
for IN O
their PRP$ O
detection NN O
efficiency NN O
, , O
identifying VBG O
76 CD O
% NN O
and CC O
60 CD O
% NN O
of IN O
the DT O
mutations NNS O
, , O
respectively RB O
. . O

Most JJS O
patients NNS O
were VBD O
found VBN O
to TO O
be VB O
compound JJ O
heterozygote NN O
. . O

Seventeen JJ O
mutations NNS O
were VBD O
distinct JJ O
, , O
of IN O
which WDT O
10 CD O
were VBD O
not RB O
reported VBN O
previously RB O
. . O

Mutations NNS O
are VBP O
small JJ O
deletions NNS O
or CC O
point NN O
mutations NNS O
frequently RB O
affecting VBG O
splice NN O
sites NNS O
. . O

Moreover RB O
, , O
a DT O
16 CD O
. . O

7 CD O
- : O
kb NN O
genomic JJ O
deletion NN O
of IN O
the DT O
3 CD O
end NN O
of IN O
the DT O
gene NN O
, , O
most RBS O
likely RB O
a DT O
result NN O
of IN O
recombination NN O
between IN O
two CD O
LINE NNP O
elements NNS O
, , O
was VBD O
identified VBN O
. . O

The DT O
most RBS O
frequently RB O
found VBN O
mutation NN O
, , O
identified VBN O
in IN O
three CD O
unrelated JJ O
Turkish PDT O
A DT B-Disease
- : I-Disease
T NN I-Disease
individuals NNS O
, , O
was VBD O
previously RB O
described VBN O
to TO O
be VB O
a DT O
Turkish JJ O
A NNP B-Disease
- : I-Disease
T NN I-Disease
founder NN O
mutation NN O
. . O

The DT O
presence NN O
of IN O
a DT O
founder NN O
mutation NN O
among IN O
relatively RB O
small JJ O
ethnic JJ O
population NN O
groups NNS O
in IN O
Western NNP O
Europe NNP O
could MD O
indicate VB O
a DT O
high JJ O
carrier NN O
frequency NN O
in IN O
such JJ O
communities NNS O
. . O

In IN O
patients NNS O
of IN O
Dutch NNP O
ethnic JJ O
origin NN O
, , O
however RB O
, , O
no DT O
significant JJ O
founder NN O
effect NN O
could MD O
be VB O
identified VBN O
. . O

The DT O
observed JJ O
genetic JJ O
heterogeneity NN O
including VBG O
the DT O
relative JJ O
high JJ O
percentage NN O
of IN O
splice NN O
- : O
site NN O
mutations NNS O
had VBD O
no DT O
reflection NN O
on IN O
the DT O
phenotype NN O
. . O

All DT O
patients NNS O
manifested VBD O
classical JJ O
A NNP B-Disease
- : I-Disease
T NN I-Disease
and CC O
increased VBD O
cellular JJ O
radioresistant NN O
DNA NNP O
synthesis NN O
. . O

Determination NN O
of IN O
the DT O
genomic JJ O
structure NN O
of IN O
the DT O
COL4A4 NNP O
gene NN O
and CC O
of IN O
novel JJ O
mutations NNS O
causing VBG O
autosomal JJ B-Disease
recessive JJ I-Disease
Alport NNP I-Disease
syndrome NN I-Disease
. . O

Autosomal NNP B-Disease
recessive JJ I-Disease
Alport NNP I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
progressive JJ O
hematuric NN B-Disease
glomerulonephritis NN I-Disease
characterized VBN O
by IN O
glomerular JJ B-Disease
basement NN I-Disease
membrane NN I-Disease
abnormalities NNS I-Disease
and CC O
associated VBN O
with IN O
mutations NNS O
in IN O
either CC O
the DT O
COL4A3 NNP O
or CC O
the DT O
COL4A4 NNP O
gene NN O
, , O
which WDT O
encode VBP O
the DT O
alpha3 NN O
and CC O
alpha4 JJ O
type NN O
IV NNP O
collagen NN O
chains NNS O
, , O
respectively RB O
. . O

To TO O
date NN O
, , O
mutation NN O
screening NN O
in IN O
the DT O
two CD O
genes NNS O
has VBZ O
been VBN O
hampered VBN O
by IN O
the DT O
lack NN O
of IN O
genomic JJ O
structure NN O
information NN O
. . O

We PRP O
report VBP O
here RB O
the DT O
complete JJ O
characterization NN O
of IN O
the DT O
48 CD O
exons NNS O
of IN O
the DT O
COL4A4 NNP O
gene NN O
, , O
a DT O
comprehensive JJ O
gene NN O
screen NN O
, , O
and CC O
the DT O
subsequent JJ O
detection NN O
of IN O
10 CD O
novel JJ O
mutations NNS O
in IN O
eight CD O
patients NNS O
diagnosed VBN O
with IN O
autosomal JJ B-Disease
recessive JJ I-Disease
Alport NNP I-Disease
syndrome NN I-Disease
. . O

Furthermore RB O
, , O
we PRP O
identified VBD O
a DT O
glycine NN O
to TO O
alanine VB O
substitution NN O
in IN O
the DT O
collagenous JJ O
domain NN O
that WDT O
is VBZ O
apparently RB O
silent JJ O
in IN O
the DT O
heterozygous JJ O
carriers NNS O
, , O
in IN O
11 CD O
. . O

5 CD O
% NN O
of IN O
all DT O
control NN O
individuals NNS O
, , O
and CC O
in IN O
one CD O
control NN O
individual JJ O
homozygous JJ O
for IN O
this DT O
glycine JJ O
substitution NN O
. . O

There EX O
has VBZ O
been VBN O
no DT O
previous JJ O
finding NN O
of IN O
a DT O
glycine JJ O
substitution NN O
that WDT O
is VBZ O
not RB O
associated VBN O
with IN O
any DT O
obvious JJ O
phenotype NN O
in IN O
homozygous JJ O
individuals NNS O
. . O

Founder NNP O
BRCA1 NNP O
and CC O
BRCA2 NNP O
mutations NNS O
in IN O
French JJ O
Canadian JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

We PRP O
have VBP O
identified VBN O
four CD O
mutations NNS O
in IN O
each DT O
of IN O
the DT O
breast NN B-Disease
cancer NN I-Disease
- : O
susceptibility NN O
genes NNS O
, , O
BRCA1 NNP O
and CC O
BRCA2 NNP O
, , O
in IN O
French JJ O
Canadian JJ O
breast NN B-Disease
cancer NN I-Disease
and CC O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
from IN O
Quebec NNP O
. . O

To TO O
identify VB O
founder NN O
effects NNS O
, , O
we PRP O
examined VBD O
independently RB O
ascertained VBN O
French JJ O
Canadian JJ O
cancer NN B-Disease
families NNS O
for IN O
the DT O
distribution NN O
of IN O
these DT O
eight CD O
mutations NNS O
. . O

Mutations NNS O
were VBD O
found VBN O
in IN O
41 CD O
of IN O
97 CD O
families NNS O
. . O

Six CD O
of IN O
eight CD O
mutations NNS O
were VBD O
observed VBN O
at IN O
least JJS O
twice RB O
. . O

The DT O
BRCA1 NNP O
C4446T NNP O
mutation NN O
was VBD O
the DT O
most RBS O
common JJ O
mutation NN O
found VBD O
, , O
followed VBN O
by IN O
the DT O
BRCA2 NNP O
8765delAG CD O
mutation NN O
. . O

Together RB O
, , O
these DT O
mutations NNS O
were VBD O
found VBN O
in IN O
28 CD O
of IN O
41 CD O
families NNS O
identified VBN O
to TO O
have VB O
a DT O
mutation NN O
. . O

The DT O
odds NNS O
of IN O
detection NN O
of IN O
any DT O
of IN O
the DT O
four CD O
BRCA1 NNP O
mutations NNS O
was VBD O
18 CD O
. . O

7x CD O
greater JJR O
if IN O
one CD O
or CC O
more JJR O
cases NNS O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
were VBD O
also RB O
present JJ O
in IN O
the DT O
family NN O
. . O

The DT O
odds NNS O
of IN O
detection NN O
of IN O
any DT O
of IN O
the DT O
four CD O
BRCA2 NNP O
mutations NNS O
was VBD O
5 CD O
. . O

3x CD O
greater JJR O
if IN O
there EX O
were VBD O
at IN O
least JJS O
five CD O
cases NNS O
of IN O
breast NN B-Disease
cancer NN I-Disease
in IN O
the DT O
family NN O
. . O

Interestingly RB O
, , O
the DT O
presence NN O
of IN O
a DT O
breast NN B-Disease
cancer NN I-Disease
case NN O
< VBZ O
36 CD O
years NNS O
of IN O
age NN O
was VBD O
strongly RB O
predictive JJ O
of IN O
the DT O
presence NN O
of IN O
any DT O
of IN O
the DT O
eight CD O
mutations NNS O
screened VBD O
. . O

Carriers NNS O
of IN O
the DT O
same JJ O
mutation NN O
, , O
from IN O
different JJ O
families NNS O
, , O
shared VBD O
similar JJ O
haplotypes NNS O
, , O
indicating VBG O
that IN O
the DT O
mutant JJ O
alleles NNS O
were VBD O
likely JJ O
to TO O
be VB O
identical JJ O
by IN O
descent NN O
for IN O
a DT O
mutation NN O
in IN O
the DT O
founder NN O
population NN O
. . O

The DT O
identification NN O
of IN O
common JJ O
BRCA1 NNP O
and CC O
BRCA2 NNP O
mutations NNS O
will MD O
facilitate VB O
carrier NN O
detection NN O
in IN O
French JJ O
Canadian JJ O
breast NN B-Disease
cancer NN I-Disease
and CC O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

Are NNP O
Dp71 NNP O
and CC O
Dp140 NNP O
brain NN O
dystrophin NN O
isoforms NNS O
related VBN O
to TO O
cognitive JJ B-Disease
impairment NN I-Disease
in IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
? . O

Molecular JJ O
study NN O
and CC O
neuropsychological JJ O
analysis NN O
were VBD O
performed VBN O
concurrently RB O
on IN O
49 CD O
patients NNS O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
in IN O
order NN O
to TO O
find VB O
a DT O
molecular JJ O
explanation NN O
for IN O
the DT O
cognitive JJ B-Disease
impairment NN I-Disease
observed VBN O
in IN O
most JJS O
DMD JJ B-Disease
patients NNS O
. . O

Complete JJ O
analysis NN O
of IN O
the DT O
dystrophin JJ O
gene NN O
was VBD O
performed VBN O
to TO O
define VB O
the DT O
localization NN O
of IN O
deletions NNS O
and CC O
duplications NNS O
in IN O
relation NN O
to TO O
the DT O
different JJ O
DMD NNP B-Disease
promoters NNS O
. . O

Qualitative JJ O
analysis NN O
of IN O
the DT O
Dp71 NNP O
transcript NN O
and CC O
testing VBG O
for IN O
the DT O
specific NN O
first JJ O
exon NN O
of IN O
Dp140 NNP O
were VBD O
also RB O
carried VBN O
out RP O
. . O

Neuropsychological JJ O
analysis NN O
assessed VBD O
verbal JJ O
and CC O
visuospatial JJ O
intelligence NN O
, , O
verbal JJ O
memory NN O
, , O
and CC O
reading VBG O
skills NNS O
. . O

Comparison NNP O
of IN O
molecular JJ O
and CC O
psychometric JJ O
findings NNS O
demonstrated VBD O
that IN O
deletions NNS O
and CC O
duplications NNS O
that WDT O
were VBD O
localized VBN O
in IN O
the DT O
distal JJ O
part NN O
of IN O
the DT O
gene NN O
seemed VBD O
to TO O
be VB O
preferentially RB O
associated VBN O
with IN O
cognitive JJ B-Disease
impairment NN I-Disease
. . O

Two CD O
altered VBD O
Dp71 NNP O
transcripts NNS O
and CC O
two CD O
deleted VBD O
Dp140 NNP O
DNA NNP O
sequences NNS O
were VBD O
found VBN O
in IN O
four CD O
patients NNS O
with IN O
severe JJ O
cerebral JJ B-Disease
dysfunction NN I-Disease
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
some DT O
sequences NNS O
located VBN O
in IN O
the DT O
distal JJ O
part NN O
of IN O
the DT O
gene NN O
and CC O
, , O
in IN O
particular JJ O
, , O
some DT O
DMD NNP B-Disease
isoforms NNS O
expressed VBD O
in IN O
the DT O
brain NN O
may MD O
be VB O
related VBN O
to TO O
the DT O
cognitive JJ B-Disease
impairment NN I-Disease
associated VBN O
with IN O
DMD NNP B-Disease
. . O
. . O

I1307K NNP O
APC NNP O
and CC O
hMLH1 JJ O
mutations NNS O
in IN O
a DT O
non JJ O
- : O
Jewish JJ O
family NN O
with IN O
hereditary JJ B-Disease
non SYM I-Disease
- : I-Disease
polyposis NN I-Disease
colorectal JJ I-Disease
cancer NN I-Disease
. . O

We PRP O
describe VBP O
a DT O
French JJ O
Canadian JJ O
hereditary NN B-Disease
non SYM I-Disease
- : I-Disease
polyposis NN I-Disease
colorectal JJ I-Disease
cancer NN I-Disease
( ( O
HNPCC NNP B-Disease
) ) O
kindred VBD O
which WDT O
carries VBZ O
a DT O
novel JJ O
truncating VBG O
mutation NN O
in IN O
hMLH1 NN O
. . O

Interestingly RB O
, , O
the DT O
I1307K NNP O
APC NNP O
polymorphism NN O
, , O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
, , O
is VBZ O
also RB O
present JJ O
in IN O
this DT O
family NN O
. . O

The DT O
I1307K NNP O
polymorphism NN O
has VBZ O
previously RB O
only RB O
been VBN O
identified VBN O
in IN O
individuals NNS O
of IN O
self NN O
- : O
reported VBD O
Ashkenazi NNP O
Jewish NNP O
origins NNS O
. . O

In IN O
addition NN O
, , O
in IN O
this DT O
family NN O
, , O
there EX O
appears VBZ O
to TO O
be VB O
no DT O
relationship NN O
between IN O
the DT O
I1307K NNP O
polymorphism NN O
and CC O
the DT O
presence NN O
or CC O
absence NN O
of IN O
cancer NN B-Disease
. . O
. . O

Identification NN O
of IN O
a DT O
novel JJ O
mutation NN O
of IN O
the DT O
CPO NNP O
gene NN O
in IN O
a DT O
Japanese JJ O
hereditary JJ B-Disease
coproporphyria NNS I-Disease
family NN O
. . O

Hereditary JJ B-Disease
coproporphyria NN I-Disease
( ( O
HCP NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disease NN I-Disease
characterized VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
coproporphyrinogen NN I-Disease
oxidase NN I-Disease
( ( O
CPO NNP O
) ) O
caused VBN O
by IN O
a DT O
mutation NN O
in IN O
the DT O
CPO NNP O
gene NN O
. . O

Only RB O
11 CD O
mutations NNS O
of IN O
the DT O
gene NN O
have VBP O
been VBN O
reported VBN O
in IN O
HCP NNP B-Disease
patients NNS O
. . O

We PRP O
report VBP O
another DT O
mutation NN O
in IN O
a DT O
Japanese JJ O
family NN O
. . O

Polymerase NNP O
chain NN O
reaction NN O
- : O
single JJ O
strand VBP O
conformational JJ O
polymorphism NN O
and CC O
direct JJ O
sequence NN O
analyses NNS O
demonstrated VBD O
a DT O
C NNP O
to TO O
T NNP O
substitution NN O
in IN O
exon JJ O
1 CD O
of IN O
the DT O
CPO NNP O
gene NN O
at IN O
nucleotide JJ O
position NN O
85 CD O
, , O
which WDT O
lies VBZ O
in IN O
the DT O
putative JJ O
presequence NN O
for IN O
targeting VBG O
to TO O
mitochondria NNS O
. . O

This DT O
mutation NN O
changes VBZ O
the DT O
codon NN O
for IN O
glutamine NN O
to TO O
a DT O
termination NN O
codon NN O
at IN O
amino NN O
acid JJ O
position NN O
29 CD O
. . O

MaeI NNP O
restriction NN O
analysis NN O
showed VBD O
two CD O
other JJ O
carriers NNS O
in IN O
the DT O
family NN O
. . O

The DT O
C NNP O
- : O
T NNP O
mutation NN O
is VBZ O
located VBN O
within IN O
a DT O
recently RB O
proposed VBN O
putative JJ O
alternative JJ O
translation NN O
initiation NN O
codon NN O
( ( O
TIC NNP O
- : O
1 CD O
) ) O
, , O
supporting VBG O
that IN O
TIC NNP O
- : O
1 CD O
is VBZ O
the DT O
real JJ O
TIC NNP O
rather RB O
than IN O
TIC NNP O
- : O
2 CD O
. . O
. . O

Human NNP B-Disease
complement NN I-Disease
factor NN I-Disease
H NNP I-Disease
deficiency NN I-Disease
associated VBN O
with IN O
hemolytic JJ B-Disease
uremic JJ I-Disease
syndrome NN I-Disease
. . O

This DT O
study NN O
reports NNS O
on IN O
six CD O
cases NNS O
of IN O
deficiency NN B-Disease
in IN I-Disease
the DT I-Disease
human JJ I-Disease
complement NN I-Disease
regulatory JJ I-Disease
protein NN I-Disease
Factor NNP I-Disease
H NNP I-Disease
( ( O
FH NNP O
) ) O
in IN O
the DT O
context NN O
of IN O
an DT O
acute JJ B-Disease
renal JJ I-Disease
disease NN I-Disease
. . O

Five CD O
of IN O
the DT O
cases NNS O
were VBD O
observed VBN O
in IN O
children NNS O
presenting VBG O
with IN O
idiopathic JJ O
hemolytic JJ B-Disease
uremic JJ I-Disease
syndrome NN I-Disease
( ( O
HUS NNP B-Disease
) ) O
. . O

Two CD O
of IN O
the DT O
children NNS O
exhibited VBD O
a DT O
homozygous JJ O
deficiency NN O
characterized VBN O
by IN O
the DT O
absence NN O
of IN O
the DT O
150 CD O
- : O
kD NN O
form NN O
of IN O
Factor NNP O
H NNP O
and CC O
the DT O
presence NN O
, , O
upon IN O
immunoblotting VBG O
, , O
of IN O
the DT O
42 CD O
- : O
kD NN O
Factor NNP O
H NNP O
- : O
like IN O
protein NN O
1 CD O
( ( O
FHL NNP O
- : O
1 CD O
) ) O
and CC O
other JJ O
FH NNP O
- : O
related VBN O
protein NN O
( ( O
FHR NNP O
) ) O
bands VBZ O
. . O

Southern NNP O
blot NN O
and CC O
PCR NNP O
analysis NN O
of IN O
DNA NN O
of IN O
one CD O
patient NN O
with IN O
homozygous JJ O
deficiency NN O
ruled VBD O
out RP O
the DT O
presence NN O
of IN O
a DT O
large JJ O
deletion NN O
of IN O
the DT O
FH NNP O
gene NN O
as IN O
the DT O
underlying VBG O
defect NN O
for IN O
the DT O
deficiency NN O
. . O

The DT O
other JJ O
four CD O
children NNS O
presented VBN O
with IN O
heterozygous JJ O
deficiency NN O
and CC O
exhibited VBD O
a DT O
normal JJ O
immunoblotting NN O
pattern NN O
of IN O
proteins NNS O
of IN O
the DT O
FH NNP O
family NN O
. . O

Factor NN B-Disease
H NNP I-Disease
deficiency NN I-Disease
is VBZ O
the DT O
only JJ O
complement NN B-Disease
deficiency NN I-Disease
associated VBN O
with IN O
HUS NNP B-Disease
. . O

These DT O
observations NNS O
suggest VBP O
a DT O
role NN O
for IN O
FH NNP O
and CC O
/ NNP O
or CC O
FH NNP O
receptors NNS O
in IN O
the DT O
pathogenesis NN O
of IN O
idiopathic JJ O
HUS NNP B-Disease
. . O
. . O

Further JJ O
evidence NN O
for IN O
a DT O
major JJ O
ancient NN O
mutation NN O
underlying VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
from IN O
linkage NN O
disequilibrium NN O
studies NNS O
in IN O
the DT O
Japanese JJ O
population NN O
. . O

The DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
mutation NN O
is VBZ O
an DT O
unstable JJ O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
, , O
present NN O
at IN O
a DT O
copy NN O
number NN O
of IN O
5 CD O
- : O
37 CD O
repeats NNS O
on IN O
normal JJ O
chromosomes NNS O
but CC O
amplified VBD O
to TO O
50 CD O
- : O
3000 CD O
copies NNS O
on IN O
DM NNP B-Disease
chromosomes NNS O
. . O

Previous JJ O
findings NNS O
in IN O
Caucasian JJ O
populations NNS O
of IN O
a DT O
DM NNP B-Disease
founder NN O
chromosome NN O
raise VB O
a DT O
question NN O
about IN O
the DT O
molecular JJ O
events NNS O
involved VBN O
in IN O
the DT O
expansion NN O
mutation NN O
. . O

To TO O
investigate VB O
whether IN O
a DT O
founder NN O
chromosome NN O
for IN O
the DT O
DM NNP B-Disease
mutation NN O
exists VBZ O
in IN O
the DT O
Japanese JJ O
population NN O
, , O
we PRP O
genotyped VBD O
families NNS O
using VBG O
polymorphic JJ O
markers NNS O
near IN O
the DT O
( ( O
CTG NNP O
) ) O
n RB O
repeat JJ O
region NN O
and CC O
constructed VBD O
haplotypes NNS O
. . O

Six CD O
different JJ O
haplotypes NNS O
were VBD O
found VBN O
and CC O
DM NNP B-Disease
alleles NNS O
were VBD O
always RB O
haplotype VBN O
A NNP O
. . O

To TO O
find VB O
an DT O
origin NN O
of IN O
the DT O
( ( O
CTG NNP O
) ) O
n RB O
repeat JJ O
mutation NN O
and CC O
to TO O
investigate VB O
the DT O
mechanism NN O
of IN O
the DT O
expansion NN O
mutation NN O
in IN O
the DT O
Japanese JJ O
population NN O
we PRP O
have VBP O
studied VBN O
90 CD O
Japanese JJ O
DM NNP B-Disease
families NNS O
comprising VBG O
190 CD O
affected JJ O
and CC O
130 CD O
unaffected JJ O
members NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
a DT O
few JJ O
common JJ O
ancestral JJ O
mutations NNS O
in IN O
both DT O
Caucasian NNP O
and CC O
Japanese JJ O
populations NNS O
have VBP O
originated VBN O
by IN O
expansion NN O
of IN O
an DT O
ancestral JJ O
n NN O
= VBD O
5 CD O
repeat NN O
to TO O
n VB O
= $ O
19 CD O
- : O
37 CD O
copies NNS O
. . O

These DT O
data NNS O
support NN O
multistep NN O
models NNS O
of IN O
triplet NN O
repeat NN O
expansion NN O
that WDT O
have VBP O
been VBN O
proposed VBN O
for IN O
both DT O
DM NNP B-Disease
and CC O
Friedreichs NNP B-Disease
ataxia NN I-Disease
. . O
. . O

The DT O
molecular JJ O
basis NN O
of IN O
C6 NNP B-Disease
deficiency NN I-Disease
in IN O
the DT O
western JJ O
Cape NNP O
, , O
South NNP O
Africa NNP O
. . O

Deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
sixth JJ I-Disease
component NN I-Disease
of IN I-Disease
human JJ I-Disease
complement NN I-Disease
( ( O
C6 NNP O
) ) O
has VBZ O
been VBN O
reported VBN O
in IN O
a DT O
number NN O
of IN O
families NNS O
from IN O
the DT O
western JJ O
Cape NNP O
, , O
South NNP O
Africa NNP O
. . O

Meningococcal JJ B-Disease
disease NN I-Disease
is VBZ O
endemic JJ O
in IN O
the DT O
Cape NNP O
and CC O
almost RB O
all DT O
pedigrees NNS O
of IN O
total JJ O
C6 NNP B-Disease
deficiency NN I-Disease
( ( O
C6Q0 NNP O
) ) O
have VBP O
been VBN O
ascertained VBN O
because IN O
of IN O
recurrent JJ O
disease NN O
. . O

We PRP O
have VBP O
sequenced VBN O
the DT O
expressed JJ O
exons NNS O
of IN O
the DT O
C6 NNP O
gene NN O
from IN O
selected VBN O
cases NNS O
and CC O
have VBP O
found VBN O
three CD O
molecular JJ O
defects NNS O
leading VBG O
to TO O
total JJ O
deficiency NN O
879delG CD O
, , O
which WDT O
is VBZ O
the DT O
common JJ O
defect NN O
in IN O
the DT O
Cape NNP O
and CC O
hitherto NN O
unreported JJ O
, , O
and CC O
1195delC CD O
and CC O
1936delG CD O
, , O
which WDT O
have VBP O
been VBN O
previously RB O
reported VBN O
in IN O
African NNP O
- : O
Americans NNPS O
. . O

We PRP O
also RB O
show VBP O
that IN O
the DT O
879delG CD O
and CC O
1195delC CD O
defects NNS O
are VBP O
associated VBN O
with IN O
characteristic JJ O
C6 NNP O
/ NNP O
C7 NNP O
region NN O
DNA NNP O
marker NN O
haplotypes NNS O
, , O
although IN O
small JJ O
variations NNS O
were VBD O
observed VBN O
. . O

The DT O
1936delG CD O
defect NN O
was VBD O
observed VBN O
only RB O
once RB O
in IN O
the DT O
Cape NNP O
, , O
but CC O
its PRP$ O
associated JJ O
haplotype NN O
could MD O
be VB O
deduced VBN O
. . O

The DT O
data NN O
from IN O
the DT O
haplotypes NNS O
indicate VBP O
that IN O
these DT O
three CD O
molecular NN O
defects NNS O
account VBP O
for IN O
the DT O
defects NNS O
in IN O
all PDT O
the DT O
38 CD O
unrelated JJ O
C6Q0 NNP O
individuals NNS O
we PRP O
have VBP O
studied VBN O
from IN O
the DT O
Cape NNP O
. . O

We PRP O
have VBP O
also RB O
observed VBN O
the DT O
879delG CD O
defect NN O
in IN O
two CD O
Dutch NNP O
C6 NNP B-Disease
- : I-Disease
deficient NN I-Disease
kindreds NNS O
, , O
but CC O
the DT O
879delG CD O
defect NN O
in IN O
the DT O
Cape NNP O
probably RB O
did VBD O
not RB O
come VBN O
from IN O
The DT O
Netherlands NNP O
. . O
. . O

Complement NNP B-Disease
C7 NNP I-Disease
deficiency NN I-Disease
: : O
seven CD O
further JJR O
molecular JJ O
defects NNS O
and CC O
their PRP$ O
associated VBN O
marker NN O
haplotypes NNS O
. . O

Seven RB O
further RBR O
molecular JJ O
bases NNS O
of IN O
C7 NNP B-Disease
deficiency NN I-Disease
are VBP O
described VBN O
. . O

All PDT O
these DT O
new JJ O
molecular NN O
defects NNS O
involve VBP O
single JJ O
- : O
nucleotide JJ O
events NNS O
, , O
deletions NNS O
and CC O
substitutions NNS O
, , O
some DT O
of IN O
which WDT O
alter NN O
splice NN O
sites NNS O
, , O
and CC O
others NNS O
codons NNS O
. . O

They PRP O
are VBP O
distributed VBN O
along IN O
the DT O
C7 NNP O
gene NN O
, , O
but CC O
predominantly RB O
towards VBZ O
the DT O
3 CD O
end NN O
. . O

All DT O
were VBD O
found VBN O
in IN O
compound NN O
heterozygous JJ O
individuals NNS O
. . O

The DT O
C6 NNP O
/ NNP O
C7 NNP O
marker NN O
haplotypes NNS O
associated VBN O
with IN O
most JJS O
C7 NNP B-Disease
defects NNS I-Disease
are VBP O
tabulated VBN O
. . O
. . O

A DT O
genome JJ O
- : O
wide JJ O
search NN O
for IN O
chromosomal JJ O
loci NN O
linked VBN O
to TO O
mental JJ O
health NN O
wellness NN O
in IN O
relatives NNS O
at IN O
high JJ O
risk NN O
for IN O
bipolar JJ B-Disease
affective JJ I-Disease
disorder NN I-Disease
among IN O
the DT O
Old NNP O
Order NNP O
Amish NNP O
. . O

Bipolar JJ B-Disease
affective JJ I-Disease
disorder NN I-Disease
( ( O
BPAD NNP B-Disease
; : O
manic JJ B-Disease
- : I-Disease
depressive JJ I-Disease
illness NN I-Disease
) ) O
is VBZ O
characterized VBN O
by IN O
episodes NNS O
of IN O
mania NN B-Disease
and CC O
/ NN O
or CC O
hypomania NN B-Disease
interspersed VBN O
with IN O
periods NNS O
of IN O
depression NN B-Disease
. . O

Compelling VBG O
evidence NN O
supports VBZ O
a DT O
significant JJ O
genetic JJ O
component NN O
in IN O
the DT O
susceptibility NN O
to TO O
develop VB O
BPAD NNP B-Disease
. . O

To TO O
date NN O
, , O
however RB O
, , O
linkage NN O
studies NNS O
have VBP O
attempted VBN O
only RB O
to TO O
identify VB O
chromosomal JJ O
loci NN O
that WDT O
cause NN O
or CC O
increase VB O
the DT O
risk NN O
of IN O
developing VBG O
BPAD NNP B-Disease
. . O

To TO O
determine VB O
whether IN O
there EX O
could MD O
be VB O
protective JJ O
alleles NNS O
that WDT O
prevent VBP O
or CC O
reduce VB O
the DT O
risk NN O
of IN O
developing VBG O
BPAD NNP B-Disease
, , O
similar JJ O
to TO O
what WP O
is VBZ O
observed VBN O
in IN O
other JJ O
genetic JJ B-Disease
disorders NNS I-Disease
, , O
we PRP O
used VBD O
mental JJ O
health NN O
wellness NN O
( ( O
absence NN O
of IN O
any DT O
psychiatric JJ B-Disease
disorder NN I-Disease
) ) O
as IN O
the DT O
phenotype NN O
in IN O
our PRP$ O
genome JJ O
- : O
wide JJ O
linkage NN O
scan NN O
of IN O
several JJ O
large JJ O
multigeneration NN O
Old NNP O
Order NNP O
Amish NNP O
pedigrees NNS O
exhibiting VBG O
an DT O
extremely RB O
high JJ O
incidence NN O
of IN O
BPAD NNP B-Disease
. . O

We PRP O
have VBP O
found VBN O
strong JJ O
evidence NN O
for IN O
a DT O
locus NN O
on IN O
chromosome NN O
4p CD O
at IN O
D4S2949 NNP O
( ( O
maximum JJ O
GENEHUNTER NNP O
- : O
PLUS NNP O
nonparametric JJ O
linkage NN O
score VBD O
= JJ O
4 CD O
. . O
5 CD O
, , O
P NNP O
= VBZ O
5 CD O
. . O
22 CD O
x JJ O
10 CD O
( ( O
- : O
4 CD O
) ) O
; : O
SIBPAL NNP O
Pempirical NNP O
value NN O
< VBD O
3 CD O
x JJ O
10 CD O
( ( O
- : O
5 CD O
) ) O
) ) O
and CC O
suggestive JJ O
evidence NN O
for IN O
a DT O
locus NN O
on IN O
chromosome NN O
4q CD O
at IN O
D4S397 NNP O
( ( O
maximum JJ O
GENEHUNTER NNP O
- : O
PLUS NNP O
nonparametric JJ O
linkage NN O
score VBD O
= JJ O
3 CD O
. . O
29 CD O
, , O
P NNP O
= VBZ O
2 CD O
. . O
57 CD O
x JJ O
10 CD O
( ( O
- : O
3 CD O
) ) O
; : O
SIBPAL NNP O
Pempirical NNP O
value NN O
< VBD O
1 CD O
x JJ O
10 CD O
( ( O
- : O
3 CD O
) ) O
) ) O
that WDT O
are VBP O
linked VBN O
to TO O
mental JJ O
health NN O
wellness NN O
. . O

These DT O
findings NNS O
are VBP O
consistent JJ O
with IN O
the DT O
hypothesis NN O
that WDT O
certain JJ O
alleles NNS O
could MD O
prevent VB O
or CC O
modify VB O
the DT O
clinical JJ O
manifestations NNS O
of IN O
BPAD NNP B-Disease
and CC O
perhaps RB O
other JJ O
related JJ O
affective JJ B-Disease
disorders NNS I-Disease
. . O

Segregation NNP O
distortion NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant NN I-Disease
disease NN I-Disease
which WDT O
, , O
in IN O
the DT O
typical JJ O
pedigree NN O
, , O
shows VBZ O
a DT O
three CD O
generation NN O
anticipation NN O
cascade NN O
. . O

This DT O
results NNS O
in IN O
infertility NN B-Disease
and CC O
congenital JJ B-Disease
myotonic JJ I-Disease
dystrophy NN I-Disease
( ( O
CDM NNP B-Disease
) ) O
with IN O
the DT O
disappearance NN O
of IN O
DM NNP B-Disease
in IN O
that DT O
pedigree NN O
. . O

The DT O
concept NN O
of IN O
segregation NN O
distortion NN O
, , O
where WRB O
there EX O
is VBZ O
preferential JJ O
transmission NN O
of IN O
the DT O
larger JJR O
allele NN O
at IN O
the DT O
DM NNP B-Disease
locus NN O
, , O
has VBZ O
been VBN O
put VBN O
forward RB O
to TO O
explain VB O
partially RB O
the DT O
maintenance NN O
of IN O
DM NNP B-Disease
in IN O
the DT O
population NN O
. . O

In IN O
a DT O
survey NN O
of IN O
DM NNP B-Disease
in IN O
Northern NNP O
Ireland NNP O
, , O
59 CD O
pedigrees NNS O
were VBD O
ascertained VBN O
. . O

Sibships NNP O
where WRB O
the DT O
status NN O
of IN O
all PDT O
the DT O
members NNS O
had VBD O
been VBN O
identified VBN O
were VBD O
examined VBN O
to TO O
determine VB O
the DT O
transmission NN O
of IN O
the DT O
DM NNP B-Disease
expansion NN O
from IN O
affected JJ O
parents NNS O
to TO O
their PRP$ O
offspring NN O
. . O

Where WRB O
the DT O
transmitting NN O
parent NN O
was VBD O
male JJ O
, , O
58 CD O
. . O

3 CD O
% NN O
of IN O
the DT O
offspring NN O
were VBD O
affected VBN O
, , O
and CC O
in IN O
the DT O
case NN O
of IN O
a DT O
female JJ O
transmitting NN O
parent NN O
, , O
68 CD O
. . O

7 CD O
% NN O
were VBD O
affected VBN O
. . O

Studies NNS O
on IN O
meiotic JJ O
drive NN O
in IN O
DM NNP B-Disease
have VBP O
shown VBN O
increased JJ O
transmission NN O
of IN O
the DT O
larger JJR O
allele NN O
at IN O
the DT O
DM NNP B-Disease
locus NN O
in IN O
non JJ O
- : O
DM NN O
heterozygotes NNS O
for IN O
CTGn NNP O
. . O

This DT O
study NN O
provides VBZ O
further JJ O
evidence NN O
that IN O
the DT O
DM NNP B-Disease
expansion NN O
tends VBZ O
to TO O
be VB O
transmitted VBN O
preferentially RB O
. . O

Diagnosis NN O
of IN O
hemochromatosis NN B-Disease
. . O

If IN O
untreated VBN O
, , O
hemochromatosis NN B-Disease
can MD O
cause VB O
serious JJ O
illness NN O
and CC O
early JJ B-Disease
death NN I-Disease
, , O
but CC O
the DT O
disease NN O
is VBZ O
still RB O
substantially RB O
under IN O
- : O
diagnosed VBN O
. . O

The DT O
cornerstone NN O
of IN O
screening NN O
and CC O
case NN O
detection NN O
is VBZ O
the DT O
measurement NN O
of IN O
serum NN O
transferrin NN O
saturation NN O
and CC O
the DT O
serum NN O
ferritin NN O
level NN O
. . O

Once RB O
the DT O
diagnosis NN O
is VBZ O
suspected VBN O
, , O
physicians NNS O
must MD O
use VB O
serum JJ O
ferritin NN O
levels NNS O
and CC O
hepatic JJ O
iron NN O
stores NNS O
on IN O
liver NN O
biopsy NN O
specimens VBZ O
to TO O
assess VB O
patients NNS O
for IN O
the DT O
presence NN O
of IN O
iron NN B-Disease
overload NN I-Disease
. . O

Liver NNP O
biopsy NN O
is VBZ O
also RB O
used VBN O
to TO O
establish VB O
the DT O
presence NN O
or CC O
absence NN O
of IN O
cirrhosis NN B-Disease
, , O
which WDT O
can MD O
affect VB O
prognosis NN O
and CC O
management NN O
. . O

A DT O
DNA NNP O
- : O
based VBN O
test NN O
for IN O
the DT O
HFE NNP O
gene NN O
is VBZ O
commercially RB O
available JJ O
, , O
but CC O
its PRP$ O
place NN O
in IN O
the DT O
diagnosis NN O
of IN O
hemochromatosis NN B-Disease
is VBZ O
still RB O
being VBG O
evaluated VBN O
. . O

Currently RB O
, , O
the DT O
most RBS O
useful JJ O
role NN O
for IN O
this DT O
test NN O
is VBZ O
in IN O
the DT O
detection NN O
of IN O
hemochromatosis NN B-Disease
in IN O
the DT O
family NN O
members NNS O
of IN O
patients NNS O
with IN O
a DT O
proven JJ O
case NN O
of IN O
the DT O
disease NN O
. . O

It PRP O
is VBZ O
crucial JJ O
to TO O
diagnose VB O
hemochromatosis NN B-Disease
before IN O
hepatic JJ B-Disease
cirrhosis NN I-Disease
develops VBZ O
because IN O
phlebotomy JJ O
therapy NN O
can MD O
avert VB O
serious JJ O
chronic JJ O
disease NN O
and CC O
can MD O
even RB O
lead VB O
to TO O
normal JJ O
life NN O
expectancy NN O
. . O
. . O

Prevalence NN O
of IN O
the DT O
I1307K NNP O
APC NNP B-Disease
gene NN O
variant NN O
in IN O
Israeli NNP O
Jews NNP O
of IN O
differing VBG O
ethnic JJ O
origin NN O
and CC O
risk NN O
for IN O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

BACKGROUND NNP O
& CC O
AIMS NNP O
Israeli NNP O
Jews NNP O
of IN O
European NNP O
birth NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
Ashkenazim NNP O
, , O
have VBP O
the DT O
highest JJS O
colorectal JJ B-Disease
cancer NN I-Disease
incidence NN O
of IN O
any DT O
Israeli NNP O
ethnic JJ O
group NN O
. . O

The DT O
I1307K NNP O
APC NNP B-Disease
gene NN O
variant NN O
was VBD O
found VBN O
in IN O
6 CD O
. . O

1 CD O
% NN O
of IN O
American JJ O
Jews NNP O
, , O
28 CD O
% NN O
of IN O
their PRP$ O
familial JJ O
colorectal NN B-Disease
cancer NN I-Disease
cases NNS O
, , O
but CC O
not RB O
in IN O
non JJ O
- : O
Jews NNS O
. . O

We PRP O
assessed VBD O
the DT O
I1307K NNP O
prevalence NN O
in IN O
Israeli NNP O
Jews NNP O
of IN O
differing VBG O
ethnic JJ O
origin NN O
and CC O
risk NN O
for IN O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

METHODS NNP O
DNA NNP O
samples NNS O
from IN O
500 CD O
unrelated JJ O
Jews NNPS O
of IN O
European JJ O
or CC O
non JJ O
- : O
European JJ O
origin NN O
, , O
with IN O
or CC O
without IN O
a DT O
personal JJ O
and CC O
/ JJ O
or CC O
family NN O
history NN O
of IN O
neoplasia NN B-Disease
, , O
were VBD O
examined VBN O
for IN O
the DT O
I1307K NNP O
variant NN O
by IN O
the DT O
allele NN O
- : O
specific JJ O
oligonucleotide NN O
( ( O
ASO NNP O
) ) O
method NN O
. . O

RESULTS NNP O
In IN O
persons NNS O
at IN O
average JJ O
risk NN O
for IN O
colorectal JJ B-Disease
cancer NN I-Disease
, , O
I1307K NNP O
was VBD O
found VBN O
in IN O
5 CD O
. . O

0 CD O
% NN O
of IN O
120 CD O
European JJ O
and CC O
1 CD O
. . O

6 CD O
% NN O
of IN O
188 CD O
non JJ O
- : O
European JJ O
Jews NNP O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
8 CD O
) ) O
. . O

It PRP O
occurred VBD O
in IN O
15 CD O
. . O

4 CD O
% NN O
of IN O
52 CD O
Ashkenazi NNP O
Israelis NNP O
with IN O
familial JJ O
cancer NN B-Disease
( ( O
P NNP O
= VBZ O
0 CD O
. . O
2 CD O
) ) O
and CC O
was VBD O
not RB O
detected VBN O
in IN O
51 CD O
non JJ O
- : O
European JJ O
Jews NNP O
at IN O
increased JJ O
cancer NN B-Disease
risk NN O
. . O

Colorectal JJ B-Disease
neoplasia NN I-Disease
occurred VBD O
personally RB O
or CC O
in IN O
the DT O
families NNS O
of IN O
13 CD O
of IN O
20 CD O
Ashkenazi NNP O
I1307K NNP O
carriers NNS O
, , O
8 CD O
of IN O
whom WP O
also RB O
had VBD O
a DT O
personal JJ O
or CC O
family NN O
history NN O
of IN O
noncolonic JJ O
neoplasia NN B-Disease
. . O

CONCLUSIONS NNP O
The DT O
I1307K NNP O
APC NNP O
variant NN O
may MD O
represent VB O
a DT O
susceptibility NN O
gene NN O
for IN O
colorectal JJ B-Disease
, , I-Disease
or CC I-Disease
other JJ I-Disease
, , I-Disease
cancers NNS I-Disease
in IN O
Ashkenazi NNP O
Jews NNP O
, , O
and CC O
partially RB O
explains VBZ O
the DT O
higher JJR O
incidence NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
in IN O
European JJ O
Israelis NNP O
. . O

Systematic JJ O
analysis NN O
of IN O
coproporphyrinogen NN O
oxidase NN O
gene NN O
defects NNS O
in IN O
hereditary JJ B-Disease
coproporphyria NNS I-Disease
and CC O
mutation NN O
update NN O
. . O

Hereditary JJ B-Disease
coproporphyria NN I-Disease
( ( O
HC NNP B-Disease
) ) O
is VBZ O
an DT O
acute JJ O
hepatic JJ B-Disease
porphyria NN I-Disease
with IN O
autosomal JJ O
dominant JJ O
inheritance NN O
caused VBN O
by IN O
deficient JJ B-Disease
activity NN I-Disease
of IN I-Disease
coproporphyrinogen NN I-Disease
III NNP I-Disease
oxidase NN I-Disease
( ( O
CPO NNP O
) ) O
. . O

Clinical JJ O
manifestations NNS O
of IN O
the DT O
disease NN O
are VBP O
characterized VBN O
by IN O
acute JJ O
attacks NNS O
of IN O
neurological JJ B-Disease
dysfunction NN I-Disease
often RB O
precipitated VBN O
by IN O
drugs NNS O
, , O
fasting NN O
, , O
cyclical JJ O
hormonal NN O
changes NNS O
, , O
or CC O
infectious JJ B-Disease
diseases NNS I-Disease
. . O

Skin NNP O
photosensitivity NN O
may MD O
also RB O
be VB O
present JJ O
. . O

The DT O
seven CD O
exons NNS O
, , O
the DT O
exon NN O
/ NNP O
intron NN O
boundaries NNS O
and CC O
part NN O
of IN O
3 CD O
noncoding VBG O
sequence NN O
of IN O
the DT O
CPO NNP O
gene NN O
were VBD O
systematically RB O
analyzed VBN O
by IN O
an DT O
exon JJ O
- : O
by IN O
- : O
exon NN O
denaturing VBG O
gradient JJ O
gel NN O
electrophoresis NN O
( ( O
DGGE NNP O
) ) O
strategy NN O
followed VBN O
by IN O
direct JJ O
sequencing NN O
in IN O
seven CD O
unrelated JJ O
heterozygous JJ O
HC NNP B-Disease
patients NNS O
from IN O
France NNP O
, , O
Holland NNP O
, , O
and CC O
Czech NNP O
Republic NNP O
. . O

Seven NNP O
novel JJ O
mutations NNS O
and CC O
two CD O
new JJ O
polymorphisms NNS O
were VBD O
detected VBN O
. . O

Among IN O
these DT O
mutations NNS O
two CD O
are VBP O
missense JJ O
( ( O
G197W NNP O
, , O
W427R NNP O
) ) O
, , O
two CD O
are VBP O
nonsense JJ O
( ( O
Q306X NNP O
, , O
Q385X NNP O
) ) O
, , O
two CD O
are VBP O
small JJ O
deletions NNS O
( ( O
662de14bp CD O
; : O
1168del3bp CD O
removing VBG O
a DT O
glycine NN O
at IN O
position NN O
390 CD O
) ) O
, , O
and CC O
one CD O
is VBZ O
a DT O
splicing VBG O
mutation NN O
( ( O
IVS1 NNP O
- : O
15c CD O
- : O
- : O
> NN O
g NN O
) ) O
which WDT O
creates VBZ O
a DT O
new JJ O
acceptor NN O
splice NN O
site NN O
. . O

The DT O
pathological JJ O
significance NN O
of IN O
the DT O
point NN O
mutations NNS O
G197W NNP O
, , O
W427R NNP O
, , O
and CC O
the DT O
in IN O
- : O
frame NN O
deletion NN O
390delGly CD O
were VBD O
assessed VBN O
by IN O
their PRP$ O
respective JJ O
expression NN O
in IN O
a DT O
prokaryotic JJ O
system NN O
using VBG O
site NN O
- : O
directed JJ O
mutagenesis NN O
. . O

These DT O
mutations NNS O
resulted VBD O
in IN O
the DT O
absence NN O
or CC O
a DT O
dramatic JJ O
decrease NN O
of IN O
CPO NNP O
activity NN O
. . O

The DT O
two CD O
polymorphisms NNS O
were VBD O
localized VBN O
in IN O
noncoding VBG O
part NN O
of IN O
the DT O
gene NN O
1 CD O
) ) O
a DT O
C NNP O
/ NNP O
G NNP O
polymorphism NN O
in IN O
the DT O
promotor NN O
region NN O
, , O
142 CD O
bp NN O
upstream NN O
from IN O
the DT O
transcriptional JJ O
initiation NN O
site NN O
( ( O
- : O
142C CD O
/ NNP O
G NNP O
) ) O
, , O
and CC O
2 CD O
) ) O
a DT O
6 CD O
bp NN O
deletion NN O
polymorphism NN O
in IN O
the DT O
3 CD O
noncoding JJ O
part NN O
of IN O
the DT O
CPO NNP O
gene NN O
, , O
574 CD O
bp NN O
downstream NN O
of IN O
the DT O
last JJ O
base NN O
of IN O
the DT O
normal JJ O
termination NN O
codon NN O
( ( O
+ JJ O
574 CD O
delATTCTT NN O
) ) O
. . O

Five CD O
intragenic JJ O
dimorphisms NNS O
are VBP O
now RB O
well RB O
characterized VBN O
and CC O
the DT O
high JJ O
degree NN O
of IN O
allelic JJ O
heterogeneity NN O
in IN O
HC NNP B-Disease
is VBZ O
demonstrated VBN O
with IN O
seven CD O
new JJ O
different JJ O
mutations NNS O
making VBG O
a DT O
total NN O
of IN O
nineteen JJ O
CPO NNP O
gene NN B-Disease
defects NNS I-Disease
reported VBN O
so RB O
far RB O
. . O
. . O

Coincidence NN O
of IN O
two CD O
novel JJ O
arylsulfatase VBD O
A NNP O
alleles NNS O
and CC O
mutation NN O
459 CD O
+ NN O
1G CD O
> NN O
A NNP O
within IN O
a DT O
family NN O
with IN O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
: : O
molecular JJ O
basis NN O
of IN O
phenotypic NN O
heterogeneity NN O
. . O

In IN O
a DT O
family NN O
with IN O
three CD O
siblings NNS O
, , O
one CD O
developed VBD O
classical JJ O
late RB O
infantile JJ O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
, , O
fatal JJ O
at IN O
age NN O
5 CD O
years NNS O
, , O
with IN O
deficient JJ O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
activity NN O
and CC O
increased VBD O
galactosylsulfatide NN O
( ( O
GS NNP O
) ) O
excretion NN O
. . O

The DT O
two CD O
other JJ O
siblings NNS O
, , O
apparently RB O
healthy JJ O
at IN O
12 CD O
( ( O
1 CD O
/ RB O
2 CD O
) ) O
and CC O
15 CD O
years NNS O
, , O
respectively RB O
, , O
and CC O
their PRP$ O
father NN O
, , O
apparently RB O
healthy JJ O
as RB O
well RB O
, , O
presented VBN O
ARSA NNP O
and CC O
GS NNP O
values NNS O
within IN O
the DT O
range NN O
of IN O
MLD NNP B-Disease
patients NNS O
. . O

Mutation NN O
screening NN O
and CC O
sequence NN O
analysis NN O
disclosed VBD O
the DT O
involvement NN O
of IN O
three CD O
different JJ O
ARSA NNP O
mutations NNS O
being VBG O
the DT O
molecular JJ O
basis NN O
of IN O
intrafamilial JJ O
phenotypic NN O
heterogeneity NN O
. . O

The DT O
late JJ O
infantile NN O
patient NN O
inherited VBN O
from IN O
his PRP$ O
mother NN O
the DT O
frequent NN O
0 CD O
- : O
type NN O
mutation NN O
459 CD O
+ NN O
1G CD O
> NN O
A NNP O
, , O
and CC O
from IN O
his PRP$ O
father NN O
a DT O
novel NN O
, , O
single JJ O
basepair NN O
microdeletion NN O
of IN O
guanine NN O
at IN O
nucleotide JJ O
7 CD O
in IN O
exon NN O
1 CD O
( ( O
7delG CD O
) ) O
. . O

The DT O
two CD O
clinically RB O
unaffected JJ O
siblings NNS O
carried VBD O
the DT O
maternal JJ O
mutation NN O
459 CD O
+ NN O
1G CD O
> NN O
A DT O
and CC O
, , O
on IN O
their PRP$ O
paternal JJ O
allele NN O
, , O
a DT O
novel JJ O
cytosine NN O
to TO O
thymidine VB O
transition NN O
at IN O
nucleotide JJ O
2435 CD O
in IN O
exon JJ O
8 CD O
, , O
resulting VBG O
in IN O
substitution NN O
of IN O
alanine JJ O
464 CD O
by IN O
valine NN O
( ( O
A464V NNP O
) ) O
. . O

The DT O
fathers NNS O
genotype VBP O
thus RB O
was VBD O
7delG CD O
/ JJ O
A464V NNP O
. . O

Mutation NNP O
A464V NNP O
was VBD O
not RB O
found VBN O
in IN O
18 CD O
unrelated JJ O
MLD NNP B-Disease
patients NNS O
and CC O
50 CD O
controls NNS O
. . O

A464V NNP O
, , O
although IN O
clearly RB O
modifying VBG O
ARSA NNP O
and CC O
GS NNP O
levels NNS O
, , O
apparently RB O
bears VBZ O
little JJ O
significance NN O
for IN O
clinical JJ O
manifestation NN O
of IN O
MLD NNP B-Disease
, , O
mimicking VBG O
the DT O
frequent JJ O
ARSA NNP O
pseudodeficiency NN O
allele NN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
in IN O
certain JJ O
genetic JJ O
conditions NNS O
MLD NNP B-Disease
- : O
like IN O
ARSA NNP O
and CC O
GS NNP O
values NNS O
need VBP O
not RB O
be VB O
paralleled VBN O
by IN O
clinical JJ O
disease NN O
, , O
a DT O
finding NN O
with IN O
serious JJ O
diagnostic JJ O
and CC O
prognostic JJ O
implications NNS O
. . O

Moreover RB O
, , O
further JJ O
ARSA NNP O
alleles NNS O
functionally RB O
similar JJ O
to TO O
A464V VB O
might MD O
exist VB O
which WDT O
, , O
together RB O
with IN O
0 CD O
- : O
type NN O
mutations NNS O
, , O
may MD O
cause VB O
pathological JJ O
ARSA NNP O
and CC O
GS NNP O
levels NNS O
, , O
but CC O
not RB O
clinical JJ O
outbreak NN O
of IN O
the DT O
disease NN O
. . O
. . O

Human NNP O
MLH1 NNP O
deficiency NN O
predisposes NNS O
to TO O
hematological JJ B-Disease
malignancy NN I-Disease
and CC O
neurofibromatosis NN B-Disease
type NN I-Disease
1 CD I-Disease
. . O

Heterozygous JJ O
germ SYM O
- : O
line NN O
mutations NNS O
in IN O
the DT O
DNA NNP O
mismatch NN O
repair NN O
genes NNS O
lead VBP O
to TO O
hereditary JJ B-Disease
nonpolyposis NN I-Disease
colorectal JJ I-Disease
cancer NN I-Disease
. . O

The DT O
disease NN O
susceptibility NN O
of IN O
individuals NNS O
who WP O
constitutionally RB O
lack VBP O
both DT O
wild JJ O
- : O
type NN O
alleles NNS O
is VBZ O
unknown JJ O
. . O

We PRP O
have VBP O
identified VBN O
three CD O
offspring VBG O
in IN O
a DT O
hereditary JJ B-Disease
nonpolyposis NN I-Disease
colorectal NN I-Disease
cancer NN I-Disease
family NN O
who WP O
developed VBD O
hematological JJ B-Disease
malignancy NN I-Disease
at IN O
a DT O
very RB O
early JJ O
age NN O
, , O
and CC O
at IN O
least JJS O
two CD O
of IN O
them PRP O
displayed VBD O
signs NNS O
of IN O
neurofibromatosis NN B-Disease
type NN I-Disease
1 CD I-Disease
( ( O
NF1 NNP B-Disease
) ) O
. . O

DNA NN O
sequence NN O
analysis NN O
and CC O
allele VB O
- : O
specific JJ O
amplification NN O
in IN O
two CD O
siblings NNS O
revealed VBD O
a DT O
homozygous JJ O
MLH1 NNP O
mutation NN O
( ( O
C676T NNP O
- : O
- : O
> NN O
Arg226Stop NNP O
) ) O
. . O

Thus RB O
, , O
a DT O
homozygous JJ O
germ NN O
- : O
line NN O
MLH1 NNP O
mutation NN O
and CC O
consequent JJ O
mismatch NN O
repair NN O
deficiency NN O
results NNS O
in IN O
a DT O
mutator NN O
phenotype NN O
characterized VBN O
by IN O
leukemia NN B-Disease
and CC O
/ NN O
or CC O
lymphoma NN B-Disease
associated VBN O
with IN O
neurofibromatosis NN B-Disease
type NN I-Disease
1 CD I-Disease
. . O
. . O

Missense JJ O
mutations NNS O
in IN O
the DT O
most RBS O
ancient JJ O
residues NNS O
of IN O
the DT O
PAX6 NNP O
paired VBD O
domain NN O
underlie IN O
a DT O
spectrum NN O
of IN O
human JJ O
congenital JJ B-Disease
eye NN I-Disease
malformations NNS I-Disease
. . O

Mutations NNS O
of IN O
the DT O
human JJ O
PAX6 NNP O
gene NN O
underlie JJ O
aniridia NN B-Disease
( ( O
congenital JJ B-Disease
absence NN I-Disease
of IN I-Disease
the DT I-Disease
iris NN I-Disease
) ) O
, , O
a DT O
rare JJ O
dominant JJ O
malformation NN B-Disease
of IN I-Disease
the DT I-Disease
eye NN I-Disease
. . O

The DT O
spectrum NN O
of IN O
PAX6 NNP O
mutations NNS O
in IN O
aniridia JJ B-Disease
patients NNS O
is VBZ O
highly RB O
biased VBN O
, , O
with IN O
92 CD O
% NN O
of IN O
all DT O
reported VBN O
mutations NNS O
leading VBG O
to TO O
premature VB O
truncation NN O
of IN O
the DT O
protein NN O
( ( O
nonsense JJ O
, , O
splicing VBG O
, , O
insertions NNS O
and CC O
deletions NNS O
) ) O
and CC O
just RB O
2 CD O
% NN O
leading VBG O
to TO O
substitution NN O
of IN O
one CD O
amino NN O
acid NN O
by IN O
another DT O
( ( O
missense NN O
) ) O
. . O

The DT O
extraordinary JJ O
conservation NN O
of IN O
the DT O
PAX6 NNP O
protein NN O
at IN O
the DT O
amino NN O
acid VBP O
level NN O
amongst NN O
vertebrates VBZ O
predicts NNS O
that WDT O
pathological JJ O
missense NN O
mutations NNS O
should MD O
in IN O
fact NN O
be VB O
common JJ O
even RB O
though IN O
they PRP O
are VBP O
hardly RB O
ever RB O
seen VBN O
in IN O
aniridia JJ B-Disease
patients NNS O
. . O

This DT O
indicates VBZ O
that IN O
there EX O
is VBZ O
a DT O
heavy JJ O
ascertainment NN O
bias NN O
in IN O
the DT O
selection NN O
of IN O
patients NNS O
for IN O
PAX6 NNP O
mutation NN O
analysis NN O
and CC O
that IN O
the DT O
missing VBG O
PAX6 NNP O
missense NN O
mutations NNS O
frequently RB O
may MD O
underlie VB O
phenotypes NNS O
distinct JJ O
from IN O
textbook NN O
aniridia NN B-Disease
. . O

Here RB O
we PRP O
present VBP O
four CD O
novel NN O
PAX6 NNP O
missense NN O
mutations NNS O
, , O
two CD O
in IN O
association NN O
with IN O
atypical JJ O
phenotypes NNS O
ectopia VBP B-Disease
pupillae NN I-Disease
( ( O
displaced VBN B-Disease
pupils NNS I-Disease
) ) O
and CC O
congenital JJ B-Disease
nystagmus NN I-Disease
( ( O
searching VBG B-Disease
gaze NN I-Disease
) ) O
, , O
and CC O
two CD O
in IN O
association NN O
with IN O
more RBR O
recognizable JJ O
aniridia NN B-Disease
phenotypes NNS O
. . O

Strikingly RB O
, , O
all DT O
four CD O
mutations NNS O
are VBP O
located VBN O
within IN O
the DT O
PAX6 NNP O
paired VBD O
domain NN O
and CC O
affect VB O
amino NN O
acids NNS O
which WDT O
are VBP O
highly RB O
conserved VBN O
in IN O
all DT O
known VBN O
paired VBD O
domain NN O
proteins NNS O
. . O

Our PRP$ O
results NNS O
support VB O
the DT O
hypothesis NN O
that IN O
the DT O
under IN O
- : O
representation NN O
of IN O
missense JJ O
mutations NNS O
is VBZ O
caused VBN O
by IN O
ascertainment JJ O
bias NN O
and CC O
suggest VBP O
that IN O
a DT O
substantial JJ O
burden NN O
of IN O
PAX6 NNP B-Disease
- : I-Disease
related JJ I-Disease
disease NN I-Disease
remains VBZ O
to TO O
be VB O
uncovered VBN O
. . O
. . O

The DT O
chromosomal JJ O
order NN O
of IN O
genes NNS O
controlling VBG O
the DT O
major JJ O
histocompatibility NN O
complex NN O
, , O
properdin NN O
factor NN O
B NNP O
, , O
and CC O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
second JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
. . O

The DT O
relationship NN O
of IN O
the DT O
genes NNS O
coding VBG O
for IN O
HLA NNP O
to TO O
those DT O
coding VBG O
for IN O
properdin NN O
Factor NNP O
B NNP O
allotypes NNS O
and CC O
for IN O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
second JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C2 NNP O
) ) O
was VBD O
studied VBN O
in IN O
families NNS O
of IN O
patients NNS O
with IN O
connective JJ O
tissue NN O
disorders NNS O
. . O

Patients NNS O
were VBD O
selected VBN O
because IN O
they PRP O
were VBD O
heterozygous JJ O
or CC O
homozygous JJ O
for IN O
C2 NNP B-Disease
deficiency NN I-Disease
. . O

12 CD O
families NNS O
with IN O
15 CD O
matings NNS O
informative JJ O
for IN O
C2 NNP B-Disease
deficiency NN I-Disease
were VBD O
found VBN O
. . O

Of IN O
57 CD O
informative JJ O
meioses NNS O
, , O
two CD O
crossovers NNS O
were VBD O
noted VBN O
between IN O
the DT O
C2 NNP B-Disease
deficiency NN I-Disease
gene NN O
and CC O
the DT O
HLA NNP O
- : O
B NNP O
gene NN O
, , O
with IN O
a DT O
recombinant JJ O
fraction NN O
of IN O
0 CD O
. . O

35 CD O
. . O

A DT O
lod JJ O
score NN O
of IN O
13 CD O
was VBD O
calculated VBN O
for IN O
linkage NN O
between IN O
C2 NNP B-Disease
deficiency NN I-Disease
and CC O
HLA NNP O
- : O
B NN O
at IN O
a DT O
maximum JJ O
likelihood NN O
value NN O
of IN O
the DT O
recombinant JJ O
fraction NN O
of IN O
0 CD O
. . O

4 CD O
. . O

18 CD O
families NNS O
with IN O
21 CD O
informative JJ O
matings NNS O
for IN O
both DT O
properdin JJ O
Factor NN O
B NNP O
allotype NN O
and CC O
HLA NNP O
- : O
B NN O
were VBD O
found VBN O
. . O

Of IN O
72 CD O
informative JJ O
meioses NNS O
, , O
three CD O
recombinants NNS O
were VBD O
found VBN O
, , O
giving VBG O
a DT O
recombinant JJ O
fraction NN O
of IN O
0 CD O
. . O

42 CD O
. . O

A DT O
lod JJ O
score NN O
of IN O
16 CD O
between IN O
HLA NNP O
- : O
B NN O
and CC O
Factor NNP O
B NNP O
allotypes NNS O
was VBD O
calculated VBN O
at IN O
a DT O
maximum JJ O
likelihood NN O
value NN O
of IN O
the DT O
recombinant JJ O
fraction NN O
of IN O
0 CD O
. . O

4 CD O
. . O

A DT O
crossover NN O
was VBD O
shown VBN O
to TO O
have VB O
occurred VBN O
between IN O
genes NNS O
for IN O
Factor NNP O
B NNP O
and CC O
HLA NNP O
- : O
D NN O
, , O
in IN O
which WDT O
HLA NNP O
- : O
D NN O
segregared VBD O
with IN O
HLA NNP O
- : O
A DT O
and CC O
B NNP O
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
the DT O
genes NNS O
for IN O
Factor NNP O
B NNP O
and CC O
C2 NNP B-Disease
deficiency NN I-Disease
are VBP O
located VBN O
outside IN O
those DT O
for IN O
HLA NNP O
, , O
that IN O
the DT O
order NN O
of IN O
genese NN O
is VBZ O
HLA NNP O
- : O
A NN O
, , O
- : O
B NN O
, , O
- : O
D NN O
, , O
Factor NNP O
B NNP O
allotype NN O
, , O
C2 NNP B-Disease
deficiency NN I-Disease
, , O
that IN O
the DT O
genes NNS O
coding VBG O
for IN O
C2 NNP B-Disease
deficiency NN I-Disease
and CC O
Factor NNP O
B NNP O
allotypes NNS O
are VBP O
approximately RB O
3 CD O
- : O
- : O
5 CD O
centimorgans NNS O
from IN O
the DT O
HLA NNP O
- : O
A DT O
and CC O
HLA NNP O
- : O
B NNP O
loci NN O
, , O
and CC O
that IN O
the DT O
apparent JJ O
lack NN O
of IN O
recombinants NNS O
between IN O
the DT O
Factor NNP O
B NNP O
gene NN O
and CC O
C2 NNP B-Disease
deficiency NN I-Disease
gene NN O
suggests VBZ O
that IN O
these DT O
two CD O
genes NNS O
lie RBR O
in IN O
close JJ O
proximity NN O
to TO O
one CD O
another DT O
. . O

Distribution NN O
of IN O
emerin NN O
and CC O
lamins NNS O
in IN O
the DT O
heart NN O
and CC O
implications NNS O
for IN O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Emerin NNP O
is VBZ O
a DT O
nuclear JJ O
membrane NN O
protein NN O
which WDT O
is VBZ O
missing VBG O
or CC O
defective JJ O
in IN O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EDMD NNP B-Disease
) ) O
. . O

It PRP O
is VBZ O
one CD O
member NN O
of IN O
a DT O
family NN O
of IN O
lamina JJ O
- : O
associated VBN O
proteins NNS O
which WDT O
includes VBZ O
LAP1 NNP O
, , O
LAP2 NNP O
and CC O
lamin NN O
B NNP O
receptor NN O
( ( O
LBR NNP O
) ) O
. . O

A DT O
panel NN O
of IN O
16 CD O
monoclonal JJ O
antibodies NNS O
( ( O
mAbs NN O
) ) O
has VBZ O
been VBN O
mapped VBN O
to TO O
six CD O
specific JJ O
sites NNS O
throughout IN O
the DT O
emerin NN O
molecule NN O
using VBG O
phage NN O
- : O
displayed VBN O
peptide IN O
libraries NNS O
and CC O
has VBZ O
been VBN O
used VBN O
to TO O
localize VB O
emerin NN O
in IN O
human JJ O
and CC O
rabbit JJ O
heart NN O
. . O

Several JJ O
mAbs NNS O
against IN O
different JJ O
emerin JJ O
epitopes NNS O
did VBD O
not RB O
recognize VB O
intercalated JJ O
discs NN O
in IN O
the DT O
heart NN O
, , O
though IN O
they PRP O
recognized VBD O
cardiomyocyte NN O
nuclei NN O
strongly RB O
, , O
both DT O
at IN O
the DT O
rim NN O
and CC O
in IN O
intranuclear JJ O
spots NNS O
or CC O
channels NNS O
. . O

A DT O
polyclonal JJ O
rabbit NN O
antiserum NN O
against IN O
emerin NN O
did VBD O
recognize VB O
both DT O
nuclear JJ O
membrane NN O
and CC O
intercalated JJ O
discs NN O
but CC O
, , O
after IN O
affinity NN O
purification NN O
against IN O
a DT O
pure JJ O
- : O
emerin NN O
band NN O
on IN O
a DT O
western JJ O
blot NN O
, , O
it PRP O
stained VBD O
only RB O
the DT O
nuclear JJ O
membrane NN O
. . O

These DT O
results NNS O
would MD O
not RB O
be VB O
expected VBN O
if IN O
immunostaining NN O
at IN O
intercalated JJ O
discs NN O
were VBD O
due JJ O
to TO O
a DT O
product NN O
of IN O
the DT O
emerin JJ O
gene NN O
and CC O
, , O
therefore RB O
, , O
cast VBD O
some DT O
doubt NN O
upon IN O
the DT O
hypothesis NN O
that WDT O
cardiac JJ B-Disease
defects NNS I-Disease
in IN O
EDMD NNP B-Disease
are VBP O
caused VBN O
by IN O
absence NN O
of IN O
emerin NN O
from IN O
intercalated VBN O
discs NN O
. . O

Although IN O
emerin NN O
was VBD O
abundant JJ O
in IN O
the DT O
membranes NNS O
of IN O
cardiomyocyte NN O
nuclei NN O
, , O
it PRP O
was VBD O
absent JJ O
from IN O
many JJ O
non SYM O
- : O
myocyte NN O
cells NNS O
in IN O
the DT O
heart NN O
. . O

This DT O
distribution NN O
of IN O
emerin NN O
was VBD O
similar JJ O
to TO O
that DT O
of IN O
lamin NN O
A NNP O
, , O
a DT O
candidate NN O
gene NN O
for IN O
an DT O
autosomal JJ O
form NN O
of IN O
EDMD NNP B-Disease
. . O

In IN O
contrast NN O
, , O
lamin FW O
B1 NNP O
was VBD O
absent JJ O
from IN O
cardiomyocyte NN O
nuclei NN O
, , O
showing VBG O
that IN O
lamin JJ O
B1 NNP O
is VBZ O
not RB O
essential JJ O
for IN O
localization NN O
of IN O
emerin NN O
to TO O
the DT O
nuclear JJ O
lamina NN O
. . O

Lamin NNP O
B1 NNP O
is VBZ O
also RB O
almost RB O
completely RB O
absent JJ O
from IN O
skeletal JJ O
muscle NN O
nuclei NN O
. . O

In IN O
EDMD NNP B-Disease
, , O
the DT O
additional JJ O
absence NN O
of IN O
lamin JJ O
B1 NNP O
from IN O
heart NN O
and CC O
skeletal JJ O
muscle NN O
nuclei NN O
which WDT O
already RB O
lack VBP O
emerin NN O
may MD O
offer VB O
an DT O
alternative JJ O
explanation NN O
of IN O
why WRB O
these DT O
tissues NNS O
are VBP O
particularly RB O
affected VBN O
. . O
. . O

Genetic JJ O
mapping NN O
of IN O
the DT O
copper NN B-Disease
toxicosis NN I-Disease
locus NN O
in IN O
Bedlington NNP O
terriers NNS O
to TO O
dog VB O
chromosome NN O
10 CD O
, , O
in IN O
a DT O
region NN O
syntenic NN O
to TO O
human JJ O
chromosome NN O
region NN O
2p13 CD O
- : O
p16 NN O
. . O

Abnormal NNP O
hepatic JJ B-Disease
copper NN I-Disease
accumulation NN I-Disease
is VBZ O
recognized VBN O
as IN O
an DT O
inherited JJ B-Disease
disorder NN I-Disease
in IN O
man NN O
, , O
mouse NN O
, , O
rat NN O
and CC O
dog NN O
. . O

The DT O
major JJ O
cause NN O
of IN O
hepatic JJ B-Disease
copper NN I-Disease
accumulation NN I-Disease
in IN O
man NN O
is VBZ O
a DT O
dysfunctional JJ O
ATP7B NNP O
gene NN O
, , O
causing VBG O
Wilson NNP B-Disease
disease NN I-Disease
( ( O
WD NNP B-Disease
) ) O
. . O

Mutations NNS O
in IN O
the DT O
ATP7B NNP O
genes NNS O
have VBP O
also RB O
been VBN O
demonstrated VBN O
in IN O
mouse NN O
and CC O
rat NN O
. . O

The DT O
ATP7B NNP O
gene NN O
has VBZ O
been VBN O
excluded VBN O
in IN O
the DT O
much JJ O
rarer NN O
human JJ O
copper NN B-Disease
overload NN I-Disease
disease NN O
non SYM B-Disease
- : I-Disease
Indian JJ I-Disease
childhood NN I-Disease
cirrhosis NN I-Disease
, , O
indicating VBG O
genetic JJ O
heterogeneity NN O
. . O

By IN O
investigating VBG O
the DT O
common JJ O
autosomal JJ O
recessive JJ O
copper NN B-Disease
toxicosis NN I-Disease
( ( O
CT NNP B-Disease
) ) O
in IN O
Bedlington NNP O
terriers NNS O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
new JJ O
locus NN O
involved VBN O
in IN O
progressive JJ O
liver NN B-Disease
disease NN I-Disease
. . O

We PRP O
examined VBD O
whether IN O
the DT O
WD NNP B-Disease
gene NN O
ATP7B NNP O
was VBD O
also RB O
causative JJ O
for IN O
CT NNP B-Disease
by IN O
investigating VBG O
the DT O
chromosomal JJ O
co NN O
- : O
localization NN O
of IN O
ATP7B NNP O
and CC O
C04107 NNP O
, , O
using VBG O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
. . O

C04107 NNP O
is VBZ O
an DT O
anonymous JJ O
microsatellite NN O
marker NN O
closely RB O
linked VBN O
to TO O
CT NNP B-Disease
. . O

However RB O
, , O
BAC NNP O
clones VBZ O
containing VBG O
ATP7B NNP O
and CC O
C04107 NNP O
mapped VBD O
to TO O
the DT O
canine NN O
chromosome NN O
regions NNS O
CFA22q11 NNP O
and CC O
CFA10q26 NNP O
, , O
respectively RB O
, , O
demonstrating VBG O
that IN O
WD NNP B-Disease
cannot NN O
be VB O
homologous JJ O
to TO O
CT NNP B-Disease
. . O

The DT O
copper NN O
transport NN O
genes NNS O
CTR1 NNP O
and CC O
CTR2 NNP O
were VBD O
also RB O
excluded VBN O
as IN O
candidate NN O
genes NNS O
for IN O
CT NNP B-Disease
since IN O
they PRP O
both DT O
mapped VBD O
to TO O
canine VB O
chromosome JJ O
region NN O
CFA11q22 NNP O
. . O

2 CD O
- : O
22 CD O
. . O

5 CD O
. . O

A DT O
transcribed JJ O
sequence NN O
identified VBN O
from IN O
the DT O
C04107 NNP O
- : O
containing VBG O
BAC NNP O
was VBD O
found VBN O
to TO O
be VB O
homologous JJ O
to TO O
a DT O
gene NN O
expressed VBN O
from IN O
human JJ O
chromosome NN O
2p13 CD O
- : O
p16 NN O
, , O
a DT O
region NN O
devoid NN O
of IN O
any DT O
positional JJ O
candidate NN O
genes NNS O
. . O

Molecular JJ O
analysis NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
in IN O
205 CD O
families NNS O
: : O
extended VBN O
genotype NN O
- : O
phenotype NN O
correlations NNS O
in IN O
FAP NNP B-Disease
and CC O
evidence NN O
for IN O
the DT O
role NN O
of IN O
APC NNP B-Disease
amino NN O
acid NN O
changes NNS O
in IN O
colorectal JJ B-Disease
cancer NN I-Disease
predisposition NN O
. . O

BACKGROUND NNP O
/ NNP O
AIMS NNP O
The DT O
development NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
and CC O
a DT O
variable JJ O
range NN O
of IN O
extracolonic JJ O
manifestations NNS O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
is VBZ O
the DT O
result NN O
of IN O
the DT O
dominant JJ O
inheritance NN O
of IN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
mutations NNS O
. . O

In IN O
this DT O
study NN O
, , O
direct JJ O
mutation NN O
analysis NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
was VBD O
performed VBN O
to TO O
determine VB O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
for IN O
nine CD O
extracolonic JJ O
manifestations NNS O
and CC O
to TO O
investigate VB O
the DT O
incidence NN O
of IN O
APC NNP B-Disease
mutations NNS O
in IN O
non JJ O
- : O
FAP NNP O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

METHODS NNP O
The DT O
APC NNP B-Disease
gene NN O
was VBD O
analysed VBN O
in IN O
190 CD O
unrelated JJ O
FAP NNP B-Disease
and CC O
15 CD O
non JJ O
- : O
FAP NNP O
colorectal JJ B-Disease
cancer NN I-Disease
patients NNS O
using VBG O
denaturing VBG O
gradient JJ O
gel NN O
electrophoresis NN O
, , O
the DT O
protein NN O
truncation NN O
test NN O
, , O
and CC O
direct JJ O
sequencing NN O
. . O

RESULTS NNP O
Chain NNP O
terminating VBG O
signals NNS O
were VBD O
only RB O
identified VBN O
in IN O
patients NNS O
belonging VBG O
to TO O
the DT O
FAP NNP B-Disease
group NN O
( ( O
105 CD O
patients NNS O
) ) O
. . O

Amino NNP O
acid NN O
changes NNS O
were VBD O
identified VBN O
in IN O
four CD O
patients NNS O
, , O
three CD O
of IN O
whom WP O
belonged VBD O
to TO O
the DT O
non JJ O
- : O
FAP NNP O
group NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
patients NNS O
. . O

Genotype NNP O
- : O
phenotype NN O
correlations NNS O
identified VBN O
significant JJ O
differences NNS O
in IN O
the DT O
nature NN O
of IN O
certain JJ O
extracolonic JJ O
manifestations NNS O
in IN O
FAP NNP B-Disease
patients NNS O
belonging VBG O
to TO O
three CD O
mutation NN O
subgroups NNS O
. . O

CONCLUSIONS NNP O
Extended NNP O
genotype NN O
- : O
phenotype NN O
correlations NNS O
made VBN O
in IN O
this DT O
study NN O
may MD O
have VB O
the DT O
potential NN O
to TO O
determine VB O
the DT O
most RBS O
appropriate JJ O
surveillance NN O
and CC O
prophylactic JJ O
treatment NN O
regimens NNS O
for IN O
those DT O
patients NNS O
with IN O
mutations NNS O
associated VBN O
with IN O
life NN O
threatening VBG O
conditions NNS O
. . O

This DT O
study NN O
also RB O
provided VBD O
evidence NN O
for IN O
the DT O
pathological JJ O
nature NN O
of IN O
amino NN O
acid NN O
changes NNS O
in IN O
APC NNP O
associated VBN O
with IN O
both DT O
FAP NNP B-Disease
and CC O
non SYM O
- : O
FAP NNP O
colorectal JJ B-Disease
cancer NN I-Disease
patients NNS O
. . O
. . O

Inherited VBN B-Disease
colorectal JJ I-Disease
polyposis NN I-Disease
and CC O
cancer NN B-Disease
risk NN O
of IN O
the DT O
APC NNP O
I1307K NNP O
polymorphism NN O
. . O

Germ NNP O
- : O
line NN O
and CC O
somatic JJ O
truncating NN O
mutations NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
are VBP O
thought VBN O
to TO O
initiate VB O
colorectal JJ B-Disease
tumor NN I-Disease
formation NN O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
syndrome NN I-Disease
and CC O
sporadic JJ O
colorectal JJ O
carcinogenesis NN O
, , O
respectively RB O
. . O

Recently RB O
, , O
an DT O
isoleucine NN O
- : O
- : O
> NN O
lysine JJ O
polymorphism NN O
at IN O
codon NN O
1307 CD O
( ( O
I1307K NNP O
) ) O
of IN O
the DT O
APC NNP B-Disease
gene NN O
has VBZ O
been VBN O
identified VBN O
in IN O
6 CD O
% NN O
- : O
7 CD O
% NN O
of IN O
the DT O
Ashkenazi NNP O
Jewish NNP O
population NN O
. . O

To TO O
assess VB O
the DT O
risk NN O
of IN O
this DT O
common JJ O
APC NNP B-Disease
allelic JJ O
variant NN O
in IN O
colorectal JJ O
carcinogenesis NN O
, , O
we PRP O
have VBP O
analyzed VBN O
a DT O
large JJ O
cohort NN O
of IN O
unselected JJ O
Ashkenazi NNP O
Jewish NNP O
subjects NNS O
with IN O
adenomatous JJ B-Disease
polyps NNS I-Disease
and CC O
. . O
or CC O
colorectal JJ B-Disease
cancer NN I-Disease
, , I-Disease
for IN O
the DT O
APC NNP O
I1307K NNP O
polymorphism NN O
. . O

The DT O
APC NNP O
I1307K NNP O
allele NN O
was VBD O
identified VBN O
in IN O
48 CD O
( ( O
10 CD O
. . O
1 CD O
% NN O
) ) O
of IN O
476 CD O
patients NNS O
. . O

Compared VBN O
with IN O
the DT O
frequency NN O
in IN O
two CD O
separate JJ O
population NN O
control NN O
groups NNS O
, , O
the DT O
APC NNP O
I1307K NNP O
allele NN O
is VBZ O
associated VBN O
with IN O
an DT O
estimated VBN O
relative JJ O
risk NN O
of IN O
1 CD O
. . O

5 CD O
- : O
1 CD O
. . O

7 CD O
for IN O
colorectal JJ B-Disease
neoplasia NN I-Disease
( ( O
both DT O
P NNP O
= NNP O
. . O
1 CD O
) ) O
. . O

Furthermore RB O
, , O
compared VBN O
with IN O
noncarriers NNS O
, , O
APC NNP O
I1307K NNP O
carriers NNS O
had VBD O
increased VBN O
numbers NNS O
of IN O
adenomas NN B-Disease
and CC O
colorectal JJ B-Disease
cancers NNS I-Disease
per IN O
patient NN O
( ( O
P NNP O
= NNP O
. . O
3 CD O
) ) O
, , O
as RB O
well RB O
as IN O
a DT O
younger JJR O
age NN O
at IN O
diagnosis NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
APC NNP O
I1307K NNP O
variant JJ O
leads VBZ O
to TO O
increased VBN O
adenoma NN B-Disease
formation NN O
and CC O
directly RB O
contributes VBZ O
to TO O
3 CD O
% NN O
- : O
4 CD O
% NN O
of IN O
all DT O
Ashkenazi NNP O
Jewish NNP O
colorectal NN B-Disease
cancer NN I-Disease
. . O

The DT O
estimated VBN O
relative NN O
risk NN O
for IN O
carriers NNS O
may MD O
justify VB O
specific JJ O
clinical JJ O
screening NN O
for IN O
the DT O
360 CD O
, , O
0 CD O
Americans NNPS O
expected VBN O
to TO O
harbor VB O
this DT O
allele NN O
, , O
and CC O
genetic JJ O
testing NN O
in IN O
the DT O
setting NN O
of IN O
long JJ O
- : O
term NN O
- : O
outcome NN O
studies NNS O
may MD O
impact VB O
significantly RB O
on IN O
colorectal JJ B-Disease
cancer NN I-Disease
prevention NN O
in IN O
this DT O
population NN O
. . O

Localization NN O
of IN O
human JJ O
BRCA1 NNP O
and CC O
its PRP$ O
loss NN O
in IN O
high JJ O
- : O
grade NN O
, , O
non SYM B-Disease
- : I-Disease
inherited VBN I-Disease
breast NN I-Disease
carcinomas NN I-Disease
. . O

Although IN O
the DT O
link NN O
between IN O
the DT O
BRCA1 NNP O
tumour SYM B-Disease
- : O
suppressor NN O
gene NN O
and CC O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
is VBZ O
established VBN O
, , O
the DT O
role NN O
, , O
if IN O
any DT O
, , O
of IN O
BRCA1 NNP O
in IN O
non JJ B-Disease
- : I-Disease
familial JJ I-Disease
cancers NNS I-Disease
is VBZ O
unclear JJ O
. . O

BRCA1 NNP O
mutations NNS O
are VBP O
rare JJ O
in IN O
sporadic JJ B-Disease
cancers NNS I-Disease
, , O
but CC O
loss NN O
of IN O
BRCA1 NNP O
resulting VBG O
from IN O
reduced VBN O
expression NN O
or CC O
incorrect VB O
subcellular JJ O
localization NN O
is VBZ O
postulated VBN O
to TO O
be VB O
important JJ O
in IN O
non JJ B-Disease
- : I-Disease
familial JJ I-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

Epigenetic JJ O
loss NN O
, , O
however RB O
, , O
has VBZ O
not RB O
received VBN O
general JJ O
acceptance NN O
due JJ O
to TO O
controversy VB O
regarding VBG O
the DT O
subcellular JJ O
localization NN O
of IN O
BRCA1 NNP O
proteins NNS O
, , O
reports NNS O
of IN O
which WDT O
have VBP O
ranged VBN O
from IN O
exclusively RB O
nuclear JJ O
, , O
to TO O
conditionally RB O
nuclear JJ O
, , O
to TO O
the DT O
ER NNP O
/ NNP O
golgi NN O
, , O
to TO O
cytoplasmic VB O
invaginations NNS O
into IN O
the DT O
nucleus NN O
. . O

In IN O
an DT O
attempt NN O
to TO O
resolve VB O
this DT O
issue NN O
, , O
we PRP O
have VBP O
comprehensively RB O
characterized VBN O
19 CD O
anti JJ O
- : O
BRCA1 NNP O
antibodies NNS O
. . O

These DT O
reagents NNS O
detect VBP O
a DT O
220 CD O
- : O
kD NN O
protein NN O
localized VBN O
in IN O
discrete JJ O
nuclear JJ O
foci NN O
in IN O
all DT O
epithelial JJ O
cell NN O
lines NNS O
, , O
including VBG O
those DT O
derived VBN O
from IN O
breast NN B-Disease
malignancies NNS I-Disease
. . O

Immunohistochemical JJ O
staining NN O
of IN O
human JJ O
breast NN O
specimens NNS O
also RB O
revealed VBD O
BRCA1 NNP O
nuclear JJ O
foci NN O
in IN O
benign JJ O
breast NN O
, , O
invasive JJ B-Disease
lobular NN I-Disease
cancers NNS I-Disease
and CC O
low JJ B-Disease
- : I-Disease
grade NN I-Disease
ductal JJ I-Disease
carcinomas NN I-Disease
. . O

Conversely RB O
, , O
BRCA1 NNP O
expression NN O
was VBD O
reduced VBN O
or CC O
undetectable JJ O
in IN O
the DT O
majority NN O
of IN O
high JJ O
- : O
grade NN O
, , O
ductal JJ B-Disease
carcinomas NN I-Disease
, , O
suggesting VBG O
that IN O
absence NN O
of IN O
BRCA1 NNP O
may MD O
contribute VB O
to TO O
the DT O
pathogenesis NN O
of IN O
a DT O
significant JJ O
percentage NN O
of IN O
sporadic JJ B-Disease
breast NN I-Disease
cancers NNS I-Disease
. . O
. . O
